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ABSTRACT 
 
 Over the course of evolution, pathogens have adapted and co-evolved 
with their respective hosts, with infectious diseases being one of the leading 
health concerns. Pathogens have developed several strategies to colonize the 
host, of which only a few have been characterized in molecular details. Utilizing 
host uptake and trafficking system, pathogenic effector proteins, called toxins, 
have exploited existing pathways as a mean to access intracellular targets and 
modulate host cellular functions. Among known targets in the human host, 
nucleus has been an infrequent, covert, and a coveted target, and very few 
external factors have been known to reach nucleus. Cytolethal Distending Toxin 
(CDT), the first known bacterial toxin to reach the mammalian-cell nucleus, 
presents an excellent model to study the retrograde trafficking of cargo to the 
nucleus. CDTs comprise a family of intracellular acting bacterial toxins whose 
actions upon eukaryotic cells cause DNA-damage, resulting in the induction of 
DNA-damage repair response, thus leading to the modulation of host cell 
functions. Most CDTs are hetero-tripartite assemblies of CdtA, CdtB, and CdtC, 
with CdtB required for CDT-mediated cell cycle arrest, and CdtA and CdtC 
required to deliver the catalytically active moiety inside the cell. Although all 
CDTs are generally considered to function as genotoxins, the extent of similarity 
and differences within the members of the CDT-family in their cellular intoxication 
properties, and the molecular components of host cellular machinery that plays a 
role in CDT-mediated intoxication, are poorly understood.  
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 In this dissertation I have identified the host factors that play an important 
role in the trafficking of CDTs to the nucleus. I have also characterized the 
similarities and divergence in the retrograde trafficking pathway utilized by 
different members of the CDT family, including the CDT produced by 
Aggregatibacter actinomycetemcomitans, Campylobacter jejuni Escherichia coli, 
and Haemophilus ducreyi. I have addressed the events spanning from cell-
surface binding, to the trafficking of CDT through the subcellular compartments of 
the host cell, as a prerequisite for toxin to reach nucleus to exert its cytotoxic 
effects.  
 My findings have enhanced the understanding of CDT intoxication 
mechanism and its potential role in the virulence properties of CDT-producing 
pathogens. Moreover, my studies will also aid in the design of novel tools to 
target specific subcellular compartments and host cell functions. For future 
studies, it will be interesting to test the premise that the functional differences 
between CDTs reflect the diversity of host cells, and tissues, that comprise the 
infection microenvironments targeted by CDT-producing pathogenic bacteria. 
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CHAPTER 1: INTRODUCTION 
 
1.1. Host-Pathogen Interactions 
Be it quorum sensing, symbioses, or pathogenesis, interactions between 
biological systems involves interplay of genetic and environmental factors, 
leading to outcomes that decide the fate of their relationship (Casadevall & 
Pirofski, 2000). Pathogens adapt their behavior and genetic expression 
depending on surrounding environment, and express factors that allow their 
optimal survival (Young, Hussell, & Dougan, 2002). Once inside the hostile 
environment of a host, pathogens deploy strategies not only to evade host-
defense barriers, but also to survive, and modulate host cell functions to 
establish a successful infection (Lara-Tejero & Galan, 2002; Oswald, 
Nougayrede, Taieb, & Sugai, 2005). A common way utilized by pathogens for the 
host cell modulation, is through the expression of virulence factors, called toxins, 
which may act in the vicinity where they are released to modulate the site where 
they are present, or diffuse away to find distant targets for a more generalized 
effect on the host. Virulence factors ultimately create conditions favorable for 
pathogen survival, and or colonizing of the host. Understanding interactions of 
virulence factors with host cells not only address the host-pathogen relationship, 
but it also sheds light on the physiology of the host cell, sometimes learning 
about the role of biomolecules with previously unknown function (Sandvig et al., 
1992; Sandvig & van Deurs, 2005). For instance, our understanding of cell 
biology, in recent past, has been significantly aided by studying host-pathogen 
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interactions as tools to identify new host factors, or discover new functions 
(Johannes & Popoff, 2008). These discoveries have a potential impact on several 
fields, including but not restricted to, understanding basic cell biology, molecular 
pathogenesis, developing therapies, and designing novel bioengineering tools 
(Baillie, 2009; Chaddock, 2013).  
 
1.2. Cytolethal Distending Toxin (CDT) 
Pathogenic bacteria have acquired attributes that promote adaptation to 
the specific and often diverse environments encountered within the host. 
Successful pathogens often actively alter, or remodel, host cells and tissues in 
order to create a more suitable niche for colonization, often through the direct 
action of bacterial protein toxins and effectors (Blanke, 2006). A novel class of 
bacterial toxins that interfere with the eukaryotic cell cycle, are called 
cyclomodulins, which includes virulence factors that either stimulate, or inhibit the 
cell cycle, creating conditions favorable for pathogen survival, and colonization of 
the host (Nougayrede, Taieb, De Rycke, & Oswald, 2005). The first bacterial 
toxins known to act in the nucleus of the target cell are Cytolethal Distending 
Toxins (CDTs), which block the host cell cycle at the transition between the G2 
and M phases by producing direct DNA lesions (Lara-Tejero & Galan, 2000; 
Whitehouse et al., 1998), acting as inhibitory cyclomodulins. DNA damage 
produced by CDTs is enough to activate cell cycle checkpoints, triggering cell 
cycle arrest, and activation of pathways associated with DNA-damage, which 
potentially allow CDT producing pathogens to modulate the host cell environment 
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for successful colonization (Comayras et al., 1997; Cortes-Bratti, Karlsson, 
Lagergard, Thelestam, & Frisan, 2001; Escalas et al., 2000; Sert et al., 1999). 
CDTs were discovered approximately 25 years ago as heat labile factors 
within culture filtrates of enterotoxigenic Escherichia coli (Johnson & Lior, 1988b) 
and Campylobacter spp. (Johnson & Lior, 1988a) that induced remarkable 
distention of mammalian cells. Since their initial discovery, CDTs have been 
associated with over two dozen Gram-negative pathogenic bacteria (Figure 1.1), 
which occupy a diverse array of host niches, including the urogenital tract, 
gastrointestinal tract, and the oral cavity (Guerra, Cortes-Bratti, Guidi, & Frisan, 
2011) mostly from the gamma- and epsilon-proteobacter families (Gargi, Reno, & 
Blanke, 2012) (Figure 1.2). Important Gram-negative pathogens that produce 
CDT include Aggregatobacter actinomycetemcomitans (Aa-CDT), 
Campylobacter jejuni (Cj-CDT), Escherichia coli (Ec-CDT), Haemophilus ducreyi 
(Hd-CDT), Helicobacter hepaticus (Hh-CDT), and Shigella dysenteria (Sd-CDT) 
(Gargi et al., 2012) (Figure 1.2). 
 
1.2.1. CDT in bacterial pathogenesis  
The importance of CDT in the pathogenicity of the Gram-negative 
pathogen comes from several clinical and human epidemiological studies, where 
the presence of genes for CDT have been linked with aggressive infections 
(Guerra, Guidi, & Frisan, 2011; Wising et al., 2005). While CDT from A. 
actinomycetemcomitans is associated with aggressive periodontitis (Tan, Song, 
& Ong, 2002), the toxin is thought to confer cytotoxicity to chancroid-causing H. 
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ducreyi isolates (Cope et al., 1997). Hd-CDT induced neutralizing antibodies 
when injected in rabbits, and caused dose-dependent pathologic skin reactions in 
both naive and immune rabbits, characterized by increased inflammatory 
responsiveness after each immunization (Wising et al., 2002). The presence of 
CDT genes was also found to be significantly associated with E. coli induced 
hemolytic uremic syndrome, characterized by haemolysis and renal failure 
(Bielaszewska et al., 2004). Furthermore, most C. jejuni isolates from Danish 
broiler chickens had CDT activity on Vero cells (Bang et al., 2001). Furthermore, 
CDTs have been demonstrated to possess immunomodulatory properties, as it is 
involved not only in the inhibition of mitogen-induced proliferation of T-cells and 
B-cells (Svensson, Tarkowski, Thelestam, & Lagergard, 2001), but also in the 
apoptosis of B- and T-cells (J. L. Smith & Bayles, 2006). These findings strongly 
suggest that CDT is an important virulence factor that contributes towards the 
pathogenesis of the source bacteria. 
 
1.2.2. CDT expression and secretion  
The cdt genes are expressed from a polycistronic operon and are well 
conserved among the toxin producing species (Akifusa, Poole, Lewthwaite, 
Henderson, & Nair, 2001; Mao & DiRienzo, 2002; Saiki, Konishi, Gomi, 
Nishihara, & Yoshikawa, 2001). In nearly all CDT-producing bacteria, CdtA, CdtB 
and CdtC subunits are encoded by slightly overlapping cdtA, cdtB and cdtC 
genes which together form a constitutively expressed operon on the 
chromosome (Figure 1.1). Amongst CDT producing bacteria, E. coli is unique as 
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this single species has at least five divergent variants of CdtB, which are also 
differentially segregated per E. coli pathotypes (Janka et al., 2003). Information 
concerning the molecular mechanism of bacterial synthesis and secretion of CDT 
is limited (Deng, Latimer, Lewis, & Hansen, 2001; Ueno et al., 2006), but it’s 
thought that processed toxin subunits assemble in the periplasm of the 
bacterium. Valuable insights into the mechanism by which CDT holotoxin might 
be synthesized and assembled in the bacterium came from a study by Ueno and 
co-workers (Ueno et al., 2006). Each of the three subunits were translated with 
an N-terminal leader sequence that allows the proteins to cross the cytoplasmic 
membrane of the bacterium. Ueno hypothesized that CdtB and CdtC precursors 
are transported across the membrane via a sec-dependent pathway coordinated 
with cleavage of the leader sequences by signal peptidase I. This results in 
accumulation of the mature proteins in the periplasmic space. Precursor CdtA 
protein is processed by signal peptidase II and modified with a glycerolipid. The 
modified hydrophobic CdtA is inserted into the periplasmic space side of the 
outer membrane, via a lipid-binding consensus sequence (lipobox), where it 
forms a complex with the mature forms of CdtB and CdtC. The precursor 
holotoxin is further processed by an unidentified protease, that removes the N-
terminus along with the glycerolipid. This cleavage step allows the now 
hydrophilic holotoxin to exit the bacterium. The cleavage of CdtA is supported by 
another study conducted on H. ducreyi, in which both 23- and 17-kDa CdtA 
peptides were found in H. ducreyi extracts. Similar results were reported for the 
Aa-Cdt (Frisk et al., 2001; Shenker et al., 2004).  
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1.2.3. Structure and activity of CDT holotoxin and subunits 
CDT holotoxin is a heterotrimeric complex comprised of three proteins: 
CdtA, CdtB and CdtC, with corresponding molecular masses ranging between 
23–30, 28–29 and 19–21 kDa, respectively, depending on the bacterial host 
species (Haghjoo & Galan, 2004; Hu, Nesic, & Stebbins, 2006) (Figure 1.4). The 
crystal structure of CDT from H. ducreyi (Hd-CDT) and A. 
actinomycetemcomitans (Aa-CDT) revealed that three subunits interact 
extensively with each other to make a stable tripartite complex (Nesic, Hsu, & 
Stebbins, 2004; Yamada, Komoto, Saiki, Konishi, & Takusagawa, 2006), and all 
three subunits are required to confer full activity to the holotoxin (Cao, Volgina, 
Huang, Korostoff, & DiRienzo, 2005; Lara-Tejero & Galan, 2001; Nesic et al., 
2004; Nesic & Stebbins, 2005; Saiki, Gomi, & Konishi, 2004; Saiki et al., 2001; 
Shenker et al., 2004; Wising et al., 2002).  
Similar to several other intracellular acting bacterial protein toxins, CDT is 
believed to possess a two-component A-B toxin’s functional architecture. While 
B-component facilitates toxin binding and uptake into sensitive host cells, A-
component, carrying the catalytic activity of the toxin, acts upon specific 
intracellular targets in a manner that will alter normal cellular function. Sharing 
structural homology with the B-chain repeats of the plant toxin ricin, CdtA and 
CdtC together are believed to comprise the B-component of CDT (Hu & 
Stebbins, 2006; Lara-Tejero & Galan, 2001; Nesic & Stebbins, 2005). Both these 
subunits present non-globular amino acid extensions at the amino- and carboxyl-
termini, which interact with each other and with the CdtB subunit.  
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An interesting exception to the CdtA/CdtB/CdtC tripartite structure 
characteristic of the CDT superfamily was discovered within S. enterica, serovar 
Typhi CDT (St-CDT) (Haghjoo & Galan, 2004), for which the gene encoding CdtB 
is not associated with genes resembling cdtA or cdtC. Instead, the cellular 
modulatory activity of St-CDT is dependent upon expression of two genes, pltB 
(pertussis-like toxin B) and pltA (pertussis-like toxin A) (Figure 1.1), which 
encode proteins resembling the B components of pertussis toxin, an unrelated 
AB5-intracellular acting toxin. The reconstituted CdtB/PltA/PltB tripartite complex 
was demonstrated to induce DNA damage within intoxicated eukaryotic cells 
(Spano, Ugalde, & Galan, 2008). Infection studies revealed that bacterial uptake 
into host cells triggers expression of cdtB/pltA/pltB, and that the PltB and PltA 
subunits are required for transport of intracellular St-CDT to the extracellular 
medium, where St-CDT then acts upon uninfected host cells in a paracrine 
manner (Spano et al., 2008). Such a mechanism has not been previously 
described for any AB-toxin, and suggests an expanded role beyond the canonical 
functions normally associated with the B components of intracellular-acting 
toxins. 
The CdtB subunit is the most conserved component of the holotoxin 
amongst all the CDT-producing bacteria (Hu et al., 2006). Adopting the canonical 
four-layered fold of the DNase I family, CdtB comprises the catalytically active A-
component of the holotoxin (Nesic et al., 2004). CDT was first demonstrated as a 
genotoxin when homology between the CdtB subunit from Ec-CDT, and Cj-CDT, 
was identified with the mammalian DNase I (Elwell & Dreyfus, 2000; Lara-Tejero 
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& Galan, 2000) (Figure 1.5). The crystal structure confirms previous data, 
demonstrating that CdtB shares five conserved residues with the active site of 
the mammalian DNase I, and possesses DNase-I like activity in vitro or when 
introduced in the mammalian cells by microinjection, or ectopic expression 
(McSweeney & Dreyfus, 2004). CdtB was shown to completely degrade an in 
vitro DNA plasmid substrate, and ectopic expression of CdtB was shown to 
induce nuclear fragmentation and a marked chromatin disruption in HeLa cells . 
Mutations of the conserved residues required for catalysis or for Mg2+ binding 
abolished the ability of CdtB to cleave DNA in vitro or to induce DNA damage 
responses in vivo (Elwell & Dreyfus, 2000; Guerra et al., 2005; Lara-Tejero & 
Galan, 2000).  
 
1.2.4. Cell surface binding  
While the cell surface binding of CDTs is still not fully characterized, 
several groups have made attempts at mapping the residues on CDTs important 
for host cell binding, and also studying the chemical nature of CDT-receptor. So 
far, conflicting views have emerged on the chemical nature of putative CDT-
receptor, which might be dependent on the cell line and species-specific CDT 
used in the study. In one study, Cao and co-workers used a modified enzyme-
linked immunosorbent assay (ELISA), with thyroglobulin-coated plastic plates to 
study the binding kinetics of wild-type and mutated Aa-CdtA and Aa-CdtC 
subunits (Cao et al., 2005). In this study, Aa-CdtA alone was able to bind 
specifically to thyroglobulin with saturation kinetics. In contrast, Aa-CdtC 
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demonstrated much lower ligand to receptor binding ratio. However, a study by 
our collaborators was not able to confirm role of N-linked glycans and glycolipids 
in the toxin binding (Eshraghi et al., 2010). Another study reported that binding of 
Ec-CdtA and CdtC to HeLa cells was blocked with N-linked fucose-containing 
glycoproteins, suggesting fucose might be an important part of receptor at least 
for Ec-CDT (McSweeney & Dreyfus, 2005). Recent reports have suggested the 
biochemical nature of the putative CDT receptor, with plasma membrane 
cholesterol, cell surface glycoproteins, and glycosphingolipids playing a major 
role in aiding cell surface binding of different CDTs (Eshraghi et al., 2010; Lin et 
al., 2011). While testing the ability of cholesterol supplementation to increase 
host cell sensitivity, it was found that increasing plasma cholesterol resulted in 
increased sensitivity to some CDTs, but not to Cj-CDT (Eshraghi et al., 2010), 
which suggested that cholesterol might be an important component for binding of 
most CDTs, but Cj-CDT. Contrarily, another group later showed that cholesterol 
depletion results in resistance to Cj-CDT (Lin et al., 2011). These results, and 
further studies that identified a cholesterol recognition amino acid consensus 
(CRAC) sequence in Aa-CdtC and a non-traditional CRAC sequence in CdtC 
from Haemophilus parasuis suggests that cholesterol may play a role in the 
binding of most, if not all, CDTs to the host cell surface (Boesze-Battaglia et al., 
2009; Zhou, Zhang, Zhao, & Jin, 2012). A genetic screen revealed a putative G 
protein–coupled receptor, TMEM181, contributes to cellular binding and 
sensitivity to Ec-CDT (Carette et al., 2009), thus proposing TMEM181 as the 
potential CDT-receptor. Later studies questioned the presence of TMEM181 on 
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the cell surface, refuting its claim as a toxin-receptor. Further studies will be 
required to fully characterize the CDT-receptor, but so far we do know that the 
receptor is rich in cholesterol and might involve the lipid rafts. 
In contrast to the studies involving CDT-receptor, studies that have 
characterized the importance of molecular determinants on CDTs, are much less 
conflicting. So far there is a general consensus that CdtA plays a major role as 
the B-moiety of the holotoxin, while CdtC playing a relatively minor or supportive 
role (Cao et al., 2005; Gargi et al., 2012). A large aromatic cluster of eight bulky 
side-chains in CdtA is conserved throughout CDT family, and is believed to be 
important for the toxin engagement with the host cell surface (Cao, Bandelac, 
Volgina, Korostoff, & DiRienzo, 2008; Nesic et al., 2004; Yamada et al., 2006). 
Mutations of the aromatic patch of Hd-CdtA do not change the stability of the 
ternary complex, but completely abolished the ability of the toxin to cause cell 
cycle arrest in HeLa cells, suggesting that it plays an indispensible role in toxin 
binding to its receptor (Nesic et al., 2004). Binding studies employing the 
thyroglobulin assay to examine the effect of single amino acid substitutions in 
CdtA supported the idea that surface-exposed heterocyclic amino acids in the 
aromatic patch region of CdtA might be essential for holotoxin binding to the cell 
surface (Cao et al., 2008). Another study later identified a tryptophan residue 
(W115) outside of the aromatic patch that is required for receptor binding, 
suggesting the binding domain on CdtA may not be restricted to just one 
aromatic patch (Li et al., 2013). Other aromatic and heterocyclic residues present 
on the surface of CDT are yet to be mapped and defined.  
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Another peculiar topological feature of CDT is a deep groove formed by 
the juxtaposition of CdtA and CdtC subunits, which is also thought to be required 
for binding to host cell receptor (Hu & Stebbins, 2006; Nesic et al., 2004). CDT 
contains putative cholesterol recognition/interaction amino acid consensus 
(CRAC) domain, which aids in the binding of CdtA/CdtC to cholesterol, a major 
component in lipid rafts, on mammalian cells (Boesze-Battaglia et al., 2009; Lai 
et al., 2013; Zhou et al., 2012) (Figure 1.3). Mutation in CRAC domain of CdtC 
resulted in decreased cell binding (Boesze-Battaglia et al., 2009; Lai et al., 2013), 
leading to reduced capacity for intracellular transfer of the active toxin subunit, 
CdtB (Boesze-Battaglia et al., 2009), and decreased cell toxicity (Boesze-
Battaglia et al., 2009; Zhou et al., 2012).  
 
1.2.5. CDT and cell cycle arrest 
The CDT-induced cell cycle arrest resembles the checkpoint response to 
ionizing radiation (IR), characterized by activation of the ATM kinase and ATM-
dependent induction of the tumor suppressor p53 and its transcriptional target, 
the cyclin-dependent kinase inhibitor p21, phosphorylation of histone H2AX, and 
re-localization of the DNA repair proteins, such as MRE11 and RAD50, to the 
sites of DNA double-strand breaks (Hassane, Lee, & Pickett, 2003; Sato et al., 
2002; Yamamoto et al., 2004). Direct demonstration of CDT-induced DNA 
fragmentation was shown using pulsed field gel electrophoresis (PFGE) analysis 
both in mammalian cells intoxicated with Hd-CDT, and in budding yeast carrying 
a conditional Cj-CdtB expressing plasmid (Frisan, Cortes-Bratti, Chaves-Olarte, 
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Stenerlow, & Thelestam, 2003; Hassane, Lee, Mendenhall, & Pickett, 2001). 
Prolonged exposure to DNA damage chronically activates the DNA damage 
response machinery, including the ATM-Chk2-p53 axis, resulting in either cell 
death or a long-term cell cycle arrest state known as cellular senescence (J. 
Smith, Tho, Xu, & Gillespie, 2010), potentially giving an advantage to pathogens 
to establish successful infection, especially in the conditions where the fast 
turnover rate of cells might present a barrier for pathogens (Abuoun et al., 2005; 
Biswas et al., 2006). 
Cell cycle arrest induced by CDTs leads to downstream events like 
apoptosis, or if the exposure is sub-lethal and prolonged, to genomic 
destabilization of the affected host cells (Bezine, Vignard, & Mirey, 2014; Gargi et 
al., 2012; Guerra, Guidi, et al., 2011). Because the DNA content of a cell is easy 
to quantify, cell cycle arrest has been widely used as a standard measure of the 
toxin activity. In this study, we have extensively used the quantification of cellular 
DNA to evaluate the sensitivity of mammalian cells against CDTs, and also to 
compare the biological activity of CDTs produced by different Gram-negative 
pathogens, or the point mutations to study the structural and functional 
implications on the toxin activity (Gargi et al., 2013; Lara-Tejero & Galan, 2001; 
Nesic et al., 2004; Peres et al., 1997; Whitehouse et al., 1998). To measure the 
cell cycle progression in intoxicated cells, we determined CCAD50 (i.e. cell cycle 
arrest dose50) values, which we defined as the toxin concentrations required to 
induce G2/M arrest in 50% of the cell population not already in G2/M (Gargi et al., 
2013).  
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1.2.6. CDT as a phosphatase 
There is not universal agreement that the cellular effects associated with 
CDT intoxication are due to the DNA degrading activity of the CdtB subunit. 
Indeed, sequence homology of CdtBs with members of a broad metalloenzyme 
superfamily led to the proposal that CdtB induces cell cycle arrest as a 
phosphatase rather than a DNase (Dlakic, 2001). Support for this hypothesis 
emerged from studies reporting that in vitro, Aa-CdtB demonstrates 
phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase activity (Shenker et 
al., 2007). Mutant proteins with altered residues known to be important for 
phosphatase activity ablated the in vitro activity of Aa-CdtB, as well as the 
capacity of Aa-CDT to induce G2/M arrest in human lymphocytes. The fact that 
CdtB is a member of the large metalloenzyme superfamily led to the proposal 
that the toxin acted upon susceptible cells or cell lines by dephosphorylation of 
the Wee1 kinase or Cdc25 phosphatase (Dlakic, 2001). These two enzymes are 
important for regulating the phosphorylation of tyrosine residues in Cdc2 kinase. 
An increase in Cdc2 phosphorylation leads to cell cycle arrest. This rationale led 
to the hypothesis that the primary mode of action of CdtB might be that of a 
phosphatase, rather than a nuclease. Additional support for the phosphatase 
mode of action came from studies showing that Aa-CdtB behaved as a 
Phosphatase and tensin homolog (PTEN) in lymphoid cell lines, which is a 
hydrolase that removes a phosphate group from PIP3 found in the plasma 
membrane of cells (Shenker et al., 2007). PIP3 activates downstream signaling 
components such as the protein kinase Akt, an activator of anabolic signaling 
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pathways necessary for cell growth. It was proposed that the action of the Cdt in 
lymphocytes causes a depletion of PIP3, which in turn inactivates the Akt 
pathway leading to cell cycle arrest and apoptosis. Examination of the PTEN 
activity of Aa-CDT was further extended to include human macrophages 
(Shenker, Walker, Zekavat, Dlakic, & Boesze-Battaglia, 2014). Unlike 
lymphocytes, macrophages did not undergo CDT-mediated apoptosis.  
To date, phosphatase activity has not been reported for any CDT other 
than Aa-CDT. Several studies have reported data suggesting that at least some 
of the cellular consequences of Aa-CDT cellular intoxication are not likely due to 
phosphatase activity of Aa-CdtB. Ectopic expression of Aa-CdtB in 
Saccharomyces cerevisiae induced DNA damage and S/G2 cell cycle arrest, 
although yeast does not possess the substrate for the reported Aa-CdtB 
phosphatidylinositol-3,4,5-triphosphate phosphatase activity (Matangkasombut et 
al., 2010). Moreover, Aa-CDT mediated apoptosis in proliferating U937 
monocytes was demonstrated to depend solely on the DNase activity of the Aa-
CdtB subunit (Rabin, Flitton, & Demuth, 2009). The phosphatidylinositol-3,4,5-
triphosphate phosphatase activity is not likely to be idiosyncratic for Aa-CdtB, as 
this subunit shares a nearly identical sequence to that of the CdtB subunit from 
H. ducreyi (Hd-CdtB), but further studies will be required to establish the ubiquity 
of phosphatase activity across all members of CDT family, and its importance in 
the virulence properties of the toxin. 
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1.2.7. CDT and apoptosis 
Depending on the cell type, eukaryotic cells exposed to CDTs have been 
shown to arrest in the G1 and/or G2 phases of the cell cycle, or undergo 
apoptosis (Comayras et al., 1997; Cortes-Bratti et al., 2001; Sert et al., 1999; 
Shenker et al., 1999). In general, CDT intoxication of cells of non-haematopoietic 
origin results in cell cycle arrest preceding apoptosis (Jinadasa, Bloom, Weiss, & 
Duhamel, 2011). In contrast, CDT intoxication of haematopoietic cells results in 
rapid apoptosis, indicating differential cellular responses to the action of CDTs 
(Ohara, Oswald, & Sugai, 2004; Shenker, Demuth, & Zekavat, 2006; Shenker et 
al., 2001). While CDT-intoxicated cells have been demonstrated to undergo 
apoptosis, there are reports that in some cases, CDTs also trigger cell survival 
pathways (Frisan et al., 2003). The survival of CDT intoxicated cells is dependent 
on the activation of the small GTPase RhoA (Frisan et al., 2003), which induces 
actin stress fiber formation, and prevents cell death via activation of the mitogen-
activated protein kinase p38 and its downstream target mitogen-activated protein 
kinase-activated protein kinase 2 (Guerra et al., 2008). The activation of RhoA is 
dependent on the dephosphorylation of the RhoA-specific guanine nucleotide 
exchange factor Net1, and it appears to be part of the DNA damage repair 
responses because it requires a functional ATM (Guerra et al., 2008).	  CDT 
intoxicated Jurkat T cells displayed increased caspase-2 and -7 activity and 
increased cell surface presentation of phosphatidylserine (Ohara et al., 2004). 
Shenker and group suggested that DNA fragmentation occurred via the apoptotic 
cascade and not directly due to DNA damage induced by CDT (Shenker et al., 
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2006). This report hypothesized that the CdtB phosphatase activity leads to 
induction of apoptosis and subsequent activation of endogenous nucleases, 
which result in DNA fragmentation. In this study, two inhibitors of apoptosis, 
overexpression of Bcl-2 and the caspase-3 inhibitor zvad, blocked apoptosis, 
DNA fragmentation as judged by the TUNEL assay and histone H2AX 
phosphorylation, but had no effect on G2 arrest (Shenker et al., 2006). Taken 
together, these data suggest that CDT may cause apoptosis in monocytes and T 
cells to limit the host immune response to the CDT-producing bacteria. 
 
1.2.8. CDT and carcinogenesis 
Several studies have begun to address whether infection with CDT-
producing pathogenic bacteria may induce changes in the host associated with 
an early neoplastic process. Using NF-κB-deficient mice to study persistent C. 
jejuni infection, one study indicated a proinflammatory role for Cj-CDT in vivo, as 
toxin producing strains were associated with significantly enhanced severity of 
gastritis and significantly higher occurrence of gastric hyperplasia and dysplasia, 
which are markers of an early neoplastic process (Fox et al., 2004). For 
Helicobacter hepaticus, which causes chronic hepatitis and typhlocolitis in some 
mice, CDT was demonstrated to be critical for persistent infection of Swiss 
Webster mice, which is characterized with severe inflammation (Ge et al., 2005). 
In another study, H. hepaticus infection of A/JCr mice demonstrated a 
significantly higher inflammatory response in strains producing Hh-CDT than 
isogenic mutant strains (Ge et al., 2007). The presence of CDT was associated 
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with a progression of inflammation to dysplasia. CDT activation of survival 
responses in cells harboring DNA damage could contribute to the accumulation 
of genetic instability within the developing inflammatory microenvironment, which 
may constitute the conditions for promoting the transformation of pre-neoplastic 
cells to malignant cells in the host. 
 
1.3. Retrograde Trafficking	  and Molecular Pathogenesis 
Following receptor engagement on the plasma membrane, endocytosis 
and endosomal protein sorting are critical events for diverse cellular functions 
such as signaling, nutrient uptake, and development. Of these processes, the 
mechanisms underlying clathrin-dependent and -independent internalization 
(Conner & Schmid, 2003; Kirkham & Parton, 2005; Mayor & Pagano, 2007), 
receptor recycling to the plasma membrane (Maxfield & McGraw, 2004), and 
membrane trafficking to compartments of the late endocytic pathway (Gruenberg 
& Stenmark, 2004) have been studied in some detail. In contrast, much less is 
known about endosomal trafficking to the biosynthetic/secretory compartments, 
which is known as retrograde transport. Exit from endosomal compartments is 
termed retrograde sorting and occurs in different parts of the endocytic pathway. 
Retrograde sorting acts on cargo molecules targeted to endosomes from the 
Golgi apparatus or the plasma membrane. These cargo proteins or lipids are 
then transported to the trans-Golgi network (TGN), Golgi membranes, or, in 
some cases, the endoplasmic reticulum (ER) via the retrograde route (Bonifacino 
& Rojas, 2006; Sandvig & van Deurs, 2005). Virulence factors also rely on these 
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transport routes to enter host cell and access its intracellular target. Thus, 
structural and mechanistic studies on pathogen products and cellular factors 
have led to the first molecular models for trafficking between endosomes and the 
TGN. Distinct features of trafficking by the retrograde route have expanded our 
understanding of cell biology, and provided new therapeutic strategies in 
immunotherapy and drug delivery. 
 
1.3.1. Receptor engagement and endocytosis 
The presence or absence of receptors on the plasma membrane surface 
often dictates the sensitivity or resistance, respectively, of host cells to specific 
intracellular-acting bacterial toxins (Blanke, 2006). Using ligand blotting assays, 
very early studies reported the binding of partially purified Cj-CDT to two peptides 
with approximate molecular masses of 45 and 59 kDa from HeLa cell membrane 
preparations and 59 kDa from CHO cell membrane preparations (Bag, 
Ramamurthy, & Nair, 1993), suggesting the presence of molecular components 
on the surface of host cells that might function as CDT receptors. 
To date, bonafide CDT receptors have not yet been identified. One study 
implicated fucose as an important determinant for Ec-CDT, as lectins targeting 
fucose moieties inhibited toxin interactions with cells to a greater extent than 
lectins targeting alternative glycans (McSweeney & Dreyfus, 2005). Another 
study indicated that the Aa-CDT holotoxin binds to surface glycosphingolipids, 
and that inhibitors of glycosphingolipid synthesis can prevent intoxication of the 
human monocytic U937 cell line (Mise et al., 2005). Mutagenesis of a human cell 
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line haploid for most chromosomes identified cell lines deficient in the 
membrane-expressed protein TMEM181 that were resistant to Ec-CDT, although 
it is not yet clear that TMEM181 functions as a cell surface receptor for this toxin 
(Carette et al., 2009). 
A recent study in which Aa-CDT, Cj-CDT, Ec-CDT, and Hd-CDT were 
compared in a head to head fashion revealed considerable differences in the 
potencies of these toxins, as well as the target cell requirements important for 
intoxication (Eshraghi et al., 2010). For example, cholesterol was found to be 
important for the cellular activities of Aa-CDT, Cj-CDT, and Hd-CDT, but not for 
those of Cj-CDT. Using mutant CHO cell lines lacking N-linked complex- or 
hybrid-carbohydrates, glycosphingolipids, or fucose, the study also reported the 
unexpected finding that N- and O-glycan, or fucosylated structures are in fact not 
required for mediating toxin binding (Eshraghi et al., 2010). The diversity of cell 
surface determinants important for CDT interactions identified in these early 
studies suggest that individual CDTs may each bind to a different receptor. It is 
attractive to speculate that CDT receptor diversity reflects the tissue tropism of 
individual CDT-producing pathogens. Following engagement with the host cell 
surface, CDTs are taken up in the endolysosomal compartments before being 
targeted retrogradely towards the nucleus. Information on the cellular uptake is 
limited, but the experiments studying Hd-CDT suggest that the toxin enters cells 
by a dynamin-dependent endocytosis that may be clathrin-dependent or 
independent (Cortes-Bratti, Chaves-Olarte, Lagergard, & Thelestam, 2000). 
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1.3.2. Retrograde trafficking	  of CDT 
In order to reach the nucleus, CDT exploits the retrograde trafficking 
pathway of the host cell (Figure 1.3). As an intracellular-acting genotoxins, CDT 
has several fundamental problems to solve in order to exert their modulatory 
activities, with the most glaring being how to transport soluble CdtB moieties from 
the cell surface to the nucleus. There are some recent indications that host cell 
requirements for the genotoxic activity of CDTs from different species may be 
divergent, raising the possibility that not all CdtB moieties travel from the cell 
surface to the nucleus along a single transport pathway (Gargi et al., 2013). 
Biochemical and fluorescence imaging studies suggest that CDTs are 
transported in a retrograde manner from the endolysosomal system to the ER via 
the Golgi complex (Guerra et al., 2005). Analogous to several other toxins, 
including Cholera- and Shiga-toxins, the catalytically active subunit (CdtB) is 
believed to escape degradation within the endocytic trafficking pathway, and 
later, translocated from the ER to the cytosol by exploiting the ER degradation 
pathway, which normally translocates misfolded proteins to the cytosol via 
protein translocons within the ER membrane (Blanke, 2006; Eshraghi et al., 
2014). One study reported that Hd-CdtB was not detected within the cytosol of 
intoxicated cells (Guerra et al., 2009). In fact, to date, there is no experimental 
evidence that any CDT subunit is translocated from the ER to the cytosol of 
intoxicated cells, leading to the suggestion that the CdtB subunits may be 
translocated directly from the ER to the nucleus (Guerra et al., 2009). On the 
contrary, given the possibility of potentially transient nature of CdtB in the cytosol, 
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detection parameters used, studies supporting the importance of ERAD pathway 
for translocation of CdtB from ER lumen to the cytosol (Eshraghi et al., 2014), 
and idea that CdtB proteins carry a nuclear localization signal, hint that CdtB 
might transition through the cytosol before reaching the nucleus (McSweeney & 
Dreyfus, 2004; Nishikubo et al., 2003). More studies are required to address this 
query.  
 
1.4. Gaps in Knowledge 
CDT is the only known bacterial toxin that reaches the nucleus of the host 
cell to cause DNA damage. Although the role of toxin in producing DNA damage 
and triggering downstream pathways is well known, mechanistic details of how 
the toxin is transported to its target are still poorly understood. Limited studies 
have tried to address the cell surface engagement (Bag et al., 1993; Boesze-
Battaglia et al., 2006; Cao et al., 2008; Eshraghi et al., 2010; Mise et al., 2005), 
followed by uptake of toxin into the cell (Cortes-Bratti et al., 2000; Guerra et al., 
2005), and involvement of specific organelles (Eshraghi et al., 2014; Guerra et 
al., 2005) in the trafficking of the toxin, but the details of the subcellular 
compartments and the host factors essential for CDT trafficking within the 
mammalian cells are largely unknown. Clearly, a major gap in the mechanism 
underlying CDT-mediated cellular intoxication is how CdtB reaches its site of 
action. The putative nuclear localization signals identified for two members of the 
CDT family, Aa-CDT and Ec-CDT, are highly divergent, suggesting that the 
mechanisms by which these two toxins are transported to the nucleus may not 
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be identical (McSweeney & Dreyfus, 2004; Nishikubo et al., 2003). Moreover, 
findings from our research group also indicate that CDTs from different 
pathogens might follow different paths to reach nucleus (Eshraghi et al., 2010; 
Gargi et al., 2013).  
 
1.5. Significance of This Study 
 The objective of this study is to address the mechanistic details of 
intoxication process of CDTs in general, and identifying the similarities and 
differences between holotoxins that are similar or distant in their sequence and 
structural homology. Another major objective of this work is to identify the host 
cell factors that are involved in the transportation process of CDTs, as an 
important step for the toxin to reach its target and elaborate its biological activity.  
 In this study, we directly compared the cellular intoxication mechanisms 
employed by CDTs produced by C. jejuni, E. coli, and H. ducreyi, three 
pathogens that colonize similar, or highly divergent host niches (i.e. the intestinal 
and urogenital tracts, respectively). Amongst CDT family, holotoxin from these 
three pathogens share relatively low sequence identity in their CdtA and CdtC 
subunits, suggesting the possibility that these toxins might interact with host cells 
in fundamentally different ways. Our studies revealed differences in the cellular 
requirements for toxin intracellular trafficking. Overall, these studies suggest that 
CDTs from different pathogens are transported within cells by distinct pathways, 
potentially relevant to their colonization niche within the host. 
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 Our study also addresses the host factors that facilitate CDT 
transportation to its target. We demonstrate the importance of an intact and 
functional Golgi apparatus for CDT activity, and localization of active subunit of 
Cj-CDT to the nucleus. We demonstrate the time dependent and transient 
localization of Cj-CdtB with the Golgi apparatus, and evidence supporting that Cj-
CdtB utilizes the cellular machinery from the late-endosomal compartments to 
the Golgi apparatus. We show that Cj-CDT trafficking and intoxication properties 
are independent of early endosome to the Golgi apparatus transition, but are 
sensitive to the endosomal maturation, and the toxin is predominantly trafficked 
out of vesicles marked by STX10, and rab9, both indicators of transition through 
the late endosomal compartments, before reaching the Golgi apparatus. Blocking 
the Golgi apparatus sorting function by small molecule inhibitors abrogated 
downstream trafficking and activity of the toxin. Moreover, when the Golgi 
apparatus block was removed, the toxin already present in the cell proceeded to 
the nucleus, and caused cell cycle arrest, suggesting that Golgi apparatus is a 
bottleneck in the CDT intoxication of host cells. We also addressed the 
importance of Golgi-membrane resident protein, COG complex, in the trafficking 
and activity of CDTs. Barring limited work done on SubAB and Shiga toxin, role 
of COG complex on the trafficking of proteins remained largely underexplored (R. 
D. Smith et al., 2009; Willett et al., 2013). In this study we applied novel 
strategies to identify components of molecular machinery involved in the 
transition of CDTs from the endolysosomal system to the Golgi apparatus.  
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 Together, our findings suggest an important role of the Golgi apparatus in 
both function and trafficking of Cj-CdtB to the ER, and ultimately to the nucleus, 
and identifies specific host cell determinants required for the intracellular 
transportation, and biological activity of CDTs.  
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1.6. Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Three independent proteins are required to make CDT holotoxin. 
Most of the known CDTs are composed of CdtA, CdtB, and CdtC, with some 
exceptions like S. typhi where PltA and PltB make holotoxin with CdtB. All CdtAs 
contain an aromatic patch, demonstrated to be important in binding to the surface 
of mammalian cells. CdtBs are most conserved amongst three proteins, and are 
the catalytic subunit of the toxin carrying conserved metal coordinating residues, 
DNase catalytic residues, and residues homologous to DNA contacting residues 
of DNase I. CdtCs contain conserved residues believed to be important in 
formation of a cell-surface binding groove. The scale bar represents primary 
sequence length equivalent to 200 residues. CDT, Cytolethal Distending Toxin; 
Plt, Pertussis like toxin. Individual genuses and species are abbreviated as 
follows: Escherichia coli (Ec), Campylobacter jejuni (Cj), 
Aggregatobacter actinomycetemcomitans (Aa), Campylobacter lari (Cl), 
Escherichia albertii (Ea), Haemophilus parasuis (Hp), Campylobacter coli (Cc), 
Haemophilus ducreyi (Hd), Campylobacter upsaliensis (Cu), Helicobacter 
hepaticus (Hh), Shigella boydii (Sb), Campylobacter fetus (Cf), Helicobacter 
pullorum (Hp), Salmonella typhi (St), Helicobacter bilis (Hb), Helicobacter cinaedi 
(Hc), Helicobacter winghamensis (Hw), Providencia alcalifaciens (Pa), 
Salmonella enterica (Se), Shigella dysenteriae (Sd).  
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Figure 1.2. Amino acid maximum likelihood phylogenies of the three 
subunits of CDT. Sequences were extracted from the NCBI non-redundant 
protein database using BLAST with the criteria that sequences have at least 30% 
identity and 50% coverage against a known set of CDT subunit sequences from 
H. ducreyi, A. actinomycetemcomitans, E. coli, E. albertii, S. dysenteriae, S. 
enterica, C. jejuni, and H. bilus.  Sequences below these threshold cut-offs were 
too divergent to be reliably aligned for phylogenetic analyses. Multiple identical 
sequences from the same species were reduced to unique representatives. The 
sequences were aligned using a combination of MAFFT and MUSCLE. 
Phylogenies were inferred using PhyML according to the LG substitution matrix. 
Clades are colored according to the dominant genus with likely horizontal gene 
transfer candidates in black. Clades dominated by sequences from a single 
species are labeled once and distinct clades of sequences from the same 
species are numbered. 
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Figure 1.3. Host cell-surface binding and internalization of CDT. CDT binds 
to a cell surface determinant, and in some cases, is affected by perturbations in 
lipid rafts. Following internalization by clathrin-coated pits to the endosomes, 
CDT is trafficked in a retrograde fashion to the Golgi-apparatus, and the 
endoplasmic reticulum (ER). From the ER, CdtB localizes to the nucleus by a yet 
unconfirmed route directly, or through the cytoplasm. Experimental techniques 
used to identify the pathway employed by CDT to trafficking inside the cell, are 
represented next to the organelles involved.  
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Figure 1.4. Crystal structure of Hd-CDT. CDT is a ternary complex comprised 
of three proteins: CdtA (modeled in blue), CdtB (red), and CdtC (green). CdtA 
and CdtC possess amino and carboxy termini that project as non-globular 
polypeptides and interact extensively with each other and with CdtB. Ribbon 
cartoon of Hd-CDT was constructed using Chimera (Pettersen et al., 2004), 
fetching PDB model 1SR4 for Hd-CDT (Nesic et al., 2004). 
 
 
 
 
CdtA	   CdtC	  
CdtB	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Figure 1.5. Structural homology between CdtB and DNase I enzymes. 
Catalytically active subunit of CDT has conserved residues homologous to 
DNase I enzymes. Main-chain/side-chain atoms of CdtB and DNase-I are shown 
in red/yellow and blue/green, respectively. Mutation in the highlighted conserved 
residues lead to loss in the DNA-digestion properties of the protein. Model 
adapted from Nesic et al., 2004 (Nesic et al., 2004).  
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CHAPTER 2: CELLULAR INTERACTIONS OF THE CDT FROM E. COLI AND 
H. DUCREYI 
 
2.1. Introduction 
The cytolethal distending toxins (CDTs) comprise a family of multi-subunit 
bacterial genotoxins that modulate the eukaryotic cell cycle (Ceelen, Decostere, 
Ducatelle, & Haesebrouck, 2006; Gargi, Reno, & Blanke, 2012; Nougayrede, 
Taieb, De Rycke, & Oswald, 2005; Ohara, Oswald, & Sugai, 2004; Oswald, 
Nougayrede, Taieb, & Sugai, 2005). CDT-mediated cell cycle arrest and the 
disruption of cytokinesis have been proposed to alter the normal barrier and 
immune functions of both epithelial cells and lymphocytes (Nougayrede et al., 
2005). Animal model studies as well as the association of cdt gene carriage in 
disease-causing bacteria from human isolates both support the importance of 
CDTs for the virulence strategies of specific pathogens (Ge, Schauer, & Fox, 
2008; Smith & Bayles, 2006).  
Most CDTs function as assembled complexes of three protein subunits, 
encoded by three contiguous genes (cdtA, cdtB, cdtC) within an operon 
(Thelestam & Frisan, 2004). Consistent with the canonical AB model of 
intracellular acting toxins (Blanke, 2006), CdtB appears to function as the 
enzymatic A-subunit. CdtB has DNase I-like activity (C. A. Elwell & Dreyfus, 
2000; Lara-Tejero & Galan, 2000) and localizes to the nucleus when expressed 
ectopically within the cytosol of mammalian cells (McSweeney & Dreyfus, 2004; 
Nishikubo et al., 2003; Wising, Magnusson, Ahlman, Lindholm, & Lagergard, 
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2010), suggesting that this subunit directly causes DNA damage within the nuclei 
of intoxicated cells. CdtA and CdtC facilitate the delivery of CdtB into cells (Cao, 
Bandelac, Volgina, Korostoff, & DiRienzo, 2008; Cao, Volgina, Huang, Korostoff, 
& DiRienzo, 2005; McSweeney & Dreyfus, 2005; Nesic & Stebbins, 2005), 
although the molecular details of how these subunits facilitate the cell-surface 
binding, uptake, and intracellular transport of CdtB remain poorly understood.  
A diverse group of Gram-negative pathogenic bacteria that colonize 
distinct niches within the host have been identified to possess cdt genes (Pickett 
& Whitehouse, 1999). The AB2 toxin architecture as well as a number of other 
key structural features appear to be generally conserved across the CDT family 
(Hu, Nesic, & Stebbins, 2006), suggesting that individual toxin members may 
interact with and intoxicate cells in a similar fashion. However, the cellular 
intoxication properties of CDTs produced by different pathogenic organisms are 
poorly understood. Recently, the sensitivity of several cell lines to CDTs from 
Aggregatibacter actinomycetemcomitans, Campylobacter jejuni, Escherichia coli, 
and Haemophilus ducreyi were demonstrated to be differentially affected by 
alterations in host glycans and membrane cholesterol (Eshraghi et al., 2010), 
suggesting that host cell requirements for CDT intoxication of mammalian cells 
may not be universally conserved. However, it remains unclear whether the 
overall mechanism and molecular basis of toxin binding, uptake, and intracellular 
transport, are broadly applicable to all members of the CDT family.  
The objective of this study was to directly compare the cellular intoxication 
mechanisms employed by CDTs produced by E. coli and H. ducreyi, two 
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pathogens that colonize highly divergent host niches (i.e. the intestinal and 
urogenital tracts, respectively). Notably, the CDTs from E. coli (Ec-CDT) and H. 
ducreyi (Hd-CDT) share only 22% and 19% sequence identity, respectively, in 
their CdtA and CdtC subunits, suggesting the possibility that these two toxins 
might interact with host cells in fundamentally different ways. These studies 
revealed differences in the cellular requirements for toxin intracellular trafficking. 
Moreover, Ec-CDT and Hd-CDT did not compete with each other for binding to 
the surface of cells, suggesting that these toxins may target and bind to discrete 
receptors. Overall, these studies suggest that Ec-CDT and Hd-CDT are 
transported within cells by distinct pathways, possibly mediated by their 
interaction with different receptors at the cell surface. 
  The text of the chapter 2 is similar to the paper published in Journal of 
Biological Science (Amandeep Gargi, Batcha Tamilselvam, Brendan Powers, 
Michael G. Prouty, Tommie Lincecum, Aria Eshraghi, Francisco J. Maldonado-
Arocho, Brenda A. Wilson, Kenneth A. Bradley and Steven R. Blanke, 2013. 
Cellular interactions of the cytolethal distending toxins from Escherichia coli and 
Haemophilus ducreyi. J. Biol. Chem. 288: 7492-7505.). 
2.2. Materials and Methods  
Cloning of cdt genes and preparation of expression strains. The cloning of 
the genes encoding Ec-CDT and Hd-CDT in plasmids for recombinant 
expression in E. coli was previously described (Eshraghi et al., 2010). 
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 Expression and purification of recombinant Ec-CDT and Hd-CDT. Each 
recombinant protein was expressed and purified as previously described 
(Eshraghi et al., 2010). Protein concentrations were quantified using the Bradford 
Protein Assay (Thermo Scientific, Rockford, IL). Recombinant proteins were used 
only when purified to at least 95% homogeneity, as estimated by resolving the 
proteins using sodium-dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis 
(PAGE), and visualizing after staining the gels with Coomassie Brilliant Blue (Bio-
Rad, Hercules, CA; data not shown). The purified, denatured subunits were 
stored at -20 °C in HEPES (20 mM, N-[2-Hydroxyethyl] piperazine-N-[2-
ethanesulphonic acid], Calbiochem,  La Jolla, CA), pH 7.5 containing urea (8 M) 
and NaCl (200 mM). 
Ec-CDT and Hd-CDT holotoxins were prepared as previously described 
(Nesic, Hsu, & Stebbins, 2004). Ec-CDT and Hd-CDT holotoxin integrity was 
evaluated using the dialysis retention assay, as previously described (Cao et al., 
2005). Ec-CDT or Hd-CDT holotoxin (5-20 µM, 1 ml) was dialyzed (100 kDa 
molecular mass cut-off tubing; Spectrum Laboratories) at 4 °C against four 250 
ml volumes of phosphate buffer saline (PBS) pH 7.4 containing 5% glycerol. After 
24 h, the dialyzed proteins were evaluated using SDS-PAGE followed by staining 
with Coomassie Brilliant blue. The gels were scanned with a CanonScan 9950F 
scanner (Canon, Lake Success, NY) using ArcSoft Photo Studio 5.5 software 
(ArcSoft, Fremont, CA). The integrity of the holotoxins was quantified by 
comparing the relative intensities of the bands corresponding to CdtA, CdtB, or 
CdtC before and after dialysis, as determined by using the UN-SCAN-IT program 
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(Silk Scientific, Inc., Orem, UT). Individual CDT subunits, each of which has a 
molecular mass less than 35 kDa, were used as negative controls.  
Mammalian cells. All mammalian cell cultures were maintained at 37 °C 
and under 5% CO2 within a humidified environment. Human cervical cancer 
epithelial (HeLa) cells (CCL-2, ATCC) were maintained in Minimal Essential 
Medium Eagle (MEM, Mediatech, Herndon, VA) with 10% fetal bovine serum 
(FBS, Mediatech). Chinese hamster ovary (CHO-K1) cells (CCL-61, ATCC) were 
maintained in Ham’s F-12K (Lonza, Walkersville, MD) with 10% FBS. Human 
epithelial colorectal adenocarcinoma (Caco-2) cells (HTB-37, ATCC) were 
maintained in MEM (Eagle) with 20% FBS. Human embryonic intestinal (INT-
407) cells (CCL-6, ATCC) were maintained in basal medium eagle (Sigma) with 
10% FBS. Complete medium was obtained by supplementing each medium 
described above with L-glutamine (2 mM, Sigma), penicillin (50 IU/ml, 
Mediatech), and streptomycin (50 µg/ml, Mediatech). 
Cell cycle phase determination. The indicated cell lines were seeded (1.5 
x 105 cells per well) in 6-well plates (Corning Inc., Corning, NY). After 18 h, the 
cells were further incubated in complete medium with or without Ec-CDT or Hd-
CDT at the indicated concentrations, or mock incubated with PBS pH 7.4. After 
48 h, the cells were analyzed for arrest at the G2/M interface, as previously 
described (Eshraghi et al., 2010). From these data, dose response curves were 
generated by plotting cells in G2/M as a function of toxin concentration. From the 
dose response curves, we determined CCAD50 (i.e. cell cycle arrest dose50) 
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values, which we defined as the toxin concentrations required to induce G2/M 
arrest in 50% of the cell population not already in G2/M. 
For both Ec-CDT and Hd-CDT, preliminary studies revealed nearly 
identical dose response curves for G2/M arrest in the presence or absence of the 
hexa-histidine tags (Figure 2.1). All subsequent studies were conducted with Ec-
CDT or Hd-CDT assembled from subunits that retained their respective hexa-
histidine tags. 
Some studies were conducted in the presence of the indicated 
concentrations of brefeldin A (BFA; MP Biomedicals), ammonium chloride 
(NH4Cl, Sigma), bafilomycin A1 (LC Laboratories, Woburn, MA), monensin 
(Sigma), or nigericin (Sigma). These studies were conducted at approximately 
the CCAD50 values determined for Hd-CDT and Ec-CDT in order to best assess 
whether each pharmacological agent inhibited, potentiated, or had no effect on 
toxin activity. 
 Flow cytometry. Analytical flow cytometry-based assays were carried out 
as previously described (Eshraghi et al., 2010). 
DNase assay. The relative in vitro DNase activities of either Ec-CdtB or 
Hd-CdtB were determined as described previously (C. A. Elwell & Dreyfus, 
2000), using purified pUC19 as the substrate. Reactions were stopped at 4 h by 
the addition of EDTA (to a final concentration of 10 mM). DNA gel loading dye 
(6x; Promega) was added to each sample, and the samples were resolved by 
employing agarose (0.8%) gel electrophoresis using Tris-acetate-EDTA (TAE, 40 
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mM Tris base, Fisher Biotech, Fair Lawn, NJ; 20 mM acetic acid, Fisher 
Scientific; 1 mM EDTA) electrophoresis buffer with constant voltage (100 V). The 
gels were stained with ethidium bromide (1 µg/ml, Bio-Rad), photographed using 
a Gel Doc EQ system (Bio-Rad), and the relative pixel densities of stained bands 
corresponding to supercoiled pUC19 were measured using UN-SCAN-IT. 
Relative DNase activity was calculated from the pixel densities of ethidium 
bromide stained bands corresponding to supercoiled pUC19, using the 
relationship: relative DNase activity = [(super-coiled pUC19 pixels from control 
reactions lacking Ec-CdtB and Hd-CdtB) – (super-coiled pUC19 pixels from 
reactions containing Ec-CdtB or Hd-CdtB)] / [super-coiled pUC19 pixels from 
control reactions lacking Ec-CdtB and Hd-CdtB]. A value of 1.0 corresponds to a 
complete loss of detectable supercoiled pUC19. 
Biotinylation of CDTs. Ec-CDT or Hd-CDT (1 ml at 5-20 µM) in PBS pH 
7.4 was incubated overnight at 4 °C with EZ Link Sulfo-NHS-LC-Biotin (10-fold 
molar excess, Thermo Scientific). The labeling reaction was arrested by the 
addition of Tris pH 8.0 (to a final concentration of 20 mM). To remove free label, 
the proteins were dialyzed at 4 °C against four changes of PBS pH 7.4 (250 ml 
each) containing 5% glycerol. Preliminary studies indicated that biotinylation 
reactions had no detectable effects on the capacity of either Ec-CDT or Hd-CDT 
to induce cell cycle arrest in G2/M. 
Internalization assay. Cells were seeded (2 × 104 per well) in 8-well 
chamber slides (Nunc; Rochester, NY). After 18 h, the slides were incubated on 
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ice for 30 min. The cells were washed two times with ice-cold PBS pH 7.4, and 
then further incubated on ice with or without biotinylated Ec-CDT or Hd-CDT (at 
the indicated concentrations) in PBS pH 7.4 with bovine serum albumin (BSA, 
3%, Sigma), or mock incubated in PBS pH 7.4 with BSA (3%). After 30 min of 
toxin pre-binding on ice, the cells were washed three times with ice-cold PBS pH 
7.4. 
To monitor CDT binding, the cells were immediately fixed by incubating 
with ice-cold 2% formaldehyde (Sigma), and then further incubated at room 
temperature for 30 min. To monitor CDT internalization, after 30 min of toxin pre-
binding on ice, the cells were incubated with pre-warmed (37 °C) complete 
medium. After 10 min, the cells were washed with ice-cold PBS pH 7.4, and fixed 
with ice-cold 2% formaldehyde. After fixing for 30 min at room temperature, the 
cells were permeabilized by incubating in PBS 7.4 containing 0.1% Triton X-100 
for 15 min, and blocked with 3% BSA for 30 min. To probe for biotinylated Ec-
CDT or Hd-CDT, the fixed and permeabilized cells were incubated at room 
temperature with streptavidin conjugated with Alexa Fluor 488 (1:200 dilution in 
PBS 7.4; Invitrogen). After 1 h, the cells were washed 3 times with 0.1% Tween-
20 (Fisher Scientific) in PBS pH 7.4. The nucleus was stained by incubating with 
4',6-diamidino-2-phenylindole (DAPI; 300 nM in PBS pH 7.4, Invitrogen) for 2 
min. Slides were washed 3 times with 0.1% Tween-20 in PBS pH 7.4 and air-
dried. The slides were mounted with ProLong Gold antifade reagent (Invitrogen) 
and cured overnight. The cells were then analyzed using DIC/fluorescence 
microscopy. 
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DIC/fluorescence microscopy. Chamber slides were analyzed using a 
DeltaVision RT microscope (Applied Precision; Issaquah, WA), using an 
Olympus Plan Apo 40x oil objective with NA 1.42 and working distance of 0.17 
mm DIC images were collected using a Photometrics CoolSnap HQ camera; 
(Photometrics, Tucson; AZ). Images were processed using SoftWoRX Explorer 
Suite (version 3.5.1, Applied Precision Inc). Deconvolution was carried out using 
SoftWoRX constrained iterative deconvolution tool (ratio mode), and analyzed 
using Imaris 5.7 (Bitplane AG, Zurich, Switzerland). 
CDT localization to the ER.  Cells were plated in an 8-well chamber slide 
to 30-40% confluency. After overnight incubation, cells were washed 2 times with 
PBS pH 7.4, followed by addition of 100 µl OPTI-MEM (Invitrogen, Grand Island, 
NY), and further incubated for 2 h before transfection. Approximately 30 min prior 
to addition to cells, the appropriate dilutions of pDsRed2-ER (0.4 µg/200 µl/well; 
Clontech, Mountain View, CA), which encodes RFP fused to the ER targeting 
sequence of calreticulin, and the ER retention sequence, KDEL; and 
Lipofectamine 2000 reagent (1 µl/200 µl/well; Invitrogen) complex were prepared 
according to the manufacturers instructions, and allowed to incubate at room 
temperature. After 30 min, OPTI-MEM was removed, and the plasmid DNA-
transfection mixture (100 µl) was added to each well in a drop-wise fashion with 
gentle agitation, and the cells were immediately incubated at 37 °C and under 
5% CO2. After 4 h, the transfection mixture was removed from the monolayers, 
and the cells were incubated in complete medium at 37 °C and under 5% CO2. 
After overnight incubation, we typically detected 80-90% of the cells within the 
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monolayer to be transfected based on the percentage of cells with RFP 
fluorescence, as determined using an Olympus CKX 41 fluorescence microscope 
(Olympus America Inc., Center Valley, PA). 
Cells that had been transfected, as described above, with pDsRed2-ER, 
were pre-incubated for 30 min in the absence or presence of NH4Cl (20 mM) at 
37 °C and under 5% CO2. The cells were then further incubated with biotinylated 
Ec-CDT or Hd-CDT (200 nM), and the cells were stained for each toxin as 
described above under “Internalization Assay”. The cells were further stained for 
actin by incubating with Alexa Fluor 647-labelled phalloidin (1 U/200 µl/well; 
Invitrogen). Images were collected using DIC/fluorescence microscopy and 
deconvoluted, as described above. For each cell, images were collected from an 
average of 30 z-planes, each at a thickness of 0.2 µm. Localization analysis was 
conducted by using the co-localization module of the DeltaVision SoftWoRx 3.5.1 
software suite. Results were expressed as the localization index, which was 
derived from calculating the Pearson’s coefficient of correlation values, which in 
these studies was a measure of localization of the indicated CDT to the ER in 
each z plane of the cell. In these studies, a localization index value of 1.0 
indicates 100% localization of Ec-CDT or Hd-CDT to the ER, whereas a 
localization index of 0.0 indicates the absence of Ec-CDT or Hd-CDT localization 
to the ER. The localization index was calculated from the analysis of a total of 50 
images collected over three independent experiments. 
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Monitoring nuclear localization of Ec-CdtB or Hd-CdtB within the nuclear 
fraction of CDT-intoxicated cells. Cells were seeded in 100 mm culture dishes 
(BD Biosciences, Durham, NC). After overnight incubation, the monolayers were 
treated with bafilomycin A1 (20 nM) for 30 min, and further incubated with Ec-
CDT or Hd-CDT (at the indicated concentrations). After 30 min, the cells were 
further incubated with fresh medium (not containing toxin) for an additional 210 
min. After 240 min total internalization of Ec-CDT or Hd-CDT, the cells were 
harvested by scraping, lysed using hypotonic buffer, and fractionated as per the 
manufacturer’s protocol (Nuclear Extract Kit, Active Motif, Carlsbad, CA). The 
fractionated samples were evaluated by western blotting, using rabbit polyclonal 
antibodies against Ec-CdtB (1:20,000 dilution; generated by Thermo Fisher 
Scientific Inc., Rockford, IL), or rabbit polyclonal antibodies against Hd-CdtB 
(1:10,000; generated by Immunological Resource Center, University of Illinois, 
Urbana, IL), cytosolic marker GAPDH (1:200; Abcam, Cambridge, MA), 
microsomal marker calnexin (1:2,000; Abcam), nuclear marker p84 (1:2,000; 
Abcam), and cell lysate loading control actin (1:1,000; NeoMarkers, Fremont, 
CA). Anti-mouse (1:2,000), and anti-rabbit (1:5,000) secondary antibodies were 
purchased from Pierce Protein Biology Products (Thermo Fisher Scientific Inc.). 
Relative amounts of CdtB were determined by densitometric analysis of the blot 
bands using the UN-SCAN-IT program.  
H2AX activation assay. Cells were transfected with pDsRed-Rab7 DN (0.4 
µg/200 µL/well), using the general transfection procedure as described above 
under “CDT localization to the ER.” The transfected monolayers were incubated 
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at 37°C with Ec-CDT (200 nM) or Hd-CDT (200 nM). After 8 hours, the cells were 
fixed and permeabilized as described above under “Internalization Assay.” To 
monitor activation of H2AX by CDT, samples were stained overnight with a rabbit 
polyclonal anti-p-H2AX antibody (1:5000 dilution; Invitrogen) at 4 °C, followed by 
incubation with goat anti-rabbit Alexa Fluor 488 antibody (1:1000 dilution; 
Invitrogen) at room temperature for 2 h. The cells were further counter stained for 
actin by incubating with Alexa Fluor 647-labelled phalloidin (1 U/200 µl/well) and 
for nuclei by incubating with DAPI (1 ng/200 µl, Invitrogen) for 30 min. The slides 
were mounted with ProLong Gold Antifade Reagent (25 µl/well; Invitrogen). 
Images were collected using DIC/fluorescence microscopy and deconvoluted, as 
described above. For each cell, images were collected from an average of 30 z-
planes, each at a thickness of 0.2 µm. H2AX activation analysis was conducted 
by using the DeltaVision SoftWoRx 3.5.1 software suite. Percentage of H2AX 
activated cells in each group of functional and dysfunctional Rab7 cells were 
calculated from approximately 50 cells from each group over three independent 
experiments.  
Monitoring nuclear localization of Ec-CdtB or Hd-CdtB using fluorescence 
microscopy. Cells were transfected with pDsRed-Rab7-DN (0.4 µg/200 µl/well), 
using the general transfection procedure as described above under “CDT 
localization to the ER” The transfected monolayers were pre-chilled for 30 min on 
ice and further incubated with Ec-CDT (200 nM) or Hd-CDT (200 nM) on ice for 
30 min. After 60 min post internalization, the cells were fixed and permeabilized 
as described above under “Internalization Assay” To monitor Ec-CdtB or Hd-
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CdtB localization to the nucleus, cells were incubated with rabbit polyclonal anti-
Ec-CdtB or anti-Hd-CdtB antibodies (1:2000 dilution) at 4 °C overnight, followed 
by incubation with goat anti-rabbit Alexa Fluor 488-labeled antibody (1:1000 
dilution; Invitrogen) at room temperature for 2 h. The cells were further counter 
stained for the nucleus by incubating with DAPI (1 ng/200 µl, Invitrogen) for 30 
min at room temperature. The slides were mounted with ProLong Gold Antifade 
Reagent (25 µl/well; Invitrogen). Images were collected using DIC/fluorescence 
microscopy and deconvoluted, as described above. For each cell, images were 
collected from an average of 30 z-planes, each at a thickness of 0.2 µm. Nuclear 
localization analysis was conducted by using the DeltaVision SoftWoRx 3.5.1 
software suite. Percentage of CdtB localization into nucleus in each group of 
functional and dysfunctional Rab7 cells were calculated from approximately 30 
cells from each group over three independent experiments. 
CdtB-localization to Rab9-enriched vesicles. Pre-chilled monolayers were 
incubated with pre-chilled Ec-CDT (200 nM) or Hd-CDT (200 nM) on ice. After 
internalization, the cells were fixed and permeabilized as described above under 
“Internalization Assay.” To probe the localization of CDT in Rab9 enriched 
vesicles, intoxicated cells were incubated with rabbit polyclonal anti-Ec-CdtB or 
anti-Hd-CdtB antibodies (1:2000 dilution), along with mouse monoclonal anti-
Rab9 antibody (1:50 dilution; Abcam) at 4 °C overnight, followed by incubation 
with goat anti-rabbit Alexa Fluor 488-labeled antibody (1:1000 dilution; 
Invitrogen) and donkey anti-mouse Alexa Fluor 568 antibody (1:1000 dilution; 
Invitrogen) at room temperature for 2 h. The cells were further counter stained for 
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actin by incubating with Alexa Fluor 647-labeled phalloidin (1 U/200 µl/well; 
Invitrogen) and for the nucleus by incubating with DAPI (1 ng/200 µl, Invitrogen) 
for 30 min at room temperature. The slides were mounted with ProLong Gold 
Antifade Reagent (25 µl/well; Invitrogen).  
Images were collected using DIC/fluorescence microscopy and 
deconvoluted, as described above. For each cell, images were collected from an 
average of 30 z-planes, each at a thickness of 0.2 µm. Localization analysis was 
conducted by using the co-localization module of the DeltaVision SoftWoRx 3.5.1 
software suite. Results were expressed as the localization index, which was 
derived from calculating the Pearson’s coefficient of correlation values, which in 
these studies was a measure of localization of the indicated CDT to the Rab9 in 
each z plane of the cell. In these studies, a localization index value of 1.0 
indicates 100% localization of Ec-CdtB or Hd-CdtB to Rab9, whereas a 
localization index of 0.0 indicates the absence of Ec-CdtB or Hd-CdtB localization 
to the Rab9. The localization index was calculated from the analysis of a total of 
50 images collected over three independent experiments. 
Cell binding assays. Mammalian cell binding assays were conducted as 
previously described (Cao et al., 2005; Lee, Hassane, Cottle, & Pickett, 2003). 
Cells were seeded (2 × 104/well) in 96-well plates (Fisher). After 18 h, the plates 
were incubated on ice. After 30 min, the cells were washed two times with ice-
cold PBS pH 7.4, and then further incubated on ice with or without biotinylated 
Ec-CDT or Hd-CDT (at the indicated concentrations) and BSA (3%) in PBS pH 
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7.4, or mock incubated with BSA (3%) in PBS pH 7.4. After 1 h on ice, the cells 
were washed three times with ice-cold PBS pH 7.4, and then fixed by adding ice-
cold 2% formaldehyde and 0.2% glutaraldehyde, and then further incubated at 
room temperature. Preliminary studies indicated that maximal binding occurred 
between 30 and 60 min (not shown). After 15 min, the plate was washed three 
times with PBS pH 7.4 at room temperature, and then incubated at room 
temperature with streptavidin-HRP conjugate (1:15,000, GE Healthcare, Little 
Chalfont, Buckinghamshire, UK) in PBS pH 7.4. After 30 min, the cells were 
washed five times with PBS pH 7.4, and then incubated at room temperature with 
TMB Ultra (100 µl, Thermo Scientific). After 30 min, the supernatant from each 
well was removed and added to an equal volume of sulfuric acid (2 N, 
Mallinckrodt Baker Inc., Paris, KY) at room temperature. The optical density at 
450 nm (O.D.450nm) was measured using a Biotek Synergy 2 plate reader (Biotek 
Instruments Inc., Winooski, VT). The O.D.450nm measured for supernatants 
collected from wells containing cells incubated with PBS pH 7.4 alone 
(background absorbance) was subtracted from the O.D.450nm measured for 
supernatants collected from wells containing cells that had been incubated with 
Ec-CDT or Hd-CDT. Relative binding was determined by dividing the O.D.450nm 
minus background at each toxin concentration by the O.D.450 nm minus 
background at the highest concentration of toxin used in these studies (200 nM). 
The dissociation constants (Kd) were calculated by non-linear regression of the 
curve generated from plotting relative binding as a function of toxin 
concentration, using GraphPad Prism (Version 4.03, GraphPad Software, La 
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Jolla, CA). Competitive binding assays were conducted as described above, 
except in the absence or presence of 100-fold molar excess of the specified non-
biotinylated proteins. 
Effects of lectin binding on CDT binding. Cell monolayers were prepared 
as described above under “Cell binding assays.” Pre-chilled cells were pre-
treated on ice with Euonymus Europaeus Agglutinin lectin (EEA, EY Labs, San 
Mateo, CA; 40 Μg/ml). After 30 min, the cells were further incubated on ice with 
or without biotinylated Ec-CDT (100 nM) or Hd-CDT (100 nM) and BSA (3%) in 
PBS pH 7.4, or mock incubated with BSA (3%) in PBS pH 7.4, in the presence, 
or absence of 40 Μg/ml EEA. After 30 min on ice, the cells were washed, fixed, 
and analyzed as described above under “Cell binding assays.” 
Statistics. Unless otherwise indicated, each experiment was performed at 
least three independent times, each time in triplicate. Statistical analyses were 
performed using Microsoft Excel (Version 11.0, Microsoft, Redmond, WA) or 
GraphPad. The Q-test was performed to eliminate data that were statistical 
outliers (Dixon, 1950). Error bars represent standard deviations. All P values 
were calculated with the Student’s t-test using paired, two-tailed distribution. A P 
value of less than 0.05 indicated that differences in the specified data were 
considered statistically significant. 
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2.3. Results  
Evaluating the relative sensitivities of mammalian cell lines to Ec-CDT and 
Hd-CDT. A recent study (Eshraghi et al., 2010) reported that considerably lower 
concentrations of Hd-CDT than Ec-CDT were required to induce phosphorylation 
of the histone protein H2AX, a marker of DNA damage, in HeLa, CHO-K1, 
Balb/3T3, Y-1 cells, OT-1, NIH/3T3, IC-21, and Raw 264.7 cells. To evaluate the 
relationship between these results and the capacity of Ec-CDT or Hd-CDT to 
induce G2/M cell cycle arrest, one of several possible downstream consequences 
of H2AX activation, we measured cell cycle progression in HeLa and CHO-K1 
cells, which have been commonly used as models for studying the function of 
bacterial toxins, including CDTs (Aragon, Chao, & Dreyfus, 1997; Bag, 
Ramamurthy, & Nair, 1993; Bouzari & Varghese, 1990; Cope et al., 1997; 
Cortes-Bratti, Chaves-Olarte, Lagergard, & Thelestam, 1999; Frisan, Cortes-
Bratti, Chaves-Olarte, Stenerlow, & Thelestam, 2003; Gelfanova, Hansen, & 
Spinola, 1999; Johnson & Lior, 1988a, 1988b; Mayer, Bueno, Hansen, & 
DiRienzo, 1999; Okuda, Kurazono, & Takeda, 1995; Sugai et al., 1998), as a 
function of Ec-CDT or Hd-CDT concentrations. From the dose response curves, 
we determined CCAD50 (i.e. cell cycle arrest dose50) values, which we defined as 
the toxin concentrations required to induce G2/M arrest in 50% of the cell 
population not already in G2/M. These studies revealed that substantially lower 
concentrations of Hd-CDT than Ec-CDT were required to induce G2/M cell cycle 
arrest in HeLa cells (Figure 2.2). For HeLa cells, CCAD50 values of 4 pM and 100 
nM were determined for Hd-CDT and Ec-CDT, respectively, indicating that Hd-
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CDT is approximately 2.5 x 104-fold more potent towards HeLa cells than Ec-
CDT (Figure 2.2). In contrast, CHO-K1 cells required only 70-fold higher 
concentrations of Ec-CDT than Hd-CDT, with CCAD50 values of 7 nM and 0.1 
nM, respectively (Figure 2.2). These results are consistent with those of the 
previous study (Eshraghi et al., 2010), which reported that HeLa and CHO-K1 
cells required approximately 1.0 x 104- and 50-fold higher concentrations, 
respectively, of Ec-CDT than Hd-CDT to induce H2AX phosphorylation. 
We also compared the relative sensitivities towards Hd-CDT and Ec-CDT 
using two intestinal cell lines (Caco-2, INT-407 cells), which had not been 
evaluated in the previous study (Eshraghi et al., 2010). These studies revealed 
that Caco-2 (Figure 2.2) and INT-407 cells (Figure 2.2) were both arrested at the 
G2/M interface at considerably lower concentrations of Hd-CDT than Ec-CDT. 
However, these cell lines again varied in their relative susceptibilities to the two 
toxins. Caco-2 cells required approximately 3 x 102-fold higher concentrations of 
Ec-CDT (CCAD50 = 3 nM) than Hd-CDT (CCAD50 = 10 pM), whereas INT-407 
cells required approximately 7 x 103-fold higher concentrations of Ec-CDT 
(CCAD50 = 40 nM) than Hd-CDT (CCAD50 = 6 pM). 
To evaluate the possibility that differences in holotoxin stability might 
underlie the highly divergent cellular potencies of Ec-CDT and Hd-CDT, we 
investigated the assembly of the heterotrimeric complexes using the dialysis 
retention assay (Cao et al., 2005; Cao, Volgina, Korostoff, & DiRienzo, 2006). 
These studies revealed that approximately 60-99% Ec-CDT or Hd-CDT were 
assembled into holotoxins, as indicated by their retention within dialysis tubing 
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with a molecular weight cutoff of approximately 100 kDa (Figure 2.3), while CdtC 
(Figure 2.3) or CdtA or CdtB (data not shown) were not retained. Even in the 
worst-case scenarios (e.g. 60% holotoxin assembly), the large differences in 
potencies robustly measured for these two toxins (more than 104-fold greater 
activity for Hd-CDT than Ec-CDT on HeLa cells) cannot readily be attributed to 
the inability of the holotoxins to assemble. 
Relative in vitro DNase activities of Ec-CdtB and Hd-CdtB. CDT-
dependent G2/M arrest of intoxicated cells has been attributed to the activation of 
cellular DNA repair pathways (Hassane, Lee, & Pickett, 2003; Li et al., 2002) in 
response to the DNase I-like enzymatic activity associated with the CdtB subunit 
of several CDTs, including Ec-CDT (C. A. Elwell & Dreyfus, 2000; Lara-Tejero & 
Galan, 2000) and Hd-CDT (Frisk et al., 2001). To evaluate whether or not 
differences in the sensitivities of HeLa cells to Ec-CDT and Hd-CDT might be 
associated with the intrinsic catalytic properties of the CdtB subunits of each 
toxin, the in vitro DNase activities of the purified recombinant Ec-CdtB and Hd-
CdtB subunits (in the absence of CdtA and CdtC) were compared. These studies 
revealed that both Ec-CdtB and Hd-CdtB demonstrated similar DNase activity in 
a dose-dependent manner (Figure 2.4). Consistent with previous reports (Cao et 
al., 2005; Frisk et al., 2001; Lara-Tejero & Galan, 2000), Ec-CdtA, Ec-CdtC, Hd-
CdtA, or Hd-CdtC did not yield detectable DNase activity (data not shown). 
These results support the idea that the disparity in cellular potencies of Ec-CDT 
and Hd-CDT are not likely due to intrinsic divergence in the DNase activities 
between these toxins’ catalytic subunits. 
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Both Ec-CDT and Hd-CDT are taken up from the plasma membrane into 
cells within 10 min. Several studies have reported that ectopic expression of 
CdtB within mammalian cells is sufficient to induce cell cycle arrest in G2/M, even 
in the absence of CdtA and CdtC (C. Elwell, Chao, Patel, & Dreyfus, 2001; Lara-
Tejero & Galan, 2000; Li et al., 2002; Nishikubo et al., 2003), strongly supporting 
a model that CdtB acts from an intracellular location. To evaluate the possibility 
that differences in cell sensitivity to Ec-CDT and Hd-CDT may be due to large 
disparities between the times required for toxin uptake from the cell surface, we 
examined the internalization of both toxins into HeLa cells using 
DIC/fluorescence microscopy. These experiments revealed that under conditions 
non-permissive for cell entry (4 °C), both Ec-CDT and Hd-CDT were visible at the 
cell surface (Figure 2.5A, C), indicating that both toxins were bound to the 
plasma membrane. When the temperature was raised to 37 °C to induce 
conditions permissive for uptake, both toxins were visible within the cell after just 
10 min (Figure 2.5B, D), indicating that Ec-CDT and Hd-CDT were both efficiently 
internalized from the plasma membrane into cells. 
Effect of BFA on toxin-induced G2/M cell cycle arrest. Hd-CDT mediated 
cell cycle arrest has been demonstrated to be sensitive to the action of BFA, 
which disrupts retrograde protein transport from the Golgi complex to the ER 
(Cortes-Bratti, Chaves-Olarte, Lagergard, & Thelestam, 2000; Guerra et al., 
2005), suggesting that this toxin is trafficked by a retrograde mechanism (Blanke, 
2006). Because the importance of an intact Golgi complex for intoxication of cells 
with Ec-CDT had not been previously studied, toxin-mediated cell cycle arrest of 
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HeLa cells was evaluated in the presence or absence of BFA and at 
approximately the respective CCAD50 values of each toxin (e.g. 5 pM for Hd-
CDT, and 100 nM for Ec-CDT). These studies revealed that for Ec-CDT, as well 
as for Hd-CDT, toxin-mediated G2/M cell cycle arrest was blocked by BFA 
(Figure 2.6A, B), which supports a model that both toxins are trafficked to the ER 
via the Golgi complex. 
Effects of endosomal acidification inhibitors on toxin-induced G2/M cell 
cycle arrest. The finding that Ec-CDT and Hd-CDT-mediated G2/M cell cycle is 
blocked in the presence of BFA prompted us to further evaluate host cell 
requirements associated with transport from the cell surface to the ER. Transport 
of a subset of intracellular acting bacterial toxins within the cell requires the 
lowering of pH within the lumen of endocytic compartments (Blanke, 2006). While 
an earlier study (Cortes-Bratti et al., 2000) reported that Hd-CDT mediated G2/M 
cell cycle arrest in HeLa cells was inhibited by several agents that block 
endosome acidification, the requirement for endosome acidification associated 
with Ec-CDT mediated G2/M cell cycle arrest had not previously been reported. 
As previously demonstrated (Cortes-Bratti et al., 2000), Hd-CDT mediated G2/M 
cell cycle arrest in HeLa cells was inhibited (Figure 2.7A, B) by the 
lysosomotropic amine, ammonium chloride (Mellman, Fuchs, & Helenius, 1986). 
In contrast, Ec-CDT mediated cell cycle arrest was not blocked in the presence 
of NH4Cl (Figure 2.7A, B). Moreover, bafilomycin A1, which blocks acidification of 
intracellular vacuoles by an alternative mechanism, inhibiting the action of 
vacuolar ATPases (Bowman, Siebers, & Altendorf, 1988), also blocked Hd-CDT-
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mediated, but not Ec-CDT-mediated G2/M cell cycle arrest (Figure 2.7C, D). 
Finally, the polyether ionophore monensin, which is known to block intracellular 
protein transport by collapsing proton gradients as a sodium/proton antiporter 
(Mollenhauer, Morre, & Rowe, 1990), and, the potassium/proton carboxylic 
ionophore, nigericin (Mellman et al., 1986), both blocked Hd-CDT-mediated, but 
not Ec-CDT-mediated G2/M cell cycle arrest (Figure 2.7E). The sensitivity of cells 
to Ec-CDT was modestly, but reproducibly, elevated in the presence of agents 
that block acidification of endosomal compartments (Figure 2.7), but we do not 
currently understand the basis for the slight enhancement in Ec-CDT cellular 
activity.  
Essentially identical results were obtained when using CHO-K1 cells in the 
presence of NH4Cl, bafilomycin A1, monensin, or nigericin (data not shown), 
indicating that the disparate effects of agents that block endosomal acidification 
on Ec-CDT- or Hd-CDT-mediated cell cycle arrest in G2/M are not idiosyncratic to 
HeLa cells. Additional studies confirmed that neither the cellular binding nor the 
uptake of either Ec-CDT or Hd-CDT into cells from the plasma membrane was 
affected by NH4Cl, bafilomycin A1, monensin, or nigericin (data not shown).  
To more quantitatively assess whether the presence of the His-tag on the 
amino-terminus of the recombinant CDT subunits might alter CDT intracellular 
trafficking, we compared the dose-response curves of the His-tagged and non-
His-tagged forms of Ec-CDT and Hd-CDT in the presence or absence of NH4Cl 
or bafilomycin A1, both of which inhibited Hd-CDT-mediated G2/M cell cycle 
arrest, but not Ec-CDT-mediated G2/M cell cycle arrest. These studies revealed 
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that the dose response curves of the His-tagged and non-His-tagged forms of 
Ec-CDT and Hd-CDT were essentially identical in the presence or absence of 
NH4Cl or bafilomycin A1 (Figure 2.1). Taken together, these data indicated that 
Ec-CDT-mediated G2/M cell cycle arrest does not require acidification of 
endosomal compartments, suggesting that Ec-CDT and Hd-CDT are transported 
from the cell surface to the ER by different pathways. 
Effects of inhibiting endosomal acidification on toxin-transport to the ER. 
While an earlier study indicated that Hd-CDT mediated G2/M cell cycle arrest in 
HeLa cells was inhibited by several agents that block endosome acidification 
(Cortes-Bratti et al., 2000), the importance of endosome acidification for 
localization of Ec-CDT or Hd-CDT to the ER, the organelle from which CdtB 
subunits have been proposed to be translocated to the cytosol (Gargi et al., 
2012), has not been reported. To evaluate whether acidification of endosomal 
vesicles is required for intracellular toxin transport to the ER, we used 
fluorescence microscopy to determine whether Ec-CDT or Hd-CDT localization to 
the ER is altered in the presence of NH4Cl. These studies revealed that Ec-CDT 
localization to the ER is not visibly altered in the presence of NH4Cl (Figure 2.8A, 
B, E). In contrast, Hd-CDT localization to the ER was significantly reduced in the 
presence of NH4Cl (Figure 2.8C, D, E). Several attempts to evaluate CDT 
localization specifically to the ER using biochemical fractionation approaches 
were inconclusive due to the inability to satisfactorily resolve the ER from other 
membrane-containing fractions, with the exception of the nucleus. These results 
indicate that transport to the ER of Hd-CDT, but not Ec-CDT, requires 
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acidification of endosomal vesicles, and moreover, suggests that Ec-CDT and 
Hd-CDT may be transported to the ER via different trafficking pathways. 
Effects of endosomal acidification inhibitors on CdtB localization to the 
nucleus. Previous reports that CdtB possesses in vitro DNase I-like activity (C. A. 
Elwell & Dreyfus, 2000; Lara-Tejero & Galan, 2000) and localizes to the nucleus 
when expressed ectopically within the cytosol of mammalian cells (McSweeney & 
Dreyfus, 2004; Nishikubo et al., 2003; Wising et al., 2010), supports a model that 
this CDT subunit functions within the nucleus of intoxicated cells. To evaluate 
whether acidification of endosomal vesicles is required for intracellular toxin 
transport to the nucleus, we fractionated cells intoxicated for 60 min with Ec-CDT 
or Hd-CDT in the absence or presence of bafilomycin A1, and used western 
blotting to determine whether the localization of the CdtB subunit is altered when 
endosomal acidification was prevented. These studies revealed that most of the 
internalized Ec-CdtB or Hd-CdtB was associated with the nuclear fraction (Figure 
2.9), while neither CdtB subunit was associated with either the cytosolic or 
microsomal fractions. In contrast to the CdtB subunits, neither the CdtA or CdtC 
subunits of Ec-CDT or Hd-CDT were detected within the nuclear fractions (data 
not shown), which is consistent with the model that only the A fragments of 
retrograde-trafficked bacterial toxins are translocated out of the ER (Blanke, 
2006) and more recently, with immunofluorescence studies of the intracellular 
trafficking of CDT from Aggregatibacter actinomycetemcomitans (Damek-
Poprawa, Jang, Volgina, Korostoff, & DiRienzo, 2012). 
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Ec-CdtB was detected within the nuclear fractions prepared from cells that 
had been incubated with Ec-CDT holotoxin in the presence or absence of 
bafilomycin A1 (Figure 2.9). In contrast, Hd-CdtB was not detected in either the 
nuclear fraction or whole cell lysates prepared from cells that had been incubated 
with Hd-CDT holotoxin in the presence of bafilomycin A1 (Figure 2.9). We 
speculate that in the presence of bafilomycin A1, Hd-CdtB is either degraded 
within the endolysosomal system or, alternatively, recycled back to the cell 
surfaces and released, although we did not investigate either of these 
possibilities further. These results indicate that the transport of Hd-CdtB, but not 
Ec-CdtB, to the nucleus requires acidification of endosomal vesicles. 
Comparing the importance of late-endosome-targeted carrier vesicle 
biogenesis for Ec-CDT-and Hd-CDT-mediated H2AX phosphorylation. One of the 
consequences resulting from inhibition of the V-ATPase-mediated pH drop is 
inhibition of endosomal carrier vesicle formation, which facilitates transport 
between endosomal compartments (Hurtado-Lorenzo et al., 2006). To more 
directly evaluate the importance of late-endosome-targeted carrier vesicle 
transport for the intracellular activity of Ec-CDT or Hd-CDT, we compared toxin-
dependent phosphorylation of H2AX in cells expressing a dominant negative 
(DN) form of Rab7, a small GTPase required for late-endosome-targeted carrier 
vesicle biogenesis (Vonderheit & Helenius, 2005). Transiently transfected HeLa 
cells expressing Rab7 (T22N) fused to DsRed, (DN-DsRed-Rab7 (T22N)), which 
is defective in nucleotide exchange and has a reduced affinity for GTP (Spinosa 
et al., 2008) were incubated with either Ec-CDT or Hd-CDT. After 8 h, the 
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monolayers were examined using fluorescence microscopy to quantify the 
number of cells with phosphorylated H2AX (p-H2AX). Because approximately 
40%-60% of the cells in any well were discovered to be expressing DN-DsRed-
Rab7 (T22N), H2AX phosphorylation could be monitored within the same well in 
both transfected and non-transfected cells. These studies revealed significantly 
fewer DN-DsRed-Rab7 (T22N) expressing cells with p-H2AX activation than in 
non-transfected cells (Figure 2.10), supporting the idea that toxin trafficking from 
early to late endosomal compartments is important for the biological activity of 
Hd-CDT but not Ec-CDT. 
Comparing the importance of late-endosome-targeted carrier vesicle 
biogenesis for Hd-CdtB trafficking to the nucleus. Because the biological activity 
of CDTs is generally considered to require their CdtB subunits to function within 
the nucleus of intoxicated cells (Gargi et al., 2012), we hypothesized that DN-
DsRed-Rab7 (T22N) blocked the cellular activity of Hd-CDT by inhibiting the 
transport of Hd-CdtB to the nucleus. To evaluate this hypothesis, the nuclear 
localization of Ec-CdtB and Hd-CdtB was compared within transiently transfected 
HeLa cells expressing DN-DsRed-Rab7 (T22N) to non-transfected HeLa cells. 
These studies revealed significantly less Hd-CdtB localized to the nucleus of 
cells expressing DN-DsRed-Rab7 (T22N) than in non-transfected cells (Figure 
2.11). In contrast, Ec-CdtB was localized to the nucleus to approximately the 
same extent in cells expressing or not expressing DN-DsRed-Rab7 (T22N) 
(Figure 2.11), indicating that late-endosome-targeted carrier vesicle biogenesis is 
important for intracellular trafficking of Hd-CdtB, but not Ec-CdtB.  
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Comparing the localization of Ec-CDT-and Hd-CDT to Rab9-enriched 
vesicles. Because late-endosome-targeted carrier vesicle biogenesis is required 
to transport cargo from early to late vesicles within the endolysosomal system, 
we hypothesized that Hd-CdtB, but not Ec-CdtB is transported through late 
endosomal vesicles. To evaluate this hypothesis, we used fluorescence imaging 
to investigate the localization of Ec-CdtB and Hd-CdtB to vesicles enriched with 
the small GTPase Rab9, which contributes to the generation and maintenance of 
late endocytic compartments (Ganley, Carroll, Bittova, & Pfeffer, 2004). These 
experiments revealed that after 30 min, visibly more Hd-CdtB co-localized with 
Rab9-enriched puncta than Ec-CdtB (Figure 2.12), supporting the hypothesis that 
Hd-CdtB, but not Ec-CdtB, is transported through late endosomal vesicles. Taken 
together with the data presented above indicating the importance of late-
endosome-targeted carrier vesicle biogenesis for Hd-CDT but not Ec-CDT, these 
results suggest that the catalytic CdtB subunits of these two toxins are trafficked 
along distinct pathways. 
Relative cell binding of Ec-CDT and Hd-CDT. Analogous to all 
intracellular-acting bacterial exotoxins (Blanke, 2006), CDTs must bind to the 
surface of target cells prior to internalization (Cao et al., 2008; Mise et al., 2005). 
Studies to evaluate the binding of Ec-CDT and Hd-CDT to HeLa cells as a 
function of toxin concentration revealed that both Ec-CDT and Hd-CDT yielded 
saturable binding curves (Figure 2.13A, B). Moreover, the presence of a 100-fold 
molar excess of non-biotinylated toxins inhibited the dose-dependent cell 
association of biotinylated toxins, indicating that the binding of both Ec-CDT and 
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Hd-CDT was largely specific, with Kd values for specific binding of 172 (±27) nM 
(Figure 2.13A) and 169 (±35) nM (Figure 2.13B), respectively.  
Despite binding to the cell surface with similar properties, it was not clear 
whether Ec-CDT and Hd-CDT were binding to the same or discrete plasma 
membrane receptors. To differentiate between these possibilities, we evaluated 
whether Ec-CDT and Hd-CDT bind competitively to the surface of HeLa cells. 
These studies revealed that the binding of biotinylated Ec-CDT to the cell surface 
was inhibited to a greater extent by 100-fold molar excess of unlabeled Ec-CDT 
than a 100-fold molar excess of unlabeled Hd-CDT (Figure 2.14A). In a similar 
manner, cell surface binding of biotinylated Hd-CDT was found to be inhibited to 
a greater extent by 100-fold molar excess of unlabeled Hd-CDT than a 100-fold 
molar excess of unlabeled Ec-CDT (Figure 2.14B). These data suggest that while 
the interactions of both Ec-CDT and Hd-CDT with host cells are largely specific, 
the two toxins may bind to distinct cell surface components. In further support of 
this idea, the cell surface binding of Ec-CDT, but not Hd-CDT, was partially 
inhibited in the presence of EEA, a fucose-specific lectin that was previously 
reported to antagonize Ec-CDT binding to HeLa cells (McSweeney & Dreyfus, 
2005) (Figure 2.14C). 
 
2.4. Discussion  
The studies presented here revealed differences in the manner in which 
CDTs from two unrelated pathogenic bacteria intoxicate mammalian cells. Hd-
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CDT induces G2/M cell cycle arrest at substantially lower concentrations than Ec-
CDT in all tested cell lines (Figure 2.S1), consistent with a recent report 
demonstrating that Hd-CDT induces H2AX activation within cells at lower 
concentrations than Ec-CDT (Eshraghi et al., 2010). The high level of 
dissimilarity between the protein sequences of the CdtA and CdtC subunits (22% 
and 19% sequence identity, respectively) does not readily reveal the reasons 
underlying the divergent potencies of Ec-CDT and Hd-CDT, but is consistent with 
the idea that these two toxins may interact with and intoxicate cells by disparate 
mechanisms. Indeed, although both Ec-CDT and Hd-CDT possess similar in vitro 
DNase activities exhibited by their catalytic CdtB subunits (Figure 2.1), are both 
efficiently taken up by cells (Figure 2.S3), and both require an intact Golgi 
complex to induce G2/M cell cycle arrest (Figure 2.2), divergence was discovered 
in the cellular requirements associated with intracellular toxin transport (Figures 
2.3 – 2.8). Hd-CDT-mediated G2/M arrest and ER localization were inhibited by 
agents that prevent acidification of endosomal compartments, while Ec-CDT-
mediated G2/M arrest and ER localization were not affected.  
How might the requirement for acidification of endosomal compartments 
relate to the cyclomodulatory activities of Ec-CDT and Hd-CDT? Intoxication of 
cells by a subset of intracellular-acting bacterial toxins requires a drop of the 
luminal pH within endosomal compartments (Abrami, Reig, & van der Goot, 
2005; Blanke, 2006; Daro, Sheff, Gomez, Kreis, & Mellman, 1997; Sandvig & van 
Deurs, 2005; Tweten, 2005), which is a normal step in vesicle maturation carried 
out by the proton-pumping vacuolar ATPase (V-ATPase) (Nishi & Forgac, 2002; 
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Sun-Wada, Wada, & Futai, 2003, 2004). For diphtheria, anthrax, or botulinum 
toxins, the pH drop induces conformational changes in the toxin structure 
required for insertion into the endosomal membrane and translocation of the 
catalytic fragment into the cytosol (Blanke, 2006; Montecucco, Papini, & Schiavo, 
1994). However, preventing acidification of endosomal compartments can also 
stall the trafficking of proteins along the endosomal pathway, such as the 
mannose 6-phosphate receptor that is normally transported from late endosomal 
vesicles to the Golgi complex (Lombardi et al., 1993; Riederer, Soldati, Shapiro, 
Lin, & Pfeffer, 1994). Inhibition of the V-ATPase-mediated pH drop inhibits 
trafficking by blocking the formation of endosomal carrier vesicles, which facilitate 
transport between endosomal compartments (Hurtado-Lorenzo et al., 2006). The 
finding that the presence of NH4Cl or bafilomycin A1 significantly inhibited 
localization of Hd-CDT to the ER (Figure 2.4) or nucleus (Figure 2.5) 
respectively, suggests that Hd-CDT intoxication requires an intracellular transport 
pathway involving late endosomal compartments. This idea is further supported 
by the importance of Rab7, which regulates the biogenesis at early endosomes 
of transport vesicles targeted for late endosomal compartments (Figures 2.6, 
2.7), as well the co-localization of Hd-CdtB with Rab9 (Figure 2.8). 
 In contrast, our data support a model that Ec-CDT transport to the ER 
occurs by a mechanism independent of late endosome-mediated trafficking. 
Notably, several reports have indicated that the retrograde transport mechanisms 
of other toxins, including Shiga toxin (Mallard et al., 1998), cholera toxin (Lencer 
et al., 1995; Orlandi, Curran, & Fishman, 1993), or ricin (Simpson, Dascher, 
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Roberts, Lord, & Balch, 1995), are also insensitive to agents that prevent 
endosomal acidification, suggesting that these toxins are transported from early 
endocytic vesicles to the ER through a pathway that bypasses late endosomal 
compartments. Additional experimental work will be required to more completely 
define the Ec-CDT and Hd-CDT intracellular trafficking mechanisms, but we 
speculate that the overall pathway of Ec-CDT transport to the ER may be more 
similar to that used by Shiga toxin, cholera toxin, or ricin, than the pathway used 
by Hd-CDT. 
The molecular basis underlying the putative targeting of Ec-CDT and Hd-
CDT to discrete intracellular trafficking pathways is unclear. However, based on 
the inability of Ec-CDT or Hd-CDT to competitively bind to the surface of cells 
(Figure 2.10A, B), we hypothesize that the two toxins utilize distinct cell surface 
receptors. Inhibition of the cell surface binding of Ec-CDT, but not Hd-CDT, by 
the fucose-specific lectin EEA (Figure 2.10C) further supports this idea. Receptor 
recognition and binding is critical for the function of intracellular-acting toxins 
because the receptor, in part, functions as a molecular “carrier” whose normal 
uptake and trafficking through the cell directly impacts the final cellular 
destination of the toxin (Blanke, 2006). A cell surface receptor for Hd-CDT has 
not yet been identified, but a genetic screen using the KBM7 chronic myeloid 
leukemia cell line revealed that a putative G protein–coupled receptor, 
TMEM181, contributes to cellular binding and sensitivity to Ec-CDT (Carette et 
al., 2009). Our competition studies (Figure 2.10) suggest that Hd-CDT and Ec-
CDT do not share the same receptor, but we cannot rule out the possibility of a 
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role for TMEM181 in conferring cell sensitivity to Hd-CDT. Consistent with the 
idea that Ec-CDT and Hd-CDT may bind to different receptors on the surface of 
sensitive cells, a recent study reported that a mutant CHO cell line, characterized 
by abbreviated glycan sequences on membrane glycoproteins and glycolipids, 
was hypersensitive to Hd-CDT, but demonstrated the same sensitivity as the 
parental CHO cells to Ec-CDT (Eshraghi et al., 2010). 
Comparing the molecular and structural basis for Ec-CDT and Hd-CDT 
receptor recognition is currently challenging because, even though the crystal 
structure has been solved for Hd-CDT (Nesic et al., 2004), high-resolution 
structural data is not yet available for the Ec-CDT holotoxin. The highly dissimilar 
protein sequences of the CdtA and CdtC subunits of Ec-CDT and Hd-CDT are 
consistent with the idea that these two toxins may interact with and intoxicate 
cells by disparate mechanisms. Additional studies will also be required to 
determine whether or not differences in intracellular trafficking pathways between 
Ec-CDT and Hd-CDT directly contribute to the disparity in the potencies exhibited 
by the two toxins towards sensitive cells. Nonetheless, we speculate that 
differential cell surface requirements for toxin association is critical for targeting 
Ec-CDT and Hd-CDT to their respective uptake and intracellular trafficking 
pathways. 
Multiple factors could potentially contribute to the differences in cellular 
potencies of Ec-CDT and Hd-CDT. For example, discrepancies in the cytosolic 
localization of the respective CdtB subunits, which is widely thought to precede 
localization to the nucleus, may contribute to differences in toxin potencies. In 
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studies to compare the levels of Ec-CdtB and Hd-CdtB within the cytosol of 
intoxicated cells, we could not detect Ec-CdtB and Hd-CdtB by either 
fluorescence microscopy or cellular fractionation and western blot analysis (data 
not shown). We speculate that the levels of Ec-CdtB and Hd-CdtB within the 
cytosol in these experiments were below our detection limits. A recent study 
reported the detection of a fluorescent version of CdtB from A. 
actinomycetemcomitans within the cytosol and nucleus (Damek-Poprawa et al., 
2012). On the other hand, in another recent study, the authors suggested that 
Hd-CdtB localization to the nucleus not require that this subunit to be first 
translocated to the cytosol (Guerra et al., 2009).  
In summary, we have identified differences in the intoxication pathways 
used by CDTs from pathogens that colonize two distinct niches. Because CDTs 
are generally believed to disrupt the normal functions of epithelial and immune 
cells comprising the mucosal barrier (Nougayrede et al., 2005; Oswald et al., 
2005), we speculate that Ec-CDT and Hd-CDT may have evolved divergently in 
response to the specific tissue and cell tropisms of the pathogenic microbes that 
produce these toxins. Finally, these results provide experimental evidence that 
caution must be applied when extrapolating the properties of individual CDTs to 
the entire family of these toxins. 
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2.5. Figures 
 
 
 
Figure 2.1. Effect of N-terminal His-tag on the activities of Ec-CDT and Hd-
CDT. Monolayers of HeLa cells were incubated in presence of the indicated 
concentrations of Hd-CDT (A, C) or Ec-CDT (B, D), with (circle) or without 
(square) N-terminal His-tag, in the presence (empty circle or square), or absence 
(filled circle or square), of NH4Cl (A, B) or bafilomycin A1 (C, D). After 24 h, the 
cells were analyzed for arrest in G2/M using flow cytometry, as described under 
“Experimental Procedures.” The data, which were combined from three 
independent experiments, were rendered as the percentage of cells in G2/M as a 
function of toxin concentration. 
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Figure 2.2. Cell line sensitivities to Ec-CDT or Hd-CDT. Monolayers of HeLa 
(A, B), CHO-K1 (C, D), Caco-2 (E, F), or INT-407 (G, H) cells were incubated in 
the absence or presence of Hd-CDT (filled squares, 10-13-10-9 M; A, C, E, G) or 
Ec-CDT (empty circles; 10-12-10-6 M; B, D, F, H). After 48 h, the cells were 
analyzed for arrest in G2/M using flow cytometry, as described under 
“Experimental Procedures.” The data were rendered as the percentage of cells in 
G2/M as a function of toxin concentration. For each cell line, there were 
characteristic differences in the baseline average of untreated cells in G2/M, as 
well as the maximum number of toxin-treated cells arrested in G2/M. The value 
associated with each dose-response curve is the CCAD50 value (+/- standard 
deviation), which was determined as described under “Experimental 
Procedures,” and derived from data combined from three or more independent 
experiments. 
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Figure 2.3. Dialysis retention assay of Ec-CDT and Hd-CDT. The assembled 
Ec-CDT and Hd-CDT holotoxins, as well as the Ec-CdtC subunit alone, were 
dialyzed in 100 kDa molecular mass cut-off dialysis tubing at 4 °C against four 
changes of PBS pH 7.4 (total dialysis exchange factor of 1.6 x 109) for a total 
time of 24 h. Identical amounts of dialyzed (labeled as “post-dialysis”) and non-
dialyzed (labeled as “pre-dialysis”) samples, were resolved using SDS-PAGE 
and visualized after staining with Coomassie Brilliant blue and destaining. The 
data shown are representative of those collected for every preparation of the Ec-
CDT or Hd-CDT holotoxins. 
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Figure 2.4. In vitro DNase activities of Ec-CdtB and Hd-CdtB. The DNase 
activities of Ec-CdtB (filled triangles) and Hd-CdtB (filled circles) were determined 
as described under Experimental Procedures, and plotted as a function of toxin 
concentration. The rendered data were combined from three independent 
experiments, each conducted in triplicate. Error bars indicate standard 
deviations. Statistical significance was calculated for the differences in relative 
DNase activities at the indicated concentrations of Ec-CdtB and Hd-CdtB. * 
indicates P < 0.05. 
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Figure 2.5. Fluorescence microscopy analysis of Ec-CDT and Hd-CDT 
uptake into cells. Binding (A, C) or internalization (10 min; B, D) of Ec-CDT (A, 
B) or Hd-CDT (C, D) (both at 100 nM) into HeLa cells was visualized using 
DIC/fluorescence microscopy, as described under Experimental Procedures. The 
data were rendered as a single z-plane (5 µm depth within each cell). Green 
puncta indicate Ec-CDT or Hd-CDT, as indicated, and blue indicates the DAPI-
stained nucleus. White bars indicate 10 µm. The data shown are representative 
of images collected during three independent experiments. 
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Figure 2.6. Effects of BFA on Ec-CDT- or Hd-CDT-induced cell cycle arrest. 
Ec-CDT (100 nM)- or Hd-CDT (5 pM)-mediated arrest of HeLa cells in G2/M was 
determined in the absence or presence of BFA (0.2 µg/ml). (A) The data are 
rendered as individual histograms representative of those collected during three 
independent experiments. Histograms indicate the number of cells (y axis, same 
scale for each histogram) at a given PI fluorescence intensity (x axis, same scale 
for each histogram), with, as indicated in the top left histogram, the left peak 
representing cells in G0/G1 phase (designated as G1) of the cell cycle, the right 
peak representing cells in G2/M (designated as G2), and the area between the 
peaks representing cells in S phase (designated as S). The results are rendered 
as bar graphs generated from data combined from three or more independent 
experiments that compare the percentage of cells arrested in G2/M in untreated 
cells (white bar), cells treated with either Ec-CDT or Hd-CDT, as indicated, in the 
absence of BFA (black bars), or cells treated with BFA in the absence or 
presence of Ec-CDT or Hd-CDT, as indicated (gray bars). Error bars represent 
standard deviations. Statistical significance was calculated for the differences 
between cell populations incubated in the absence or presence of BFA. 
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Figure 2.7. Effects of agents that inhibit acidification of endosomal 
compartments on Ec-CDT- or Hd-CDT-induced cell cycle arrest. Ec-CDT 
(100 nM)- or Hd-CDT (5 pM)-mediated arrest of HeLa cells in G2/M was 
determined, as indicated in the absence or presence of NH4Cl (20 mM; A, B), 
bafilomycin A1 (20 nM; C, D), monensin (10 nM; E), or nigericin (100 nM; E). (A, 
C) The data are rendered as individual histograms representative of those 
collected during three independent experiments. In (C), bafilomycin A1 is 
abbreviated as baf. A1 in the 2 lower panels. (B, D, E) The results are rendered 
as bar graphs generated from data combined from three independent 
experiments that compare the percentage of cells arrested in G2/M phase in 
untreated cells (white bars), cells treated with Ec-CDT or Hd-CDT, as indicated, 
in the absence of pharmacological agents (black bars), or cells treated with 
pharmacological agents, as indicated, in the absence or presence of Ec-CDT or 
Hd-CDT (gray bars). Error bars represent standard deviations. Statistical 
significance was calculated for the differences between cell populations 
incubated in the absence or presence of the indicated agent. 
 
 
no treatment          NH4Cl
Ec-CDT/baf. A1    Hd-CDT/baf. A1 
 no treatment        bafilomycin A1
 Ec-CDT/NH4Cl    Hd-CDT/NH4Cl
A.
B.
C.
D.
80
60
40
20
  0
ce
lls
 in
 G
2/M
 (%
)
80
60
40
20
  0
ce
ll 
co
un
t
relative DNA content
ce
ll 
co
un
t
relative DNA content
P = 0.05
P = 0.004
P = 0.04
P = 0.0006
NH4Cl
Hd-CDT
Ec-CDT
-
-
-
-
-
+ -
-
+
-
- -
-
+
+ +
+ +
-
-
-
-
-
+ -
-
+
-
- -
-
+
+ +
+ +
Hd-CDT
Ec-CDT
bafilomycin A1
ce
lls
 in
 G
2/M
 (%
)
monensin
nigericin
Hd-CDT
Ec-CDT
P = 0.001
100
80
60
40
20
0
P = 0.0004
 P = 0.001
P = 0.001
-
-
-
-
-
-
-
+ -
-
-
+
-
-
-
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
+
+
-
-
-
+
E.
 Ec-CDT              Hd-CDT  Ec-CDT                Hd-CDT 
P = 0.02 P = 0.02
P = 0.4
P = 0.5
ce
lls
 in
 G
2/M
 (%
)
    
80 
 
 
 
Figure 2.8. Effects of agents that inhibit acidification of endosomal 
compartments on Ec-CDT or Hd-CDT localization to the ER. HeLa cells that 
had been transiently transfected with pDsRed2-ER were incubated with Ec-CDT 
(200 nM; A, B, E) or Hd-CDT (200 nM; C, D, E) at 37 °C for 60 min in the 
absence (A, C, E) or presence (B, D, E) of NH4Cl (20 mM), were imaged using 
fluorescence microscopy. (A-D) Cellular actin was counterstained with phalloidin 
conjugated with Alexa Fluor 647. Images were representative of those collected 
from three independent experiments. The data were rendered as a single z-plane 
(5 µm depth within each cell). As labeled, green puncta indicate either Ec-CDT or 
Hd-CDT, red puncta indicate ER, white or blue filaments indicate actin, and Ec-
CDT or Hd-CDT localized to ER is indicated by yellow puncta. White bars 
indicate 10 µm. The solid white boxes are digitally enlarged images of the smaller 
dashed white boxes. (E) The results are rendered as a bar graph generated from 
data combined from three independent experiments that compare the Pearson’s 
correlation coefficient for Ec-CdtB or Hd-CdtB co-localized with ER in cells 
treated with Ec-CDT or Hd-CDT, as indicated, in the absence of NH4Cl (black 
bars), or cells treated with toxin, as indicated, in the presence of NH4Cl (gray 
bars). Error bars represent standard deviations. Statistical significance was 
calculated for differences in the Pearson’s correlation coefficient between cell 
populations incubated in the presence or absence of NH4Cl. 
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Figure 2.9. Effects of inhibiting acidification of endosomal compartments 
on Ec-CdtB or Hd-CdtB localization to the nucleus. HeLa cells pretreated with 
bafilomycin A1 (20 nM) were incubated at 37 °C with either Ec-CDT (100 nM) or 
Hd-CDT (100 nM). After 30 min, the cells were washed and then further 
incubated at 37 °C. After another 210 min, the monolayers were lysed and 
fractionated as described under Experimental Procedures. (A) Western blots are 
shown, which are representative of three independent experiments. The whole 
cell lysate (CL), microsomal fraction (M), nuclear fraction (N), and cytosolic 
fraction (CS) were each analyzed by western blot analysis for CdtB, calnexin (ER 
marker, representing microsomes), GAPDH (cytosolic marker), and p84 (nuclear 
matrix marker). Arrowheads indicate CdtB in the nuclear fraction of bafilomycin 
A1-treated cells. (B) Quantitative rendering of the western blot data for CdtB, as 
shown in Part (A), using densitometric analysis. For each toxin (Ec-CDT or Hd-
CDT) and for each treatment (+/- bafilomycin A1), the data were rendered as bar 
graphs showing the amount of CdtB in each fraction relative to the pixels for 
CdtB in the cell lysate normalized to 1.0. The data are combined from 3 
independent experiments. Error bars represent standard deviations. Statistical 
significance was calculated for the difference between amount of CdtB in whole 
cells lysate (black bar to the left of white), against nuclear fraction (white bar). 
re
la
tiv
e 
C
dt
B
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
wh
ole
 ce
ll l
ys
ate
 
wh
ole
 ce
ll l
ys
ate
 
wh
ole
 ce
ll l
ys
ate
 
wh
ole
 ce
ll l
ys
ate
 
nu
cle
us
 
cy
tos
ol 
mi
cro
so
me
s 
nu
cle
us
 
cy
tos
ol 
mi
cro
so
me
s 
nu
cle
us
 
cy
tos
ol 
mi
cro
so
me
s 
nu
cle
us
 
cy
tos
ol 
mi
cro
so
me
s 
P = 0.12 P = 0.30 P = 0.08 P = 0.02
(+) bafilomycin (+) bafilomycin
 (-) bafilomycin   (+) bafilomycin 
-p84 (nucleus) 
-calnexin (ER) 
-GAPDH (cytosol) 
Hd-CDT 
 (-) bafilomycin   (+) bafilomycin 
CL   N   CS   M    CL   N   CS   M  Ec-CDT    CL   N   CS   M     CL   N   CS   M  Hd-CDT
Ec-CDT 
-CdtB 
A.
B.
Hd-CDT Ec-CDT 
    
82 
 
 
 
 
Figure 2.10. Evaluating the effects of ectopic expression of dominant-
negative Rab7 (T22N) on Ec-CDT- or Hd-CDT-mediated activation of H2AX. 
HeLa cells that had been transiently transfected with a plasmid harboring the 
gene encoding dominant negative DsRed-Rab7 (T22N) (Rab7-DN) were 
incubated with Ec-CDT (200 nM; A, C) or Hd-CDT (200 nM; B, C) at 37 °C. After 
8 h, the monolayers were fixed and imaged using fluorescence microscopy. (A 
and B) Cellular actin was counterstained with phalloidin conjugated with Alexa 
Fluor 647. Images were representative of those collected from three independent 
experiments. The data were rendered as a single z-plane (5 µm depth within 
each cell). As labeled, green puncta indicate phospho-H2AX (pH2AX), red 
puncta indicate Rab7-DN, white filaments indicate actin, and the blue staining 
indicates the nucleus. White bars indicate 10 µm. (C) Quantification of Ec-CDT- 
or Hd-CDT-mediated activation of H2AX. The data, which were combined from 
three independent experiments, are rendered as the percentage of cells within 
the monolayers with activated H2AX, as indicated by presence of green 
fluorescence within the nucleus, relative to untransfected cells. 
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Figure 2.11. Effects of ectopic expression of dominant-negative Rab7 
(T22N) on Ec-CdtB or Hd-CdtB localization to the nucleus. HeLa cells that 
had been transiently transfected with a plasmid harboring the gene encoding 
dominant negative DsRed-Rab7 (T22N) (Rab7-DN), were chilled to 0 °C on ice 
for 30 min, and then incubated on ice with either Ec-CDT (200 nM) or Hd-CDT 
(200 nM), both of which had also been pre-chilled on ice. After 30 min, the cells 
were washed once with ice-cold PBS pH 7.4, and then further incubated at 37 
°C. After 60 min, the monolayers were fixed and evaluated by fluorescence 
imaging. (A and B) Images were representative of those collected from three 
independent experiments. The data were rendered as a single z-plane 
(approximately 5 µm depth within each cell). As labeled, green puncta indicate 
either Ec-CdtB (A) or Hd-CdtB (B), red puncta indicate cells expressing DsRed-
Rab7-DN, and the blue staining indicates the nucleus. White scale bars indicate 
10 µm. (C) The results are rendered as a bar graph generated from data 
combined from three independent experiments that compare the percentage of 
cells with at least one green puncta (corresponding to either Ec-CdtB (white bars) 
or Hd-CdtB (black bars)) localized to the nucleus in cells expressing or not 
expressing Rab7-DN. Error bars represent standard deviations. Statistical 
significance was calculated for differences in the percentage of nuclear 
localization of either Ec-CdtB or Hd-CdtB between cell populations expressing or 
not expressing DsRed-Rab7-DN. 
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Figure 2.12. Evaluating the co-localization of Ec-CdtB or Hd-CdtB with 
Rab9. HeLa cells that had been prechilled on ice for 30 min, were incubated on 
ice with either Ec-CDT (100 nM) or Hd-CDT (100 nM), each of which had also 
been prechilled on ice. After 30 min, the cells were washed once with PBS pH 
7.4, and then further incubated at 37 °C. After 30 min, the cells were fixed and 
imaged using fluorescence microscopy. (A and B) Images were representative of 
those collected from three independent experiments. The data were rendered as 
a single z-plane (approximately 5 µm depth within each cell). As labeled, green 
puncta indicate either Ec-CdtB or Hd-CdtB, red puncta indicate Rab9, and Ec-
CdtB or Hd-CdtB co-localized with Rab9 is indicated by yellow puncta. White 
bars indicate 10 Μm. The solid white boxes are digitally enlarged images of the 
smaller dashed white boxes. (C) The results are rendered as a bar graph 
generated from data combined from three independent experiments that 
compare the Pearson’s correlation coefficient for Ec-CdtB or Hd-CdtB co-
localized with Rab9 in cells treated with Ec-CDT or Hd-CDT, as indicated. Error 
bars represent standard deviations. Statistical significance was calculated for 
differences in the Pearson’s correlation coefficient between cell populations 
incubated with Ec-CDT or Hd-CDT. 
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Figure 2.13. Cell surface binding of Ec-CDT and Hd-CDT. The data are 
rendered as the relative binding after 30 min of biotinylated forms of Ec-CDT (A) 
or Hd-CDT (B) to HeLa cells as a function of toxin concentration (1-200 nM) in 
the absence (indicated on the graphs as “total binding,” empty circles (A) or 
squares (B)) or presence (indicated on the graphs as “non-specific binding,” filled 
triangles (A) or diamonds (B)) of 100-fold molar excess of non-biotinylated Ec-
CDT (A) or Hd-CDT (B). Specific binding (indicated on the graphs as “specific 
binding,” filled circles (A) or squares (B)) was computationally derived by 
subtracting the non-specific binding data from the total binding data. The 
normalized data from three independent experiments, each conducted in 
triplicate, were combined. Kd values were calculated using non-linear regression, 
and indicated directly on the graphs, with the error bars indicating standard 
deviations.   
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Figure 2.14. Competitive cell surface binding of Ec-CDT and Hd-CDT in the 
absence or presence of cognate or non-cognate toxins. The data are 
rendered as the relative binding after 30 min of Ec-CDT (A) or Hd-CDT (B) to 
HeLa cells as a function of toxin concentration (1-200 nM) in the presence or 
absence of 100-fold molar excess of non-biotinylated cognate or non-cognate 
toxins, as indicated. The data were normalized and combined from three 
independent experiments, each conducted in triplicate, and rendered as line 
graphs comparing the relative binding of biotinylated Ec-CDT (A) or Hd-CDT (B) 
in the absence or presence of 100-fold molar excess of unlabeled Ec-CDT or Hd-
CDT, as indicated. Error bars are standard deviations. (C) The data are rendered 
as normalized relative binding of 100 nM of biotinylated Ec-CDT, or Hd-CDT to 
HeLa cells for 30 minutes, in the absence or presence of the lectin EEA (40 
µg/ml). Data are combined from three independent experiments, each conducted 
in triplicate. Error bars represent standard deviations. Statistical significance was 
calculated for differences in the cell-surface binding of Ec-CDT or Hd-CDT 
between cell populations incubated in the absence or presence of the lectin EEA. 
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CHAPTER 3: INTERACTIONS OF CDT WITH THE GOLGI APPARATUS 
 
3.1. Introduction 
One of the toxins reported to be secreted by Campylobacter jejuni, 
mammalian pathogen of the intestinal tract, is Cytolethal Distending Toxin (CDT) 
(Johnson & Lior, 1988; Young, Davis, & Dirita, 2007), member of a larger 
growing family of exotoxins (Gargi, Reno, & Blanke, 2012). These toxins have a 
tripartite structure, comprised of three proteins, of which CdtA and CdtC are 
thought to facilitate the delivery of the catalytically active subunit CdtB to its 
intracellular target (Lara-Tejero & Galan, 2001; Lee, Hassane, Cottle, & Pickett, 
2003). Though there is evidence that CdtB possess phosphodiesterase activity 
(Jinadasa, Bloom, Weiss, & Duhamel, 2011), structural and functional homology 
to DNase-I like enzymes suggest CDTs might function within the nucleus by 
damaging the DNA, thereby arresting the host cell cycle, potentially helping the 
intestinal pathogen to establish a successful infection (Biswas et al., 2006; Lara-
Tejero & Galan, 2000; Nesic, Hsu, & Stebbins, 2004; Pickett & Whitehouse, 
1999). To access their intracellular targets in the eukaryotic cells, soluble factors 
engage with cell surface determinants, followed by uptake into intracellular 
compartments. Protein transportation between the various membranous 
compartments is further mediated by cargo vesicles that bud off from the donor 
organelle and fuse with the target acceptor organelle (Bonifacino & Glick, 2004). 
Bacterial toxins, including CDTs, exploit these very same pathways where they 
utilize receptor-mediated endocytosis and vesicular trafficking, eventually to 
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reach the nucleus. The evidence indicating that CdtB does reach the nucleus are 
transient transfection, biochemical fractionation, and imaging (Gargi et al., 2013; 
Lara-Tejero & Galan, 2000; McSweeney & Dreyfus, 2004). However the specific 
details of how CdtB produced by C. jejuni, and other CDT-producing pathogens 
in general, access their intra-cellular target, are poorly understood. 
Although little is known about the exact steps involved in Cj-CDT transport 
to the nucleus, studies with CDTs released by other pathogens has revealed that 
CDT subunits localize with GM1-enriched membrane regions which are 
characteristic of membrane rafts, and cell surface cholesterol depletion reduced 
the binding activity of Cj-CDT on the cell membrane, leading to impaired toxin 
uptake, and attenuation of toxin-induced cell cycle arrest (Boesze-Battaglia et al., 
2006; Lin et al., 2011). Following cellular uptake, the toxin enters the 
endolysosomal system (Gillespie et al., 2013; Guerra, Cortes-Bratti, Guidi, & 
Frisan, 2011). The catalytically active subunit is transported through the 
endoplasmic reticulum (ER), and the exit from ER is important for the toxin 
activity, before finally getting into the nucleus (Damek-Poprawa, Jang, Volgina, 
Korostoff, & DiRienzo, 2012; Eshraghi et al., 2014). Yet very little is known about 
how the toxin gets to the ER. Studies with CDTs isolated from several other 
pathogens, including H. ducreyi, E. coli, and A. actinomycetemcomitans, have 
indicated the importance of an intact Golgi apparatus for the toxin function, and 
its affect on toxin transport to its target (Cortes-Bratti, Chaves-Olarte, Lagergard, 
& Thelestam, 2000; Gargi et al., 2013; Guerra et al., 2005). CDT is thought to 
traffic retrogradely through the Golgi apparatus based on sensitivity of cells to the 
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disruption of membrane transport by brefeldin A, and in addition Hd-CdtB that 
had been tagged with a sulfation motif, was sulfated when applied on mammalian 
cells (Guerra et al., 2005), suggesting that the toxin passes through the Golgi 
apparatus. However, the details of the mechanism by with Cj-CDT is transported 
to and engages with the Golgi apparatus, the importance of sub-Golgi 
compartments, and its implications on toxin’s biological activity are poorly 
understood. Moreover, no Golgi-resident protein associated with CDT-mediated 
cargo vesicle transport has been identified.  
In this study we demonstrate the importance of an intact and functional 
Golgi apparatus for toxin function, and localization, of active subunit of Cj-CDT to 
the nucleus. We demonstrate the time dependent and transient localization of Cj-
CdtB with the Golgi apparatus, and provide evidence supporting that Cj-CdtB 
utilizes the cellular machinery from the late-endosomal compartments to the 
Golgi apparatus. We show that Cj-CDT trafficking and intoxication properties are 
independent of early endosome to the Golgi apparatus transition, but are 
sensitive to the endosomal maturation, and the toxin is predominantly trafficked 
out of vesicles marked by STX10, and rab9, both indicators of transition through 
the late endosomal compartments, before reaching the Golgi apparatus. Blocking 
the Golgi apparatus sorting function by small molecule inhibitors abrogated 
downstream trafficking, and Cj-CDT mediated cell cycle arrest. Moreover, when 
the Golgi apparatus block was removed, the toxin already present in the cell 
proceeded to the nucleus, and caused cell cycle arrest, suggesting that Golgi 
apparatus is a bottleneck in the CDT intoxication of host cells. We also identified 
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the Golgi-membrane resident protein, COG complex, as the Golgi-receptor for 
incoming CDT-containing vesicles. Together, our findings suggest an important 
role of the Golgi apparatus in both function and trafficking of Cj-CdtB to the ER, 
and ultimately to the nucleus, and identifies specific host cell determinants 
required for the intracellular transportation, and biological activity of CDT 
produced by C. jejuni.  
 
3.2. Materials and Methods 
Cloning of cdt genes and preparation of expression strains. The plasmids 
used for recombinant expression of Cj-CDT in E. coli were constructed as 
previously described (Gargi et al., 2013). 
 
 Expression and purification of recombinant Cj-CDT. Recombinant forms of 
Cj-CdtA, Cj-CdtB, and Cj-CdtC, were expressed and purified as previously 
described (Eshraghi et al., 2010). Protein concentrations were quantified using 
the Bradford Protein Assay (Thermo Scientific, Rockford, IL). Recombinant 
proteins were used only when purified to at least 95% homogeneity, as estimated 
by resolving the proteins using sodium-dodecyl sulfate (SDS)-polyacrylamide gel 
electrophoresis (PAGE), and visualizing after staining the gels with Coomassie 
Brilliant Blue (Bio-Rad, Hercules, CA). The purified, denatured subunits were 
stored at -20 °C in HEPES (20 mM, N-[2-Hydroxyethyl] piperazine-N-[2-
ethanesulphonic acid], Calbiochem,  La Jolla, CA), pH 7.5 containing urea (8 M, 
Thermo Scientific) and NaCl (200 mM, Thermo Scientific). 
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 Dialysis retention assay. Cj-CDT holotoxin was prepared as previously 
described (Gargi et al., 2013). CDT holotoxin was purified to stoichiometric 
equivalence using gel filtration chromatography, and the holotoxin integrity was 
evaluated using the dialysis retention assay, as previously described (Cao, 
Volgina, Huang, Korostoff, & DiRienzo, 2005). Cj-CDT (5-20 µM, 1 ml) was 
dialyzed (100 kDa molecular mass cut-off tubing; Spectrum Laboratories) at 4 °C 
against four 250 ml volumes of PBS pH 7.4 containing 5% glycerol. After 24 h, 
the dialyzed proteins were evaluated using SDS-PAGE followed by staining with 
Coomassie Brilliant blue. The gels were scanned with a CanonScan 9950F 
scanner (Canon, Lake Success, NY) using ArcSoft Photo Studio 5.5 software 
(ArcSoft, Fremont, CA). The integrity of the holotoxins was quantified by 
comparing the relative intensities of the bands corresponding to CdtA, CdtB, or 
CdtC before and after dialysis, as determined by using the UN-SCAN-IT program 
(Silk Scientific, Inc., Orem, UT). Individual CDT subunits, each of which has a 
molecular mass less than 35 kDa, were used as negative controls to 
demonstrate that individual subunits diffused out of the dialysis bag.  
 
 Mammalian cells. All mammalian cell cultures were maintained at 37°C 
and under 5% CO2 within a humidified environment. Human colon colorectal 
carcinoma (HCT-116) cells (CCL-247, ATCC) were maintained in McCoy’s 5A 
media (ATCC) with 10% fetal bovine serum (FBS, Atlanta Biologicals, Flowery 
Branch, GA). Human cervical cancer epithelial (HeLa) cells (CCL-2, ATCC) were 
maintained in Minimal Essential Medium Eagle (MEM, Mediatech, Herndon, VA) 
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with 10% FBS. Chinese hamster ovary (CHO-K1) cells (CCL-61, ATCC) were 
maintained in Ham’s F-12K (Lonza, Walkersville, MD) with 10% FBS. Complete 
medium was obtained by supplementing each medium described above with L-
glutamine (2 mM, Sigma), penicillin (50 IU/ml, Mediatech), and streptomycin (50 
µg/ml, Mediatech). 
 
Flow cytometry. Analytical flow cytometry-based assays were carried out 
as previously described (Gargi et al, 2013). Briefly, HCT116, HeLa, or CHO-K1 
cells were intoxicated with indicated concentrations of Cj-CDT, in the absence or 
presence of indicated agents in a 12-well plates for 24 h, followed by two washes 
with Dulbecco's PBS (DPBS, Cellgro), detached with 0.05% trypsin/EDTA 
(Invitrogen), washed again with DPBS, and fixed with ice-cold 70% ethanol for 
minimum of 1 h, or maximum of 6 months at -20°C. After hydrating with PBS for 
30 minutes, cells were stained with a 10 µg/ml propidium iodide (PI) solution in 
PBS, containing 0.1% Triton-X100, and 100 µg/ml RNase-A. The fluorescence 
was quantified for 104 cells using a FACSCanto flow cytometer (BD Biosciences, 
San Jose, CA) with BD FACSDIVA acquisition software (BD Biosciences). Flow 
cytometry data were subsequently analyzed using FCS4 Express analysis 
software (De Novo Software, Glendale, CA). 
 
 Cell cycle phase determination. The indicated cell lines were seeded (8 x 
104 cells/800 µl/well) in 12-well plates (Corning Inc., Corning, NY). After 18 h, the 
cells were further incubated in complete medium in the absence or presence of 
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Cj-CDT at the indicated concentrations, or mock incubated with PBS pH 7.4. 
After 24 h, the cells were analyzed for arrest at the G2/M interface, as previously 
described (Gargi et al., 2013). From these data, dose response curves were 
generated by plotting cells in G2/M as a function of toxin concentration. From the 
dose response curves, we determined CCAD50 (i.e. cell cycle arrest dose50) 
values, which we defined as the toxin concentrations required to induce G2/M 
arrest in 50% of the cell population not already in G2/M. 
 For Cj-CDT, preliminary studies revealed nearly identical dose response 
curves for G2/M arrest in the presence or absence of the hexa-histidine tags. All 
subsequent studies were conducted with Cj-CDT assembled from subunits that 
retained their respective hexa-histidine tags. 
 Some studies were conducted in the presence of the indicated 
concentrations of brefeldin A (BFA; MP Biomedicals), Exo2 (Sigma), golgicide A 
(GCA; Sigma) ammonium chloride (NH4Cl, Sigma), bafilomycin A1 (LC 
Laboratories, Woburn, MA), monensin (Sigma), nigericin (Sigma), Retro-1 (kind 
gift from Julien Barbier), or Retro-2 (kind gift from Julien Barbier). These studies 
were conducted at approximately the CCAD50 values determined for Cj-CDT in 
order to best assess whether each pharmacological agent inhibited, potentiated, 
or had no effect on toxin activity. 
 
DIC/fluorescence microscopy. Chamber slides were analyzed using a 
DeltaVision RT microscope (Applied Precision; Issaquah, WA), using an 
Olympus Plan Apo 40x oil objective with NA 1.42 and working distance of 0.17 
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mm DIC images were collected using a Photometrics CoolSnap HQ camera; 
(Photometrics, Tucson; AZ). Images were processed using SoftWoRX Explorer 
Suite (version 3.5.1, Applied Precision Inc). Deconvolution was carried out using 
SoftWoRX constrained iterative deconvolution tool (ratio mode), and analyzed 
using Imaris 5.7 (Bitplane AG, Zurich, Switzerland). 
 
CDT localization inside the cell. HCT116, HeLa, or CHO-K1 cells were 
pretreated in the absence or presence of BFA (0.2 µg/ml) at 37 °C for 30 min. 
Cells were chilled for 30 min on ice, washed once with cold media, and replaced 
with pre-chilled media in the absence or presence of Cj-CDT (100 nM) in 
complete growth medium. After 30 min binding on ice, toxin containing media 
was removed, and replaced with pre-warmed media, and incubated at 37 °C At 
specified time points post internalization, cells were fixed and permeabilized as 
described above under “Internalization Assay.” To monitor Cj-CdtB localization to 
the Golgi, cells were incubated with rat polyclonal anti-Cj-CdtB antibody (1:500 
dilution), and mouse polyclonal anti-Giantin antibody (1:1000 dilution), or mouse 
polyclonal anti-TGN46 antibody (1:500 dilution) or anti-GM130 rabbit polyclonal 
antibody (1:1000 dilution), or mouse TOM20 polyclonal antibody (1:500 dilution), 
at 4 °C overnight, followed by incubation with anti-rat Alexa Fluor 488-labeled 
goat antibody (1:1000 dilution; Invitrogen) and anti-mouse Alexa Fluor 568-
labeled goat antibody (1:1000 dilution; Invitrogen) or anti-rabbit Alexa Fluor 568-
labeled goat antibody (1:1000 dilution; Invitrogen) at room temperature for 2 h. 
The cells were further counter stained for the nucleus by incubating with DAPI (1 
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ng/200 µl, Invitrogen) for 2 min at room temperature. The slides were mounted 
with ProLong Gold Antifade Reagent (25 µl/well; Invitrogen). Images were 
collected using DIC/fluorescence microscopy and deconvolved, as described 
above. For each cell, images were collected from an average of 30 z-planes, 
each at a thickness of 0.2 µm. Golgi localization analysis was conducted by using 
the DeltaVision SoftWoRx 3.5.1 software suite. Percentage of CdtB localization 
with giantin, TGN46, or GM130 in each group of treated cells were calculated 
from approximately 30 cells over three independent experiments. 
 
CDT localization to the Golgi apparatus. Mammalian cells were plated in 
an 8-well chamber slide to 30-40% confluency. After overnight incubation, cells 
were washed 2 times with PBS pH 7.4, followed by addition of 100 µL OPTI-
MEM (Invitrogen, Grand Island, NY), and further incubated for 2 h before 
transfection. Approximately 30 min prior to addition to cells, the appropriate 
dilutions of pECFP-Golgi (0.4 µg/200 µl/well), which encodes a fusion protein 
consisting of enhanced cyan fluorescent protein (ECFP) and a sequence 
encoding the N-terminal 81 amino acids of human beta 1,4-
galactosyltransferase, which contains the membrane-anchoring signal peptide 
that targets the fusion protein to the trans-medial region of the Golgi apparatus; 
and Lipofectamine 2000 reagent (1 µl/200 µl/well; Invitrogen) complex were 
prepared according to the manufacturers instructions, and allowed to incubate at 
room temperature. After 30 min, OPTI-MEM was removed, and the plasmid 
DNA-transfection mixture (100 µl) was added to each well in a drop-wise fashion 
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with gentle agitation, and the cells were immediately incubated at 37 °C and 
under 5% CO2. After 4 h, the transfection mixture was removed from the 
monolayers, and the cells were incubated in complete medium at 37 °C and 
under 5% CO2. After overnight incubation, we typically detected 80-90% of the 
cells within the monolayer to be transfected based on the percentage of cells with 
ECFP fluorescence, as determined using an Olympus CKX 41 fluorescence 
microscope (Olympus America Inc., Center Valley, PA). 
Images were collected using DIC/fluorescence microscopy and 
deconvoluted, as described above. For each cell, images were collected from an 
average of 30 z-planes, each at a thickness of 0.2 µm. Localization analysis was 
conducted by using the co-localization module of the DeltaVision SoftWoRx 3.5.1 
software suite. Results were expressed as the localization index, which was 
derived from calculating the Pearson’s coefficient of correlation values, which in 
these studies was a measure of localization of the indicated CDT to the Golgi 
apparatus in each z plane of the cell. In these studies, a localization index value 
of 1.0 indicates 100% localization of Cj-CDT to the Golgi apparatus, whereas a 
localization index of 0.0 indicates the absence of Cj-CDT localization to the Golgi 
apparatus. The localization index was calculated from the analysis of a total of 30 
images collected over three independent experiments. 
 
 Monitoring nuclear localization of Cj-CdtB within the nuclear fraction of 
CDT-intoxicated cells. Cells were seeded in 100 mm culture dishes (BD 
Biosciences, Durham, NC). After overnight incubation, the monolayers were 
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treated with bafilomycin A1 (20 nM) for 30 min, and further incubated with Cj-
CDT (100 nM). After 30 min, the cells were further incubated with fresh medium 
(not containing toxin) for an additional 210 min. After 240 min total internalization 
of Cj-CDT, the cells were harvested by scraping, and lysed and fractionated in 
the presence of protease and phosphatase inhibitors. Briefly, scraped cells were 
lysed using hypotonic buffer, and fractionated by isolating the nuclear pellet by 
centrifuging the cell lysate at 600g for 5 min. The fractionated samples were 
evaluated by western blotting, using rabbit polyclonal antibodies against Cj-CdtB 
(1:20,000 dilution; generated by Thermo Fisher Scientific Inc., Rockford, IL), 
cytosolic marker GAPDH (1:200; Abcam, Cambridge, MA), nuclear marker p84 
(1:2,000; Abcam), and cell lysate loading control actin (1:1,000; NeoMarkers, 
Fremont, CA). Anti-mouse (1:2,000), and anti-rabbit (1:5,000) secondary 
antibodies were purchased from Pierce Protein Biology Products (Thermo Fisher 
Scientific Inc.). Relative amounts of CdtB were determined by densitometric 
analysis of the blot bands using the UN-SCAN-IT program. 
 
RNA interference. Four synthetic siRNA duplex oligomers (19-mers) 
targeting human syntaxin 5 (first: CAGAACAUUGAGUCGACAA, second: 
CAAUCUUGGCAAAGCGCAA, third: GCUCCAGGAUUUCGUGAGA, fourth: 
GAGCCCAGCUGGACGUUGA), four 19-mers targeting human syntaxin 10 (first: 
GGAAGAGACCAUCGGUAUA, second: CGACCAAUGAGCUGCGGAA, third: 
AGGUGUUCGUGGAGCGGAU, fourth: AGGAAGUUGGCCAAAGUAU) were 
purchased from Dharmacon. Cells were transfected using Lipofectamine 
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(Invitrogen) according to the manufacturer's protocol. Experiments were carried 
out 2 days after transfection. Concentrations of 25 nM of siRNA were used for 
transfection. 
 
 Preparing stable cell lines with COG4 and COG8 knock-down. Mission 
shRNA transduction particles were purchased from Sigma targeting specific 
genes in the mammalian cells. For COG4, 
CCGGGTGACCGAGATCCTCGATTACCTCGAGGTAATCGAGGATCTCGGTCA
CTTTTTTG, COG8: 
CGGGTGTCCGGAACAGTTATTATGCTCGAGCATAATAACTGTTCCGGACAC
TTTTTG sequences were targeted. HCT116 cells were seeded overnight for 
80% confluency. Lentiviral particles with constructs targeting COG4, or COG8, 
were added to the cells in growth media containing polybrene. After 24 h 
incubation, media was removed, and replaced with fresh growth media, and 
incubated for additional 24 h. Media was removed and replaced with fresh media 
containing puromycin, and incubated for additional 48 – 72 h, allowing for 
Puromycin selection. Media with dead cells was replaced every 24 h. Surviving 
colonies of HCT116 cells were trypsinized, suspended in fresh media, and plated 
in a 96-well plate, serially diluted by a factor of 2, starting at 1:100 dilution of 
original cell suspension. Wells with a single cell colony were selected and 
passaged to expand stable cell line clonality. 
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H2AX activation assay. Cells were pretreated with BFA (0.2 µg/ml), or 
transfected with plasmids pDsRed-Rab5 DN, pDsRed-Rab9 DN, pDsRed-Rab11 
DN, mChActA, COG4-mChActA, or COG8-mChActA (0.4 µg/200 µl/well), or 
siRNA 19-mers against STX5 or STX10 (25 nM), using the general transfection 
procedure as described above under “CDT localization to the Golgi apparatus.” 
The treated monolayers, or stable COG4- or COG8-knockdown cell lines, were 
incubated at 37°C with Cj-CDT (100 nM). After 4 hours, the cells were fixed and 
permeabilized as described above under “Internalization Assay.” To monitor 
activation of H2AX by CDT, samples were stained overnight with a rabbit 
polyclonal anti-p-H2AX antibody (1:5000 dilution; Invitrogen) at 4 °C, followed by 
incubation with goat anti-rabbit Alexa Fluor 488 antibody (1:1000 dilution; 
Invitrogen) at room temperature for 2 h. The cells were further counter stained for 
nuclei by incubating with DAPI (1 ng/200 µl, Invitrogen) for 30 min. The slides 
were mounted with ProLong Gold Antifade Reagent (25 µl/well; Invitrogen). 
Images were collected using DIC/fluorescence microscopy and deconvoluted, as 
described above. For each cell, images were collected from an average of 30 z-
planes, each at a thickness of 0.2 µm. H2AX activation analysis was conducted 
by using the DeltaVision SoftWoRx 3.5.1 software suite. Percentage of H2AX 
activated cells in each group of cells were calculated from approximately 50 cells 
from each group over three independent experiments. 
 
 Monitoring nuclear localization of Cj-CdtB using fluorescence microscopy. 
Cells were pretreated with BFA (0.2 µg/ml), or transfected with pDsRed-Rab5 
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DN, pDsRed-Rab9 DN, pDsRed-Rab11 DN, mChActA, COG4-mChActA, or 
COG8-mChActA (0.4 µg/200 µl/well), using the general transfection procedure as 
described above under “CDT localization to the ER.” The transfected monolayers 
were pre-chilled for 30 min on ice and further incubated with Cj-CDT (100 nM) on 
ice for 30 min. After 60 min post internalization, the cells were fixed and 
permeabilized as described above under “Internalization Assay” To monitor Cj-
CdtB localization to the nucleus, cells were incubated with rat polyclonal anti-Cj-
CdtB antibody (1:500 dilution) at 4 °C overnight, followed by incubation with goat 
anti-rat Alexa Fluor 488-labeled antibody (1:1000 dilution; Invitrogen) at room 
temperature for 2 h. The cells were further counter stained for the nucleus by 
incubating with DAPI (1 ng/200 µl, Invitrogen) for 30 min at room temperature. 
The slides were mounted with ProLong Gold Antifade Reagent (25 µl/well; 
Invitrogen). Images were collected using DIC/fluorescence microscopy and 
deconvoluted, as described above. For each cell, images were collected from an 
average of 30 z-planes, each at a thickness of 0.2 µm. Nuclear localization 
analysis was conducted by using the DeltaVision SoftWoRx 3.5.1 software suite. 
Percentage of CdtB localization into nucleus in each group of treated cells were 
calculated from approximately 30 cells over three independent experiments. 
 
Transmission Electron Microscopy. Samples were treated according to the 
manufacturer’s protocol. In short, HCT116 cells were fixed with cold Karnovsky’s 
EM fixative (2.5% paraformaldehyde, 2% glutaraldehyde in 0.1 M Sorenson’s 
phosphate buffer, pH 7.2) overnight at 4°C. Fixed cells were rinsed with 0.1 M 
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Sorenson’s phosphate buffer pH 7.2 three times. Cells were further fixed with 2% 
OsO4 on ice for 20 sec. Samples were microwaved two times for 8 s, with a 20 s 
break, followed by incubation on ice for 20 s, and on shaker at room temperature 
for 5 min. This sequence was repeated 5 times, for a total of about 30 min 
incubation in OsO4. Retaining OsO4 on the cells, 3% K3[Fe(CN)6] was added and 
cells were further incubated at room temperature for 15min on shaker.  OsO4 and 
K3[Fe(CN)6] were removed and cells were rinsed with pure water three times. 
Cells were dehydrated with 25, 50, 75, 95, and 100% ethanol, and a 1:1 mixture 
of 100% ethanol and acetonitrile. In each dehydration step, cells were 
microwaved for 40 s and incubated at room temperature for 2 min on shaker. 
Cells were further microwaved for 30 s in 100% acetonitrile, followed by 2 min 
incubation at room temperature on shaker twice. For the cell infiltration, 1:1 
mixture of acetonitrile and epoxy resin mixture (LX-112 resin, DDSA, NMA, and 
DMP-30) was added to the cells, and microwaved for 30 s followed by shaking at 
room temperature for 10min, and repeated two times.  The process was further 
repeated twice with 1:3 mixture of acetonitrile and epoxy resin mixture (30 s 
microwaving and 20 min incubation at room temperature). Cells were embedded 
in epoxy resin mixture with 30 s microwaving and shaking for 30 min at room 
temperature. Epoxy resin mixture was replaced with fresh epoxy resin mixture, 
and cells were incubated at room temperature one more hour on shaker before 
polymerizing overnight at 65°C. Epoxy resin embedded cells were trimmed in 0.5 
X 0.5 mm squares or trapezoid block face using razor blade. Cells were 
sectioned 60 nm thin using Diatome diamond knife and Leica Ultracut Uct Ultra 
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Microtome.  Sections were captured on 200-mesh hexagonal copper or nickel 
grids. Samples were stained with 7% uranly acetate for 1 h and 0.3% lead citrate 
for 5 min. Stained samples were observed under Phillips CM200 transmission 
electron microscope. 
 
 Statistics. Unless otherwise indicated, each experiment was performed at 
least three independent times, each time in triplicate. Statistical analyses were 
performed using Microsoft Excel (Version 11.0, Microsoft, Redmond, WA) or 
GraphPad Prism (Version 5, La Jolla, CA). The Q-test was performed to 
eliminate data that were statistical outliers. Error bars represent standard 
deviations. All P values were calculated with the Student’s t-test using paired, 
two-tailed distribution. A P value of less than 0.05 indicated that differences in the 
specified data were considered statistically significant.  
 
 
3.3. Results 
Effects of brefeldin A (BFA) on Cj-CDT-induced G2/M cell cycle arrest. 
Several studies have reported that Hd-CDT-, Aa-CDT-, or Ec-CDT-mediated 
mammalian cell cycle arrest is blocked in the presence of BFA (Akifusa, 
Heywood, Nair, Stenbeck, & Henderson, 2005; Cortes-Bratti et al., 2000; Gargi et 
al., 2013; Guerra et al., 2005), suggesting that an intact Golgi apparatus is 
required for the cellular action of these toxins. BFA is an antifungal agent that 
alters Golgi apparatus integrity by inhibiting at least two factors, Golgi brefeldin A 
	  	   110 
resistance factor 1 (GBF1), which is involved in coordinating coating events 
within the pre-Golgi to Golgi complex continuum (Lowery et al., 2013) and BFA-
inhibited guanine nucleotide exchange factor 1 (BIG1), which is required to 
maintain the normal morphology of the Golgi (Togawa, Morinaga, Ogasawara, 
Moss, & Vaughan, 1999). Because the importance of an intact Golgi complex for 
intoxication of cells with Cj-CDT had not been previously studied, Cj-CDT-
mediated cell cycle arrest was evaluated in the presence or absence of BFA. In 
studies of Cj-CDT cellular activity, we primarily use human-derived HCT116 
intestinal cells, which have been widely used as an in vitro model for studying C. 
jejuni infection (McAuley et al., 2007). When HCT116 cells incubated with BFA 
(200 ng/ml) were examined by transmission electron microscopy (TEM), the 
characteristic Golgi stacks were no longer visibly detectable (data not shown), 
consistent with the idea that BFA causes the dispersion of the stacked Golgi 
cisternae so that protein transport through the Golgi apparatus is no longer 
functional (Nebenfuhr, Ritzenthaler, & Robinson, 2002; Sciaky et al., 1997). 
Moreover, immunofluorescence microscopy indicated that the giantin stained 
clusters typical of an intact Golgi apparatus were dispersed in the presence of 
BFA (200 ng/ml; Figure 3.6). Together, these preliminary experiments supported 
the idea that the concentration of BFA employed in our subsequent studies of Cj-
CDT cellular activity and localization was sufficient to disrupt the intact Golgi 
apparatus within HCT116 cells. 
 Monolayers of HCT116 cells were pre-incubated at 37 °C for 30 min in the 
absence or presence of BFA (200 ng/ml), and then was further incubated in the 
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absence or presence of Cj-CDT holotoxin (5 nM), which was generated by 
refolding together the Cj-CdtA, Cj-CdtB, and Cj-CdtC subunits that had been 
purified as recombinant proteins expressed individually in Escherichia coli, as 
previously described for Ec-CDT and Hd-CDT (Gargi et al., 2012; Gargi et al., 
2013). The concentration of Cj-CDT used in these experiments (5 nM) was 
determined in preliminary studies to induce cell cycle arrest of approximately half 
the HCT116 cells within a monolayer (Figure 3.1). Because preliminary 
experiments established that the presence or absence of a hexa-histidine peptide 
fused to the amino-terminus of all three subunits comprising the CDT holotoxin 
had no detectable effect on toxin function, His-tagged proteins were used for all 
the experiments conducted in this study (Figure 3.1). After 24 h, Cj-CDT-
intoxicated monolayers were evaluated for cell cycle progression by quantifying 
DNA content by flow cytometry. These studies revealed that HCT116 cells 
exposed to Cj-CDT exhibited 60% cell population at the G2/M interface. In 
contrast, HCT116 cells, that have been pre-incubated with BFA, demonstrated 
cell cycle progression at levels similar to those measured in monolayers mock 
incubated with PBS and not treated either with BFA or Cj-CDT (Figure 3.2). 
These data indicate that Cj-CDT-mediated cell arrest is inhibited in the presence 
of BFA. Consistent with these results, we also found that HCT116 cells 
preincubated with Exo2, which selectively inhibits GBF1 at trans-Golgi network, 
as a primary target among the ArfGEFs, or Golgicide A (Gol A), a highly specific 
and reversible inhibitor of the cis-Golgi ArfGEF GBF1 (Saenz et al., 2009), also 
blocked Cj-CDT mediated cell cycle arrest (Figure 3.2).  
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 To test the intoxication properties of Cj-CDT on the biological systems 
other than HCT116 cells, HeLa and CHO-K1 cell lines were tested for the 
capacity of Cj-CDT to induce cell cell arrest. The concentration of Cj-CDT used in 
these experiments to induce cell cycle arrest in approximately half the HeLa or 
CHO-K1 cells (CCAD50) was determined to be 4.5 nM, or 31 nM, respectively 
(Figure 3.3). BFA, Exo2, and golgicide A-dependent inhibition of Cj-CDT-
mediated cell cycle arrest was recapitulated in HeLa and CHO-K1 cells using the 
toxin dose close to, or slightly above the CCAD50 dose established in HCT116 
cells, for the respective cell line (Figure 3.4), which have been widely used to 
study the mechanism of Cj-CDT intoxication, suggesting that the requirement of 
an intact and functional Golgi apparatus for Cj-CDT cellular function is not 
idiosyncratic to HCT116 cell lines. Taken together, these results are consistent 
with a model that an intact Golgi apparatus is a requirement for Cj-CDT cellular 
intoxication. 
Effects of brefeldin A (BFA) on Cj-CDT-localization to the nucleus. While 
the demonstration that Cj-CDT-mediated cell cycle arrest is blocked in the 
presence of BFA is consistent with the idea that an intact Golgi apparatus is 
important for toxin action, these data do not provide an explanation for why an 
intact Golgi apparatus is important for Cj-CDT function. Previous studies reported 
that subsequent to uptake from the cell surface, the catalytic CdtB domain of Cj-
CDT (Damek-Poprawa, Korostoff, Gill, & DiRienzo, 2013), as well as Aa-CDT, 
Ec-CDT, and Hd-CDT, localizes to the nucleus (DiRienzo, 2014; Gargi et al., 
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2013), which has been proposed to be the site of toxin action (Lara-Tejero & 
Galan, 2000). In preliminary immunofluorescence imaging studies, we confirmed 
that CdtB was visible within nuclei of HCT116 cells within 90 min subsequent to 
Cj-CDT holotoxin application to the monolayers (Figure 3.5), which was similar to 
the time frame earlier reported for Ec-CDT and Hd-CDT (Gargi et al., 2013). To 
evaluate whether an intact and functional Golgi apparatus is important for Cj-
CdtB trafficking to the nucleus, we performed a “pulse” type of experiment in 
which cell entry of Cj-CDT was synchronized so that only pre-bound holotoxin at 
the cell surface was taken up into cells, allowing for monitoring of the uptake and 
trafficking of the “front-wave” of toxin into the cell. Monolayers of HCT116 cells 
were pre-incubated at 37 °C in the absence or presence of BFA (200 ng/ml), 
cooled to 4 °C, and then further incubated at 4 °C min in the absence or 
presence of Cj-CDT (100 nM). After 30 min, the monolayers were washed at 4 °C 
to remove unbound Cj-CDT, and then further incubated at 37 °C. Under these 
conditions, significantly fewer fluorescent puncta corresponding to immuno-
stained Cj-CdtB were detected within the nuclei of HCT116 cells incubated in the 
presence than absence of BFA (Figure 3.6) indicating that BFA blocked nuclear 
localization of Cj-CdtB. To validate that BFA was sufficient to block Cj-CDT-
mediated activation of the DNA repair response at the same higher toxin 
concentrations used for fluorescence imaging, HCT116 were pre-incubated in the 
absence or presence of BFA (200 ng/ml), and then further incubated at 37 °C 
with Cj-CDT at 100 nM rather than 5 nM, as described earlier. The monolayers 
were then assayed for both activation of H2AX (4 h) and cell cycle arrest (24 h). 
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These studies revealed that BFA blocked Cj-CDT-mediated H2AX activation and 
cell cycle arrest to the same extent in cells incubated with 100 nM Cj-CDT as 5 
nM Cj-CDT (data not shown), indicating that an intact functional Golgi apparatus 
is important for Cj-CDT cellular activity at both low and high toxin concentrations. 
Taken together, these results are consistent with a model that an intact Golgi 
apparatus is necessary for both Cj-CdtB arrival at the nucleus, which in turn is 
required for toxin mediated DNA damage. 
Evaluation of Cj-CDT localization with the Golgi apparatus. Our data are 
consistent with the idea that a functional Golgi apparatus is important for Cj-CDT 
localization to the nucleus, as well as toxin-dependent activation H2AX and 
subsequent arrest of cell cycle progression at the G2/M interface. However, these 
data do not address a possible functional role of the Golgi apparatus for toxin 
localization to the nucleus and toxin intracellular activity. The activity of several 
bacterial toxins, including cholera toxin and shiga toxin, depends on an intact and 
functional Golgi apparatus (Lauvrak, Torgersen, & Sandvig, 2004b; Lencer, Hirst, 
& Holmes, 1999). Because the physiological function of the Golgi apparatus is to 
receive, sort, move, and package macromolecules for delivery to different cellular 
targets, the Golgi apparatus is thought to play an integral role in trafficking to the 
endoplasmic reticulum, where the active fragment of these toxins are retro-
translocated to the cytosol (Bonifacino & Rojas, 2006). To evaluate the possibility 
that Cj-CdtB intracellular trafficking might involve the Golgi apparatus, we 
investigated whether CdtB localizes to the Golgi apparatus. HCT116 cells that 
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had been pre-chilled on ice, were pre-incubated on ice with Cj-CDT (100 nM) for 
30 min, and then further incubated at 37 °C. The cells were analyzed by 
fluorescence microscopy at several time points to determine the capacity of Cj-
CDT to localize to Golgi apparatus. These studies revealed the presence of 
green puncta, corresponding to Cj-CdtB, co-localized with red puncta, 
corresponding to giantin, a conserved Golgi membrane marker (Linstedt & Hauri, 
1993), indicating that Cj-CdtB co-localizes to the Golgi apparatus. Co-localization 
of Cj-CdtB with giantin was initially observed at 20 minutes, which decreased 
significantly at 30 min (Figure 3.5), suggesting that Cj-CdtB trafficks through the 
Golgi apparatus, preceding trafficking to the nucleus at 90 min. These results 
were further confirmed from experiments indicating that Cj-CdtB co-localizes with 
both the trans-Golgi marker TGN46, and cis-Golgi marker GM130 (data not 
shown). Collectively, these results are consistent with a model that Cj-CDT is 
transiently and rapidly trafficked to the Golgi apparatus as a requisite step for 
localization to the nucleus and the toxin’s cellular activity. 
Evaluation of Cj-CdtB trafficking from early endolysosomal compartments 
to the Golgi apparatus. The results discussed above are consistent with the idea 
that toxin trafficking through the Golgi apparatus is important for Cj-CdtB 
ultimately reaching the nucleus prior to causing DNA damage. However, these 
data do not address the trafficking of Cj-CDT within host cells prior to arriving at 
the Golgi apparatus. Previous work had demonstrated that Aa-CDT, Ec-CDT, 
and Hd-CDT are all taken up into early endolysosomal compartments (Gargi et 
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al., 2013). Consistent with these studies conducted with CDTs from other 
pathogen species, preliminary immunofluorescence imaging studies here 
revealed that Cj-CdtB co-localizes with early endosomal antigen-1 (EEA1) within 
10 min of synchronized uptake from the cell surface (data not shown). In 
addition, Cj-CDT-colocalization with EEA1 was visibly greater at 10 min than at 
15 and 20 min (data not shown), suggesting that Cj-CDT-colocalization with the 
Golgi apparatus is transient. These data are consistent with the idea that 
subsequent to cell entry, Cj-CDT is trafficked through early endosomal 
compartments. 
  To evaluate if Cj-CDT may disembark directly from early endosomal 
compartments to the Golgi apparatus, we measured the capacity of toxin to 
produce cell cycle arrest in G2/M interface in cells incubated in the absence or 
presence of two inhibitors, Retro-1 and Retro-2, which selectively re-localize 
SNARE protein syntaxin 5 (STX5), and to some extent STX6, thereby perturbing 
the early endosomal to Golgi trafficking, without affecting cellular morphology or 
other trafficking pathways (Stechmann et al., 2010). HCT116 cells that had been 
pre-incubated at 37 °C in the absence or presence of Retro-1 (10 µM) or Retro-2 
(30 µM), were incubated further in the absence or presence of Cj-CDT (5 nM) at 
37 ºC under 5% CO2. After 24 h, the monolayers were evaluated for cell cycle 
progression by cellular DNA content analysis. These studies revealed that Cj-
CDT induced the same degree of HCT116 cell cycle arrest at the G2/M interface 
in the absence or presence of Retro-1 or Retro-2 (Figure 3.7), suggesting that Cj-
CDT-dependent cell cycle arrest is not sensitive to Retro-1 or Retro-2 
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perturbation of STX5 mediated vesicular transport from early endosomal 
compartments to the Golgi apparatus. To further evaluate this idea, we compared 
the effects of Retro-1 on the Golgi apparatus localization of Cj-CdtB, or cholera 
toxin B subunit (CTxB), which previously was demonstrated to be transported 
from early endolysosomal compartments to the Golgi apparatus. These data 
revealed that in HCT116 cells, Retro-1 blocked the Golgi apparatus localization 
of CTxB, but not of Cj-CdtB, suggesting while Cj-CDT is not affected by 
perturbations in STX5, similar perturbations in STX5 affects the trafficking of 
CTxB to the Golgi apparatus (Figure 3.8).  
 Further validation of these results were derived from studies in which we 
evaluated the effects of disrupting the machinery involved in the fusion of 
vesicles originating from early endosomes destined for the Golgi apparatus on 
the capacity of Cj-CDT to localize to the Golgi apparatus. Docking and fusion of 
cargo-containing vesicles with the target organelles is mediated by molecular 
machines comprised of SNARE [SNAP (Soluble NSF Attachment Protein) 
Receptor] complex, which are present on the membranes of transport vesicles or 
target compartments. Syntaxins (STX) are an integral component of a subclass 
of SNAREs, called Q-SNAREs, which are involved in the trafficking of cargo 
within specific intracellular compartments. For early endosomal compartments 
destined to the Golgi transport, we used shRNA to knock down STX5, which is 
part of the STX5/Ykt6/GS28/GS15 SNARE complex, implicated in early 
endosome to Golgi apparatus trafficking (Amessou et al., 2007; Tai et al., 2004). 
HCT116 cells that were transfected with four siRNA constructs targeting different 
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parts of STX5 mRNA transcript (Dharmacon, Chicago, IL), showing about 90% 
knock-down of STX5 expression levels (Figure 3.9), were intoxicated with Cj-
CDT holotoxin or CTxB, and probed for the localization of Cj-CdtB, or CTxB, with 
the Golgi apparatus. These data revealed that knocking down STX5, while 
significantly reduced the localization of CTxB with giantin, had minimal effect on 
Cj-CdtB localization with giantin (data not shown). Furthermore, STX5-knock 
down cells treated with Cj-CDT demonstrated H2AX activation similar to wild-
type HCT116 cells (Figure 3.10). Taken together, these results suggest that Cj-
CdtB might traffic to the Golgi apparatus utilizing a pathway independent of early 
endosome to Golgi trafficking, which prompted us to explore alternate pathways 
Cj-CdtB might employ to disembark from the endolysosomal system.  
Evaluation of Cj-CdtB enrichment in late endolysosomal compartments. 
Our results above is consistent with a model that although Cj-CDT localizes to 
early endosomal vesicles subsequent to uptake from the cell surface, direct 
trafficking from these compartments to the Golgi apparatus is neither required for 
toxin cellular activity or Cj-CdtB arrival at the nucleus. However, these data do 
not address whether Cj-CdtB trafficking beyond early endosomal compartments 
is important for Cj-CDT cellular activity. To evaluate this possibility, we examined 
the effects of perturbing maturation of early endolysosomal compartments on the 
downstream trafficking of Cj-CDT and cellular activity of Cj-CdtB. To evaluate the 
effects of endosomal pH perturbing lysosomotropic agents on the biological 
activity of Cj-CDT, we first tested the correlation of late endosomal maturation on 
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the cytotoxic activity of Cj-CDT. HCT116 cells preincubated with ammonium 
chloride (20 mM), were intoxicated with Cj-CDT (5 nM), and analyzed for cell 
cycle progression 24 hours post-intoxication. These studies revealed that cell 
incubated in the presence of ammonium chloride demonstrated resistance to Cj-
CDT-mediated cell cycle arrest (Figure 3.11). Moreover, cells pretreated with 
bafilomycin A1 (20 nM), which inhibits the action of vacuolar ATPase, thus 
blocking the acidification of intracellular vacuoles, also demonstrated resistance 
to Cj-CDT-mediated cell cycle arrest (Figure 3.11). These data indicate that the 
transport of Cj-CdtB to the Golgi apparatus is sensitive to pH-neutralizing drugs 
that affect vesicular transport at the late endosomal compartments. These 
findings were confirmed by the effect of polyether ionophore monensin, which is 
known to block intracellular protein transport by collapsing proton gradients as a 
sodium/proton antiporter, and, the potassium/proton carboxylic ionophore, 
nigericin, both of which significantly reduced the levels of cells arrested in G2/M 
interface in response to Cj-CDT intoxication (Figure 3.12).  Taken together, these 
results suggest late endosomal biogenesis might be important for the capacity of 
Cj-CDT to produce cell cycle arrest, and the Cj-CdtB might be targeted to the 
Golgi compartments from the late endosomes.  
  Our results above are consistent with a model that normal maturation of 
early to late endosomal vesicles is important for Cj-CDT cellular activity. 
However, these data do not address whether Cj-CDT is trafficked beyond early 
compartments to late endolysosomal vesicles. To evaluate this possibility, we 
used fluorescence imaging to visualize the localization of Cj-CdtB with the small 
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GTPase Rab9, which contributes to the generation and maintenance of late 
endosomal compartments (Ganley, Carroll, Bittova, & Pfeffer, 2004). HCT116 
cells that were pre-chilled on ice, and then pre-incubated with Cj-CDT (100 nM) 
at 4 °C. After 30 min, the monolayers were washed to removed unbound Cj-CDT, 
and then further incubated at 37 °C, which are conditions that are permissive for 
uptake of surface-bound Cj-CDT. At 0, 10, and 20 min, HCT116 cells were 
analyzed for localization of Cj-CdtB with Rab9 using immunofluorescence 
microscopy. Our data revealed that green puncta, indicating Cj-CdtB, and red 
puncta, indicating Rab9, demonstrate significant co-localization, indicated by 
yellow puncta, within 10 min of Cj-CDT internalization (data not shown). Because 
we demonstrated above that Cj-CdtB localization to the Golgi apparatus is not 
detectable until 20 min after altering medium conditions to allow Cj-CDT uptake, 
these results are consistent with the model that the toxin is trafficked through late 
endolysosomal compartments prior to reaching the Golgi apparatus. 
Evaluation of Cj-CdtB trafficking from late endolysosomal compartment to 
the Golgi apparatus. The results above are consistent with a model that 
subsequent to uptake from the plasma membrane, Cj-CDT trafficking within the 
endolysosomal system from early to late endosomal compartments is important 
for the toxin’s cellular activity. However, these data did not address whether toxin 
egress from late to endosomal compartment is required for the toxin’s cellular 
activity. To evaluate the importance of Cj-CDT trafficking out of late endosomal 
compartments, we compared Cj-CDT-dependent phosphorylation of H2AX (as an 
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early marker of DNA-damage response, (Kuo & Yang, 2008; Sharma, Singh, & 
Almasan, 2012)) in untransfected HCT116 cells versus HCT116 cells that had 
been transiently transfected with a plasmid expressing a gene encoding and 
dominant-negative form of Rab9 (DN-Rab9 (S21N)) fused to DsRed, (DN-
DsRed-Rab9 (S21N)), which is defective in nucleotide exchange and has a 
reduced affinity for GTP (Choudhury et al., 2002). The GTPase Rab9, 
component of the late endosome-to-TGN pathway, is required for efficient 
trafficking of cargo, like furin, from late endosomes to the Golgi apparatus (Chia, 
Gasnereau, Lieu, & Gleeson, 2011; Pfeffer, 2009). We evaluated the importance 
of a functional Rab9 in the retrograde trafficking of Cj-CDT in HCT116 cells. 
Monolayers of HCT116 cells that contained cells expressing and not expressing 
DN-DsRed-Rab9 (S21N) were incubated at 37 °C in the absence or presence of 
Cj-CDT (100 nM), and then scored after 4 h for the percentage of cells with 
visible H2AX phosphorylation. Because not all cells within HCT116 monolayers 
were successfully transfected (as indicated by the lack of red fluorescence 
corresponding to the expression of DN-DsRed-Rab9 (S21N), we scored pDN-
DsRed-Rab9 transfected and non-transfected cells simultaneously within 
individual wells for H2AX phosphorylation. These studies revealed significantly 
fewer cells with nuclear-localized green fluorescence corresponding to 
phosphorylated H2AX in cells expressing DN-DsRed-Rab9 (Figure 3.13). These 
data indicate that Cj-CDT-mediated activation of the host cell’s DNA repair 
response is inhibited in cells in which egress from late endosomal vesicles is 
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impaired, which is consistent with the idea that Cj-CDT trafficking through late 
endolysosomal compartments is important for toxin mediated cellular activity. 
  Although the above results support a model that Cj-CDT trafficking 
through late endolysosomal compartments is required for toxin cellular activity, 
these data do not address whether egress of Cj-CDT from late endosomal 
vesicles is important for toxin localization to the Golgi apparatus or the nucleus, 
both of which we have demonstrated are required for toxin activity. To evaluate 
this idea, we determined the extent to which Cj-CdtB is localized to the Golgi 
apparatus and nucleus in cells in which egress from late endolysosomal vesicles 
was impaired. Monolayers of HCT116 cells that contained cells expressing and 
not expressing DN-DsRed-Rab9 (S21N) were pre-chilled on ice to prevent the 
internalization of cell surface membrane components, and then further incubated 
on ice in the presence or absence of Cj-CDT (100 nM). After 30 min, the 
monolayers were washed to removed unbound Cj-CDT, and then further 
incubated at 37 °C to allow for uptake and intracellular trafficking of plasma 
membrane-bound toxin. After 20 and 90, the cells were monitored for Cj-CDT 
localization to the Golgi apparatus and nucleus, respectively, using 
immunofluorescence microscopy. These studies revealed that Cj-CdtB 
colocalization with giantin, and DAPI-stained nuclei, were significantly reduced in 
cells expressing DN-Rab9 versus untransfected cells (data not shown), indicating 
that functional Rab9 GTPase is important for the downstream trafficking of Cj-
CdtB to the Golgi apparatus, and the nucleus. Taken together, these results 
suggest that toxin egress from late endolysosomal vesicles is important for 
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subsequent localization of the Golgi apparatus and nucleus, which is consistent 
with a model that Cj-CDT trafficking through late-endolysosomal compartments is 
required for toxin localization and function within the nucleus.  
  Although the results described above support the idea that Cj-CdtB 
trafficking through the late endosomes is important for toxin localization to the 
Golgi apparatus and nucleus, these data don’t address whether Cj-CDT is 
trafficked directly from late-endolysosomal compartments to the Golgi apparatus. 
To evaluate this possibility, we investigated the effects of disrupting a known 
pathway for the trafficking of membrane-associated cargo from late-endosomal 
vesicles to the Golgi apparatus. Specifically, steady-state levels of syntaxin10 
(STX10) were knocked-down using STX10-specific siRNAs. STX10 is part of the 
STX10/STX16/Vti1A/VAMP3-containing SNARE complex, which is important for 
trafficking of the mannose phosphate receptor from late endosomal 
compartments to the TGN (Amessou et al., 2007; Ganley, Espinosa, & Pfeffer, 
2008; Saint-Pol et al., 2004). Western blot analysis indicated significantly less 
STX10 in cells transfected with STX10-specific siRNAs than in untransfected 
cells, or in cells transfected with a scrambled siRNA (Figure 3.14), and 
quantification indicated that cellular STX10 in STX10-knockdown cells was less 
than 10% in cells transfected with the scrambled siRNA (Figure 3.14). 
Untransfected HCT116 cells or HCT116 cells transfected with either STX10-
specific siRNA or scrambled siRNA were incubated at 37 °C with Cj-CDT (100 
nM). The monolayers were visualized using immuno-fluorescence microscopy for 
phosphorylated H2AX within the nucleus of host cells at 4 h, a time at which we 
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detected a significantly great number of cells with activated H2AX in cells 
incubated in the presence than absence of Cj-CDT. These experiments revealed 
significantly less green fluorescence, corresponding to nuclear localized 
phosphorylated H2AX, in HCT116 cells transfected with STX10-specific siRNA 
than in HCT116 cells transfected with scrambled siRNA or untransfected 
HCT116 cells (Figure 3.15), indicating that Cj-CDT-dependent H2AX activation 
was inhibited in cells which STX10 was knocked down. These data suggest that 
a functional STX10-dependent late-endosomal to Golgi apparatus trafficking 
pathway is important for Cj-CDT cellular function, which is consistent with the 
idea that Cj-CDT trafficking from late endolysosomal compartments to the Golgi 
apparatus is important for toxin-mediated cellular activity. 
  Although the results described above support a model that a functional 
STX10-dependent late-endosomal to Golgi apparatus trafficking pathway is 
required for Cj-CDT cellular activity, these data do not address whether this 
same pathway is important for toxin transit from late endosomal compartments to 
the Golgi apparatus, and ultimately the nucleus. To evaluate this possibility, 
untransfected HCT116 cells, or, HCT116 cells transfected with either STX10-
specific siRNA or scrambled siRNA were prechilled on ice, and then further 
incubated on ice with Cj-CDT (100 nM). After 30 min, the monolayers were 
washed to remove unbound Cj-CDT, and then further incubated at 37 °C to allow 
the internalization and trafficking of surface bound toxin, and the cells were 
examined by fluorescence microscopy for Cd-CdtB co-localization with giantin, 
as a marker for localization to the Golgi apparatus, and, DAPI, as a marker for 
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localization to the nucleus. These experiments revealed significantly less green 
fluorescence associated with giantin-enriched structures, corresponding to the 
Golgi apparatus at 20 min in HCT116 cells transfected with STX10-specific 
siRNA than in HCT116 cells transfected with scrambled siRNA or untransfected 
HCT116 cells (data not shown), indicating that Cj-CDT localization to the Golgi 
apparatus was inhibited in cells which STX10 was knocked down. In addition, 
there was significantly less green fluorescence associated with the DAPI stain, 
corresponding to the nucleus at 90 min in HCT116 cells transfected with STX10-
specific siRNA than in HCT116 cells transfected with scrambled siRNA or 
untransfected HCT116 cells (data not shown), indicating that Cj-CDT localization 
to the nucleus was inhibited in cells which STX10 was knocked down. Taken 
together, these data suggest that a functional STX10-dependent late-endosomal 
to Golgi apparatus trafficking pathway is important for Cj-CDT localization to the 
Golgi apparatus and subsequently to the nucleus, consistent with the idea that 
Cj-CDT transitions from late endolysosomal compartments to the Golgi 
apparatus by a vesicular-mediated pathway involving the 
STX10/STX16/Vti1A/VAMP3-containing SNARE complex. 
 
Evaluation of the importance of tethering of Cj-CDT-containing vesicles to 
the Golgi complex.The results described above are consistent with a model that 
a functional STX10-dependent late-endosome to Golgi apparatus trafficking 
pathway is important for the transition of endolysosomal-localized Cj-CDT to the 
Golgi apparatus. However, these data do not address whether Golgi-specific 
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targeting of Cj-CDT-containing vesicles (CCVs) is important for toxin localization 
to the nucleus and cellular activity. Golgi specific tethering of vesicular targeting 
and fusion machinery (Willett et al., 2013) is mediated by the conserved 
oligomeric Golgi (COG) complex, a Golgi membrane resident hetero-octamer 
composed of 8 subunits (COG1 to COG8), which is required for tethering and 
docking vesicles targeting the Golgi apparatus. To evaluate the importance of the 
Golgi tethering machinery for Cj-CDT mediated cellular activity, we compared the 
toxin-dependent DNA damage response in the parental HCT116 cell line versus 
two HCT116 cell lines where two components of the COG complex, COG4 and 
COG8, had been stably knocked down using COG4- specific or COG8-specific 
shRNAs (data not shown). Stable HCT116 cell lines with either COG4 or COG8 
knocked down, or, HCT116 cells stably transfected with a scrambled shRNA, 
were incubated at 37 °C in the absence or presence of Cj-CDT (100 nM). After 4 
h, the monolayers were visualized using immuno-fluorescence microscopy for 
phosphorylated H2AX within the nucleus. These experiments revealed 
significantly less green fluorescence, corresponding to nuclear localized 
phosphorylated H2AX, in HCT116 cells stably transfected with COG4- specific or 
COG8-specific shRNAs than in HCT116 cells transfected with scrambled shRNA 
or untransfected HCT116 cells (Figure 3.16), indicating that Cj-CDT-dependent 
H2AX activation was inhibited in cells which COG4 or COG8 was knocked down. 
These data suggest that a functional COG complex is important for Cj-CDT 
cellular function, which is consistent with the idea that CCV-specific targeting of 
the Golgi apparatus is important for toxin-mediated cellular activity. 
	  	   127 
 Although the results described above support a model that a functional 
COG complex is required for Cj-CDT cellular activity, these data do not address 
whether a functional COG complex is important for toxin transit from late 
endosomal compartments to the Golgi apparatus, and ultimately the nucleus. To 
evaluate this possibility, stable HCT116 cell lines with either COG4 or COG8 
knocked down, or, HCT116 cells stably transfected with a scrambled shRNA, 
were pre-chilled on ice, and then further incubated on ice in the absence or 
presence of Cj-CDT (100 nM) that had also been pre-chilled on ice. After 30 min, 
the monolayers were washed with ice-cold PBS pH 7.4 to remove unbound toxin, 
and then further incubated at 37 °C in order to allow for the uptake and 
intracellular trafficking of plasma membrane bound Cj-CDT. After 20 min, the 
cells were examined by fluorescence microscopy for Cd-CdtB co-localization with 
giantin, as a marker for toxin localization to the Golgi apparatus, and, after 90 
min, were examined for co-localization with DAPI, as a marker for toxin 
localization to the nucleus. These experiments revealed significantly less green 
fluorescence associated with giantin-enriched structures, corresponding to the 
Golgi apparatus at 20 min, in HCT116 cells stably transfected with COG4- or 
COG8- specific shRNA than in HCT116 cells transfected with scrambled shRNA 
or untransfected HCT116 cells (data not shown), indicating that Cj-CDT 
localization to the Golgi apparatus was inhibited in cells which COG4 or COG8 
had been knocked down. In addition, there was significantly less green 
fluorescence associated with the DAPI stain, corresponding to the nucleus at 90 
min, in HCT116 cells transfected with COG4- or COG8-specific shRNA than in 
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HCT116 cells transfected with scrambled shRNA or untransfected HCT116 cells 
(Figure 3.17), indicating that Cj-CDT localization to the nucleus was inhibited in 
cells which COG4 or COG8 was knocked down. Taken together, these data 
suggest that a functional COG complex-dependent tethering of CCVs is 
important for localization of Cj-CdtB to the Golgi apparatus and nucleus, which is 
consistent with the hypothesis that tethering of vesicles originating from late 
endolysosomal compartments to the Golgi apparatus is a critical step for 
trafficking of Cj-CdtB to the nucleus and toxin-mediated activation of the DNA 
repair response. 
Evaluation of the effects of mis-targeting Cj-CDT-containing vesicles. The 
results described above are consistent with the idea that a functional COG 
complex is important for localization of Cj-CdtB to the Golgi apparatus and 
nucleus, as well as toxin-dependent activation of the host cell DNA repair 
response. These findings suggest that the COG complex is critical for tethering 
CCVs to the Golgi apparatus as a requisite step for the transition of Cj-CdtB from 
CCVs to the lumen of the trans-Golgi network, and provides an opportunity to 
definitively establish a causal link between Cj-CdtB localization to the Golgi 
apparatus as step that is essential for the toxin’s cellular activity. Specifically, we 
adopted an approach to determine the effects of mis-targeting CCVs away from 
the Golgi apparatus on toxin function. HCT116 cells were co-transfected with a 
plasmid overexpressing either the gene encoding siRNA-resistant COG4 or 
COG8, each fused to mCherry (mCh) fluorescent protein and the mitochondrial-
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targeting ActA sequence from Listeria, which were called COG4-mChActA or 
COG8-mChActA, respectively (Willett et al., 2013), and COG4- and COG8-
specific siRNA. Preliminary studies validated that in HCT116 cells expressing 
either COG4-mChActA or COG8-mChActA, red puncta corresponding to either 
COG4-mChActA or COG8-mChActA were significantly more co-localized with 
TOM20, a mitochondrial resident protein, than cells expressing mChActA alone, 
indicating that mislocalized COG proteins do in fact localize to mitochondria (data 
not shown). 
  To evaluate the consequences of mis-targeting CCVs to mitochondria on 
Cj-CDT cellular activity, HCT116 cells transiently co-transfected with siRNA 
against COG4, and a plasmid expressing siRNA-resistant COG4-mChActA, or 
with siRNA against COG8, and a plasmid expressing siRNA-resistant COG8-
mChActA, were incubated at 37 °C in the absence or presence of Cj-CDT (100 
nM). After 4 h, the monolayers were visualized using immuno-fluorescence 
microscopy for phosphorylated H2AX within the nucleus. These experiments 
revealed significantly less green fluorescence, corresponding to nuclear localized 
phosphorylated H2AX, in HCT116 cells transiently co-transfected with siRNA 
against COG4, and a plasmid expressing siRNA-resistant COG4-mChActA, or 
with siRNA against COG8, and a plasmid expressing siRNA-resistant COG8-
mChActA than in HCT116 cells transfected with scrambled siRNA or 
untransfected HCT116 cells (Figure 3.18). These data indicate that mistargeting 
of COG4-mChActA or COG8-mChActA inhibits Cj-CdtB-mediated activation of 
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H2AX, further validating the importance of the COG complex for targeting of 
cytolethal distending toxin-containing vesicles (CCVs) within the cell.  
  Although the results described above further validate the requirement for a 
functional COG complex for Cj-CDT cellular activity, these data do not address 
whether mis-targeting COG complexes to mitochondria results in mis-targeting of 
CdtB to mitochondria. HCT116 cells transiently co-transfected with siRNA 
against COG4, and a plasmid expressing siRNA-resistant COG4-mChActA, or 
with siRNA against COG8, and a plasmid expressing siRNA-resistant COG8-
mChActA, HCT116 cells transfected with scrambled siRNA, or untransfected 
HCT116 cells, were pre-chilled on ice, and then further incubated on ice with Cj-
CDT (100 nM) that had also been pre-chilled on ice. After 30 min, the 
monolayers were washed with pre-chilled PBS pH 7.4 to remove unbound Cj-
CDT, and then further incubated at 37 °C to allow for the uptake and intracellular 
trafficking of plasma membrane Cj-CDT. After 20 min, the cells were examined 
by fluorescence microscopy for Cd-CdtB co-localization with giantin, as a marker 
for toxin localization to the Golgi apparatus, and, after 90 min, were examined for 
co-localization with DAPI, as a marker for toxin localization to the nucleus. These 
experiments revealed significantly less green fluorescence associated with 
giantin-enriched structures, corresponding to the Golgi apparatus at 20 min, in 
HCT116 cells expressing COG4-mChActA or COG8-mChActA, than in the 
HCT116 parental cells (data not shown), indicating that Cj-CDT localization to the 
nucleus was inhibited in cells which COG4 or COG8 was mis-targeted to 
mitochondria. In addition, there was significantly less green fluorescence 
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associated with the DAPI stain, corresponding to the nucleus at 90 min, in 
HCT116 cells expressing COG4-mChActA or COG8-mChActA than in the 
HCT116 parental cells (data not shown), indicating that Cj-CDT localization to the 
nucleus was inhibited in the cells in which COG4 or COG8 was targeted to the 
mitochondria.  
 Finally, because we had already demonstrated that COG4-mChActA or 
COG8-mChActA are retargeted to mitochondria in HCT116 cells, we evaluated 
whether CdtB is localized to mitochondria in these same cells. HCT116 cells 
transiently co-transfected with siRNA against COG4, and a plasmid expressing 
siRNA-resistant COG4-mChActA, or with siRNA against COG8, and a plasmid 
expressing siRNA-resistant COG8-mChActA, HCT116 cells transfected with 
scrambled siRNA, or untransfected HCT116 cells, were pre-chilled on ice, and 
then further incubated on ice with Cj-CDT (100 nM) that had also been pre-
chilled on ice. After 30 min, the monolayers were washed with pre-chilled PBS 
pH 7.4 to remove unbound Cj-CDT, and then further incubated at 37 °C to allow 
for the uptake and intracellular trafficking of plasma membrane Cj-CDT. After 20 
min, the cells were examined by fluorescence microscopy for Cd-CdtB co-
localization with TOM20, as a marker for toxin localization to mitochondria. These 
experiments revealed significantly greater green fluorescence associated with 
TOM20-enriched structures, corresponding to mitochondria, in HCT116 cells 
expressing COG4-mChActA or COG8-mChActA, than in the HCT116 parental 
cells (Figure 3.19), indicating that Cj-CdtB localized to mitochondria in cells in 
which COG4 or COG8 was targeted to mitochondria. Taken together, these data 
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provide strong causal evidence that the correct targeting of Cj-CDT from late 
endolysosomal system to the Golgi apparatus is an essential step for subsequent 
toxin localization to the nucleus and toxin-mediated DNA damage. 
 
3.4. Discussion 
There is substantial evidence that CDTs localize to the nuclei of host cells, 
whereby the active Cj-CdtB induces the activation of the DNA repair response, 
presumably through this subunit’s DNAse I-like enzymatic activity (DiRienzo, 
2014; Gargi et al., 2012). However, the mechanistic details by which members of 
the CDT family transition from the surface of the host cell cells to the nucleus 
remain poorly understood. Several lines of evidence suggest that, similar to 
cholera, Shiga, and pertussis toxins, CDTs usurp retrograde trafficking pathways, 
in which protein cargo are moved through the cell to the endoplasmic reticulum 
(ER), where the active subunits are translocated from the ER lumen to the 
cytosol. Retro-translocation is thought to be absolutely required for access to the 
host target molecule to the toxin’s active subunit. A major gap in knowledge has 
been the mechanism of how Cj-CDT is trafficked from the cell surface to the 
nucleus, which previous studies have strongly implicated as the site of Cj-CdtB 
action. Here, we provide evidence supporting a model that subsequent to uptake 
from the cell surface into the endolysosomal system, Cj-CDT is trafficked from 
early to late endolysosomal compartments. Localization of Cj-CdtB to the nucleus 
requires egress of the toxin from the endolysosomal system, and for Cj-CdtB. 
Although our data revealed an association between transient Cj-CdtB localization 
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to the TGN, and, toxin mediated cellular activity, these data did not definitively 
establish that Cj-CdtB trafficking through the Golgi apparatus is essential for the 
toxin’s cellular activity. To do so, we demonstrated that an approach involving the 
mistargeting of CDT-containing vesicles, originating from late endosomal 
compartments, to mitochondria rather than the Golgi apparatus, was sufficient to 
completely block Cj-CDT mediated DNA damage. To our knowledge, this is the 
first evidence that CDT targeting to the Golgi apparatus is essential for the toxin 
to reach its ultimate site of action. 
An intact and functional Golgi apparatus was found to be critical for Cj-
CDT trafficking to the nucleus as a requisite step for toxin mediated DNA 
damage. Bacterial exotoxins that access intracellular targets via retrograde 
trafficking are taken up into the endolysosomal system, from where they must 
move to the ER for retro-translocation of their active subunits to the cytosol. 
Many studies have revealed two overall intracellular routes by which toxins move 
from the endolysosomal system to the ER. Several toxins have been 
demonstrated to move directly from the endolysosomal system to the ER, by a 
mechanism requiring vesicular trafficking. Alternatively, some bacterial toxins, 
including cholera-, shiga-, and pertussis toxins are trafficked through the Golgi 
apparatus as a requisite step preceding toxin action were based primarily on the 
requirement for an intact Golgi apparatus (Falnes & Sandvig, 2000). The exact 
mechanism that differentiates toxins that undergoes direct trafficking to the ER, 
from toxins that must transit through the Golgi apparatus along the way, is still 
not known. 
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The discovery that Cj-CdtB localization to the nucleus, and, toxin-
dependent activation of the DNA repair response requires the presence of the 
conserved oligomeric Golgi (COG) complex, not only extended our 
understanding of the host machinery required for toxin association with the Golgi 
apparatus, but also provided an opportunity to evaluate the requirement of Golgi-
specific targeting of cytolethal distending toxin-containing vesicles (CCVs) for 
toxin activity.  
Previous work demonstrated that some bacterial toxins, including cholera 
(Lencer et al., 1999) and shiga toxins (Lauvrak, Torgersen, & Sandvig, 2004a), 
are trafficked to the Golgi apparatus from early compartments within the 
endolysosomal system. Here, we demonstrate a different scenario, where Cj-
CDT does not exit the endolysosomal system from early compartments, but 
rather is trafficked to late endolysosomal compartments. Our studies 
demonstrating that Cj-CDT-mediated cellular intoxication and Cj-CdtB 
localization to the nucleus occur in a syntaxin10-dependent manner were 
consistent with a model that Cj-CDT is trafficked from late endolysosomal 
compartments to the Golgi apparatus. The studies here revealed the importance 
of an intact Golgi apparatus for the trafficking of Cj-CdtB to the nucleus as a 
requisite step for Cj-CdtB-mediated DNA damage. How might the requirement for 
an intact Golgi apparatus relate to the cellular activity of Cj-CDT? Typically, 
studies that have reported the blocking of bacterial toxin cellular activities with 
BFA have interpreted these results to indicate the requirement for toxin trafficking 
through the Golgi apparatus. The pathway from TGN to ER in almost all cells is, 
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however, sensitive to Brefeldin A, a fungal metabolite known to induce tubulation 
of the TGN and subsequent dispersion into endosomes and ER membranes 
(Nambiar, Oda, Chen, Kuwazuru, & Wu, 1993). The effects of Exo2 are different, 
in that this small molecule inhibitor collapses the Golgi stacks, but does not affect 
the TGN (Feng et al., 2004). Retrograde transport of cholera toxin from the 
plasma membrane to the endoplasmic reticulum requires the trans-Golgi network 
but not the Golgi apparatus in Exo2-treated cells (Feng et al., 2004). In contrast 
to Cj-CDT, cholera toxin is not sensitive to Exo2, suggesting that this toxin might 
bypass the Golgi cisternae trafficking directly to the ER (Feng et al., 2004). The 
demonstration that Cj-CdtB localization to the nucleus as well as Cj-CdtB-
dependent activation of H2AX were inhibited not only by BFA, by also by Exo2, is 
consistent with the idea that, unlike for cholera toxin, trans-Golgi apparatus is 
involved in the vesicular trafficking of Cj-CdtB.  
In conclusion, this study has demonstrated that Golgi-specific targeting of 
Cj-CDT to the Golgi apparatus is essential for toxin to reach nucleus and 
elaborate its cytotoxic activity. This study will impact our understanding on the 
role of host’s molecular machinery in pathogenesis.  
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3.5. Figures 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Cj-CDT mediated cell cycle arrest in HCT116 cells. (A) Dose 
response curve of Cj-CDT mediated cell cycle arrest. Monolayers of HCT116 
cells were incubated in the presence of Cj-CDT (0.01 -100 nM). After 24 h, the 
cells were analyzed for G2/M arrest using flow cytometry, as described under 
“Experimental Procedures.” The data were rendered as the percentage of cells 
detected in G2/M arrest as a function of toxin concentration. Data were collected 
from 3 independent experiments. Error bars represent standard deviations. (B) 
Effect of His-tag on the cell cycle arrest properties of Cj-CDT. Monolayers of 
HCT116 cells were incubated in presence of Cj-CDT (0.1 - 100 nM), without, or 
with, N-terminal His-tag. After 24 h, the cells were analyzed for arrest in G2/M 
using flow cytometry. The results are rendered as bar graphs generated from 
data combined from three  independent experiments that compare the 
percentage of cells arrested in G2/M in Cj-CDT with N-terminal Hist-tag (while 
bars), or without His-tag (black bars). Error bars represent standard deviations. 
Statistical significance was calculated for the differences between cell 
populations incubated in the presence of Cj-CDT with, or without N-terminal His-
tag. 
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Figure 3.2. Importance of the Golgi apparatus for Cj-CDT activity in HCT116 
cells. Cj-CDT (5 nM)-mediated arrest of HCT116 cells in G2/M was determined in 
the absence or presence of BFA (0.2 µg/ml; A - B), Exo2 (50 µM; C), or Golgicide 
A (20 µM; D). (A) The data are rendered as individual histograms representative 
of those collected during three independent experiments. Histograms indicate the 
number of cells (y axis, same scale for each histogram) at a given PI 
fluorescence intensity (x axis, same scale for each histogram), with, as indicated 
in the top left histogram, the left peak representing cells in G0/G1 phase 
(designated as G1) of the cell cycle, the right peak representing cells in G2/M 
(designated as G2), and the area between the peaks representing cells in S 
phase (designated as S). (B – D) The results are rendered as bar graphs 
generated from data combined from three independent experiments that 
compare the percentage of cells arrested in G2/M in untreated cells (white bars), 
cells treated with Cj-CDT, in the absence of drug (black bars) or cells treated with 
the drug in the absence or presence of Cj-CDT, as indicated by gray bars (BFA, 
B; Exo2, C; or GCA, D). Error bars represent standard deviations. Statistical 
significance was calculated for the differences between cell populations 
incubated in the absence or presence of the pharmacological agents. 
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Figure 3.3. Dose response curve of Cj-CDT mediated G2/M arrest in HeLa, 
and CHO-K1 cells. Monolayers of HeLa (A), and CHO-K1 (B) cells were 
incubated in the presence of Cj-CDT (0.01 -100 nM). After 24 h, the cells were 
analyzed for G2/M arrest using flow cytometry, as described under “Experimental 
Procedures.” The data were rendered as the percentage of cells detected in 
G2/M arrest as a function of toxin concentration. Data were collected from 3 
independent experiments. Error bars represent standard deviations. 
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Figure 3.4. Importance of the Golgi apparatus for Cj-CDT activity in HeLa 
and CHO-K1 cells. Monolayers of HeLa (A – C), or CHO-K1 (D – F) cells, were 
intoxicated with Cj-CDT close their respective CCAD50 values (5 nM Cj-CDT for 
HeLa cells, and 100 nM Cj-CDT CHO-K1 cells) that were pre-incubated in the 
absence or presence of BFA (0.2 µg/ml; A, D), Exo2 (50 µM; B, E), or Golgicide 
A (20 µM; C, F). After 24 h, the cells were analyzed for arrest in G2/M using flow 
cytometry. The data were rendered as the percentage of cells in G2/M as a 
function of Cj-CDT intoxication and presence of small molecule inhibitor. Error 
bars represent standard deviations. Statistical significance was calculated for the 
differences between cell populations incubated in the absence or presence of 
indicated pharmacological agents. 
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Figure 3.5. Cj-CdtB co-localization with the Golgi apparatus. HCT116 cells 
that had been prechilled on ice for 30 min, were incubated with prechilled Cj-CDT 
(100 nM). After 30 min, the cells were washed once with PBS pH 7.4, and then 
further incubated at 37 °C. (A) After 0, 5, 10, 20, 30, or 90 mins, the cells were 
fixed, and probed for Cj-CdtB and giantin, using fluorescence microscopy. 
Images are representative of those collected from three independent 
experiments. The data were rendered as a single z-plane (approximately 5 µm 
depth within each cell). As labeled, green puncta indicate Cj-CdtB, red puncta 
indicate giantin, and Cj-CdtB co-localized with giantin is indicated by yellow 
puncta. (B) The results are rendered as bar graphs generated from data 
combined from three independent experiments. Error bars represent standard 
deviations.  
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A.          B. 
 
 
 
 
 
 
 
Figure 3.6. Effects of Golgi dysfunction on Cj-CdtB localization to the 
nucleus. HCT116 cells were incubated with 100 nM Cj-CDT at 37 °C for 90 min 
in the absence or presence of BFA (0.2 µg/ml), and were imaged using 
fluorescence microscopy. (A) Images were representative of those collected from 
three independent experiments. The data were rendered as a single z-plane (5 
µm depth within each cell). As labeled, green puncta indicate Cj-CdtB, and blue 
fluorescence indicate nucleus. White bars indicate 10 µm. (B) The results are 
rendered as a bar graph generated from data combined from three independent 
experiments that compare the Pearson’s correlation coefficient for Cj-CdtB co-
localized with nucleus in cells treated with Cj-CDT, in the absence (black bars), 
or presence (gray bars) of BFA. Error bars represent standard deviations. 
Statistical significance was calculated for differences in the Pearson’s correlation 
coefficient between cell populations incubated in the presence or absence of 
BFA. 
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Figure 3.7. Effect of inhibiting cargo transition from early endosome to the 
Golgi apparatus, on Cj-CDT mediated cell cycle arrest. Monolayers of 
HCT116 cells were exposed to Retro-1 (10 µM) or Retro-2 (30 µM) for 30 min at 
37 °C. After 30 min, cells were intoxicated by Cj-CDT (5 nM), and further 
incubated at 37 °C. After 24 h, holotoxin mediated arrest of HCT116 cells in G2/M 
was determined in the absence or presence of Retro-1 or Retro-2. The results 
are rendered as bar graphs generated from data combined from three  
independent experiments that compare the percentage of cells arrested in G2/M 
in untreated cells (white bars), cells treated with Cj-CDT, or cells treated with 
Retro-1 or Retro-2 in the absence or presence of Cj-CDT, as indicated (gray 
bars). Error bars represent standard deviations. Statistical significance was 
calculated for the differences between cell populations incubated in the absence 
or presence of Retro-1 or Retro-2. Error bars represent standard deviations.  
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A.        B.  
 
      
 
 
 
 
 
 
Figure 3.8. Effect of inhibiting cargo transition from early endosome to the 
Golgi apparatus, on the localization of CTxB, or Cj-CdtB, with the Golgi 
apparatus. Monolayer of HCT116 cells were treated with Retro-1 (10 µM) at 37 
°C. After 30 minutes, cells were chilled on ice for additional 30 minutes, and 
treated with prechilled alexa-488 labeled Cholera Toxin B-subunit (CTxB-488; 
100 nM), or Cj-CDT (100 nM). After 30 min, the cells were washed once with 
PBS pH 7.4, and incubated at 37 °C. After 60 min, the cells were fixed, probed 
with the antibodies against specified antigens, and imaged using fluorescence 
microscopy. Images are representative of those collected from three independent 
experiments. The data were rendered as a single z-plane (approximately 5 µm 
depth within each cell). As labeled, green puncta indicate CTxB-488 or Cj-CdtB, 
red puncta indicate giantin, and toxin co-localized with giantin is indicated by 
yellow puncta. (B) The results are rendered as bar graphs generated from data 
combined from three independent experiments that compare the localization of 
the toxin with the Golgi apparatus in the absence (white bars), or presence (black 
bars), of Retro-1. Error bars represent standard deviations. Statistical 
significance was calculated for the differences between cell populations 
incubated in the absence or presence of the Retro-1.  
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Figure 3.9. Western Blot analysis of STX5 expression in HCT116 cells 
treated with siRNA for STX5. HCT116 cells were transfected with a mixture of 
four different STX5-siRNAs, as detailed in Materials and Methods, and tested for 
the levels of STX5 expression using Western Blot analysis, compared to the 
control untreated cells. Actin was used as the loading control. STX5 expression 
was normalized against the actin expression in the respective cell line, and 
quantified to compare the expression levels of STX5. The results are rendered as 
bar graphs generated from data combined from three  independent experiments 
that compare the relative expression of STX5 in cells treated with siRNA, 
compared to the untreated control. Error bars represent standard deviations.  
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Figure 3.10. Cj-CDT activates H2AX in cells with knocked-down STX5. 
HCT116 cells that had been transiently transfected with siRNA targeting STX5, 
were incubated with Cj-CDT (100 nM) at 37 °C. After 4 h, the monolayers were 
fixed and imaged using fluorescence microscopy. Cells were probed for H2AX 
activation in response to CDT-mediated DNA damage. Green puncta indicates 
phosphorylated H2AX, with nucleus counter stained blue with DAPI. Images are 
representative of three experiments.  
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Figure 3.11. Effect of late-endosomes transport block on Cj-CDT mediated 
cell cycle arrest. (A) Cj-CDT (5 nM)-mediated arrest of HCT116 cells in G2/M 
was determined, as indicated in the absence or presence of NH4Cl (20 mM), or 
bafilomycin A1 (20 nM). The results are rendered as bar graphs generated from 
data combined from three independent experiments that compare the percentage 
of cells arrested in G2/M phase in untreated cells (white bars), cells treated with 
Cj-CDT, cells treated with pharmacological agents (black bars), or cells treated 
with Cj-CDT in the presence of pharmacological agents (gray bars). Error bars 
represent standard deviations. Statistical significance was calculated for the 
differences between cell populations incubated in the absence or presence of the 
indicated agent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
25
50
75
100
%
 c
el
ls
 in
 G
2/
M
P = 0.7
PBS
Cj-CDT (5 nM)
NH Cl (50 mM)
bafilomycin (50 nM)
+
-
-
-
-
+
-
-
-
-
+
-
-
+
+
-
-
-
-
+
-
-
+
+
P = 0.3
P = 0.004
4
	  	   147 
 
 
 
 
 
 
 
 
Figure 3.12. Cj-CDT activity is blocked in cells treated with monensin, and 
nigericin. Cj-CDT (5 nM)-mediated arrest of HCT116 cells in G2/M was 
determined, as indicated in the absence or presence of monensin (50 nM), or 
nigericin (200 nM). The results are rendered as bar graphs generated from data 
combined from three independent experiments that compare the percentage of 
cells arrested in G2/M phase in untreated cells (white bars), cells treated with Cj-
CDT, cells treated with pharmacological agents (black bars), or cells treated with 
Cj-CDT in the presence of pharmacological agents (gray bars). Error bars 
represent standard deviations. Statistical significance was calculated for the 
differences between cell populations incubated in the absence or presence of the 
indicated agents. 
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Figure 3.13. Effect of dominant-negative isoform of Rab9 on Cj-CDT 
mediated H2AX activation. HCT116 cells that had been transfected with the 
plasmid expressing the dominant negative isoform of Rab9, DN-DsRed-Rab9 
(S21N), were incubated at 37 °C in the absence or presence of Cj-CDT (100 
nM), and then scored for the percentage of cells with visible H2AX 
phosphorylation. After 4 h, the monolayers were fixed and imaged using 
fluorescence microscopy. Images were representative of those collected from 
three independent experiments. The data were rendered as a single z-plane (5 
µm depth within each cell). As labeled, green puncta indicate phospho-H2AX 
(pH2AX), red puncta indicate the dominant-negative isoform of Rab9, and the 
blue staining indicates the nucleus.  
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Figure 3.14. Western Blot analysis of STX10 expression in HCT116 cells 
treated with siRNA for STX10. HCT116 cells were transfected with a mixture of 
four different STX10-siRNAs, as detailed in Materials and Methods, and tested 
for the levels of STX10 expression using Western Blot analysis, compared to the 
control untreated cells. Actin was used as the loading control. (A) Western Blot 
analysis of STX10 expression. Data is representative of three independent 
experiments. (B) STX10 expression was normalized against the actin expression 
in the respective cell line, and quantified to compare the expression levels of 
STX10. The results are rendered as bar graphs generated from data combined 
from three  independent experiments that compare the relative expression of 
STX10 in cells treated with siRNA, compared to the untreated control. Error bars 
represent standard deviations.  
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Figure 3.15. Effect of STX10 knock-down on Cj-CDT mediated H2AX 
activation. HCT116 cells that had been transiently transfected siRNA targeting 
STX10 were incubated with Cj-CDT at 37 °C. After 4 h, the monolayers were 
fixed and imaged using fluorescence microscopy. Images were representative of 
those collected from three independent experiments. The data were rendered as 
a single z-plane (5 µm depth within each cell). As labeled, green puncta indicate 
phospho-H2AX (pH2AX), and the blue staining indicates the nucleus.  
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Figure 3.16. Effect of COG4 and COG8 knockdown on Cj-CDT activity. 
Monolayer of HCT116 cells with COG4 or COG8 knockdown, were incubated 
with Cj-CDT (100 nM) at 37 °C against wildtype HCT116 cells. After 4 h, the 
monolayers were fixed and probed for the activation of H2AX. (A) Data is 
representative of three independent experiments. Green puncta indicate 
phospho-H2AX, nucleus is stained blue. (B) The results are rendered as bar 
graphs generated from data combined from three independent experiments that 
compare the Cj-CDT mediated H2AX activation in wildtype cells (white bars), 
against the cells with COG knock-down (black bars). Error bars represent 
standard deviations. 
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Figure 3.17. Effect of COG4 and COG8 knockdown on Cj-CdtB transport to 
the nucleus. Monolayer of HCT116 cells, without or with COG4 or COG8 
knockdown, were incubated on ice for 30 minute, followed by incubation with 
prechilled Cj-CDT (100 nM). After 30 min, the cells were washed once with PBS 
pH 7.4, and incubated at 37 °C. After 90 min, the cells were fixed, probed for Cj-
CdtB, and imaged using fluorescence microscopy. (A) Data is representative of 
three independent experiments. Green puncta indicate Cj-CdtB, with nucleus 
counterstained blue. (B) The results are rendered as bar graphs generated from 
data combined from three independent experiments that compare the localization 
of Cj-CdtB in the nucleus of wildtype cells (white bars), against the cells with 
COG knock-down (black bars). Error bars represent standard deviations. 
 
Cj-CdtB nucleus Cj-CdtB nucleus Cj-CdtB nucleus 
COG8 knock-down COG4 knock-down wt HCT116 cells 
	  	   153 
 
 
 
A.        B.  
  
 
 
 
 
 
Figure 3.18. Effect of misdirecting COGs on Cj-CDT mediated H2AX 
activation. HCT116 cells that had been transiently transfected with a plasmid 
harboring the gene encoding siRNA resistant isoform of COG4, fused with 
mCherry gene, and mitochondrial localization signal, ActA (COG4-mChActA), 
were incubated with Cj-CDT (100 nM) at 37 °C. After 4 h, the monolayers were 
fixed and imaged using fluorescence microscopy. The data were analyzed for 
level of phospho-H2AX (pH2AX) in response of Cj-CDT intoxication in untreated, 
or transfected cells. (A) The data, which is representative of three independent 
experiments, shows activated H2AX, as indicated by presence of green 
fluorescence within the nucleus, and cells expressing mis-localized COG4 are 
represented by red fluorescence. (B) The results are rendered as bar graphs 
generated from data combined from three independent experiments that 
compare the Cj-CDT mediated activation levels of H2AX in wildtype HCT116 
cells (white bars), or cells with mis-directed COG4 or COG8 (black bars). Error 
bars represent standard deviations. Statistical significance was calculated for the 
differences between Cj-CDT treated cell populations without or with COG 
mislocalization.  
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Figure 3.19. Cj-CdtB co-localize with the mitochondria in cells expressing 
COG4-mChActA. HCT116 cells that had been transiently transfected with a 
plasmid harboring the gene encoding siRNA resistant isoform of COG4, fused 
with mCherry gene, and mitochondrial localization signal, ActA (COG4-
mChActA), were incubated with Cj-CDT (100 nM) at 37 °C. After 1 h, the 
monolayers were fixed and imaged using fluorescence microscopy. The data 
were analyzed for the localization of Cj-CdtB with TOM20, a mitochondrial 
marker. The data, which is representative of three independent experiments, 
shows Cj-CdtB indicated in green fluorescence, TOM20 in red fluorescence, and 
Cj-CdtB localization on the mitochondria, in yellow fluorescence, which was 
quantified against the wild-type cells with unperturbed COG4.  
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CHAPTER 4: CHARACTERIZING THE BINDING PROPERTIES OF HD-CDT 
 
4.1. Introduction 
Cytolethal Distending Toxins (CDTs) are AB toxins where B-moiety, 
comprised of CdtA and CdtC, is required to facilitate the delivery of A-moiety, 
CdtB, inside the cell (Sandvig et al., 2004). It is understood that CdtA and CdtC 
aid in the binding of holotoxin to the host cell, leading to the toxin uptake, 
eventually guiding CdtB through the retrograde pathway to help reach nucleus 
(Gargi, Reno, & Blanke, 2012). But the molecular details of how CdtA and CdtC 
deliver CdtB inside the cell, is not known. 
Since the seminal paper that published first crystal structure of a CDT 
holotoxin (Nesic, Hsu, & Stebbins, 2004), numerous studies have attempted to 
evaluate the functional roles of distinct domains present on the toxin, aiming to 
characterize its potential role in cell surface receptor engagement. Studying the 
domains on the toxin has also paralleled the study of host cell determinants that 
might engage with the toxins, but the understanding of toxin’s determinants 
required for host cell binding, is still emerging (Eshraghi et al., 2010).  
Not surprisingly, different groups have reported differing views on the 
relative importance of CdtA against CdtC in cell binding. Based on multiple 
structure-activity studies, it is understood that CdtA and, to a lesser extent, CdtC 
subunit proteins bind to cells in culture (Cao, Volgina, Huang, Korostoff, & 
DiRienzo, 2005; Kanno, Korostoff, Volgina, & DiRienzo, 2005; McSweeney & 
Dreyfus, 2005). Yet in other studies it has been suggested that CdtC may aid the 
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entry of CdtB into the cell (Akifusa, Heywood, Nair, Stenbeck, & Henderson, 
2005), with CdtA having much less significant role to play. While investigating the 
cell surface binding of CDT produced by A. actinomycetemcomitans, a group 
reported that while Aa-CdtA bound to HEp-2 cells both at 4 ºC and 37 ºC, Aa-
CdtC bound to cell surface only at 37ºC, while Aa-CdtB did not bind to HEp-2 
cells at either temperature, indicating that the availability of Aa-CdtC-binding sites 
may be dependent on normal physiologic conditions (Akifusa et al., 2005). In 
vitro studies report that both CdtA and CdtC recognize gangliosides, such as 
GM1 and GM3 (Mise et al., 2005), or N-linked fucose-containing glycoproteins 
(McSweeney & Dreyfus, 2005). It has become quite clear that the nature of CDT-
receptor is not the same for all CDTs, and further characterization is required to 
find a co-relation between the toxin receptor and the species-specific CDT. 
Another problem that needs to be solved, which I have partially addressed in this 
chapter, is to characterize the residues present on CDT subunits that engage 
with the host cell receptor, thus initiating first step towards cellular intoxication by 
the CDTs. Understanding CDT determinants that interact with host receptor will 
not only impart better understanding in the molecular pathogenesis of CDTs, but 
will also help in developing strategies to block such interactions, and help fight 
infectious diseases.   
It is not clear how CdtA or CdtC interact with the cell receptor, or with each 
other, and possibly contribute towards cytotoxic properties of the holotoxin. I 
started out by characterizing the residues on CdtA and CdtC, beyond the ones 
reported by earlier studies (Nesic et al., 2004). An aromatic patch on Hd-CdtA, 
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composed of three tryptophans and a tyrosine residue (W91, W98, W100, and 
Y102), is shown to be important for toxin binding and cellular activity of Hd-CDT 
(Nesic et al., 2004). My findings expand the involvement of aromatic residues on 
the surface of CdtA, which are responsible for the toxin interactions with the cell 
surface. I also evaluated potential microdomains on the surface of CdtC, 
specifically around the putative receptor-binding groove on the toxin subunit, 
which might be important for engaging with the host cell surface. My findings 
contribute towards refining the role of molecular determinants involved in the B-
moiety of the AB toxin, CDT.  
 
4.2. Materials and Methods  
 
Cloning of cdt genes and preparation of expression strains. The cloning of 
the genes encoding Hd-CDT subunits in plasmids for recombinant expression in 
E. coli was previously described (Eshraghi et al., 2010).  
 
Site-directed mutagenesis. Mutagenesis was performed using the 
QuikChange mutagenesis kit from Stratagene (La Jolla, CA). First, 
complementary mutagenic primers were engineered with the desired mutation in 
the center of the primer and 10 to 15 bases of correct sequence on either side. 
Reaction mixtures were prepared as described in the QuikChange protocol with 
pET15b-Hd-CdtA or pET15b-CdtC as the plasmid template for generation of 
various CdtA or CdtC mutants. After cycling of the reaction mixture 18 times in a 
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thermal cycler, the resulting mixture was digested with DpnI, and the resulting 
DNA was transformed into chemically competent E. coli DH5α cells. The 
resulting mutant plasmids were isolated, and the entire gene was sequenced to 
ensure that the appropriate mutations were introduced, while the rest of the gene 
sequences remained unchanged. 
 
Expression and purification of recombinant Hd-CDT. Each recombinant 
protein was expressed and purified as previously described (Eshraghi et al., 
2010). Protein concentrations were quantified using the Bradford Protein Assay 
(Thermo Scientific, Rockford, IL). Recombinant proteins were used only when 
purified to at least 95% homogeneity, as estimated by resolving the proteins 
using sodium-dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), 
and visualizing after staining the gels with Coomassie Brilliant Blue (Bio-Rad, 
Hercules, CA; data not shown). The purified, denatured subunits were stored at -
20 °C in HEPES (20 mM, N-[2-Hydroxyethyl] piperazine-N-[2-ethanesulphonic 
acid], Calbiochem,  La Jolla, CA), pH 7.5 containing urea (8 M) and NaCl (200 
mM). 
Hd-CDT holotoxins were prepared as previously described (Nesic et al., 
2004). Toxin integrity was evaluated using the dialysis retention assay, as 
previously described (Cao et al., 2005). Hd-CDT holotoxin (5-20 µM, 1 ml) was 
dialyzed (100 kDa molecular mass cut-off tubing; Spectrum Laboratories) at 4 °C 
against four 250 ml volumes of PBS pH 7.4 containing 5% glycerol. After 24 h, 
the dialyzed proteins were evaluated using SDS-PAGE followed by staining with 
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Coomassie Brilliant blue. The gels were scanned with a CanonScan 9950F 
scanner (Canon, Lake Success, NY) using ArcSoft Photo Studio 5.5 software 
(ArcSoft, Fremont, CA). The integrity of the holotoxins was quantified by 
comparing the relative intensities of the bands corresponding to CdtA, CdtB, or 
CdtC before and after dialysis, as determined by using the UN-SCAN-IT program 
(Silk Scientific, Inc., Orem, UT). Individual CDT subunits, each of which has a 
molecular mass less than 35 kDa, were used as negative controls.  
 
Mammalian cells. Mammalian cell cultures were maintained at 37 °C and 
under 5% CO2 within a humidified environment. Human cervical cancer epithelial 
(HeLa) cells (CCL-2, ATCC) were maintained in Minimal Essential Medium Eagle 
(MEM, Mediatech, Herndon, VA) with 10% fetal bovine serum (FBS, Mediatech). 
Complete medium was obtained by supplementing MEM with L-glutamine (2 mM, 
Sigma), penicillin (50 IU/ml, Mediatech), and streptomycin (50 µg/ml, Mediatech). 
 
Cell cycle phase determination. The indicated cell lines were seeded (1.5 
x 105 cells per well) in 6-well plates (Corning Inc., Corning, NY). After 18 h, the 
cells were further incubated in complete medium with or without Ec-CDT or Hd-
CDT at the indicated concentrations, or mock incubated with PBS pH 7.4. After 
48 h, the cells were analyzed for arrest at the G2/M interface, as previously 
described (Eshraghi et al., 2010). From these data, dose response curves were 
generated by plotting cells in G2/M as a function of toxin concentration. From the 
dose response curves, we determined CCAD50 (i.e. cell cycle arrest dose50) 
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values, which we defined as the toxin concentrations required to induce G2/M 
arrest in 50% of the cell population not already in G2/M. 
Preliminary intoxication studies with Hd-CDT revealed nearly identical 
dose response curves for G2/M arrest in the presence or absence of the hexa-
histidine tags. All subsequent studies were conducted with toxin assembled from 
subunits that retained their respective hexa-histidine tags. 
 
Molecular modeling. Molecular modeling of CDT holotoxin, or subunits, 
was performed using UCSF Chimera, an extensible molecular modeling system 
(Pettersen et al., 2004). Protein structure of Hd-CDT was fetched using PDF 
code “1SR4” for the holotoxin (Nesic et al., 2004), and surface topology was 
studied using Chimera software. Residues with peculiar properties, like charged 
residues or aromatic, were marked for this study. Information collected from 
molecular modeling was used to target the residues on CdtA and CdtC to be 
investigated for their role in toxin binding and activity.  
 
Flow cytometry. Analytical flow cytometry-based assays were carried out 
as previously described (Eshraghi et al., 2010). Briefly, 8 x 104 HeLa cells were 
seeded in a 12-well plate. After overnight incubation, cells were intoxicated for 
additional 24 h, then washed with PBS (pH = 7.4), detached with 0.05% 
trypsin/EDTA (Invitrogen), and harvested in 1 ml PBS containing 10% FBS. Cells 
were spun down at 600g for 5 minutes, and permeabilized with 70% ethanol at 
least for one hour at -20ºC. Cells were hydrated by incubating in PBS for 30 
	  	   166 
minutes, and stained with 10 µg/ml propidium iodide (PI) solution containing 
0.1% Triton X-100, and 100 µg/ml RNase-A. After incubating for one hour at 
room temperature, samples were analyzed for DNA content using FACS Canto 
Flow Cytometry Analyser (BD Biosciences) with CellQuest acquisition software 
(BD Biosciences). Flow cytometry data were subsequently analyzed using FACS 
analysis software. 
 
Protease sensitivity assays. Wild-type Hd-CDT, or respective mutants 
were incubated in a Tris buffer (50 mM Tris-HCl, 100 mM NaCl, 2 mM DTT; pH 
8.0) with various concentrations of trypsin (0, 53, 213, and 640 µg/ml) at 4°C. 
After 1 h, reaction was stopped by adding sodium dodecyl sulfate (SDS) sample 
buffer (4% SDS, 100 mM Tris, 0.4 mg bromophenol blue/ml, 0.2 M DTT, 20% 
glycerol). The samples were boiled for 3 min and resolved by SDS-
polyacrylamide gel electrophoresis (PAGE) (16% acrylamide; 70 V for 25 min 
and then 200 V for an additional 100 min). The gels were soaked in fixing 
solution (25% isopropanol, 10% acetic acid) for 15 min and then placed in 
Coomassie blue stain (10% acetic acid, 0.06 mg/ml Coomassie brilliant blue G-
250). After 10 h, the gels were rinsed twice with H2O, preserved by soaking in 
water with 3% glycerol for 10 h, and dried between gel drying films. 
 
Cell binding assay. Mammalian cell binding assays were conducted as 
previously described (Cao et al., 2005; Lee, Hassane, Cottle, & Pickett, 2003). 
Cells were seeded (2 × 104/well) in 96-well plates (Fisher). After 18 h, the plates 
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were incubated on ice. After 30 min, the cells were washed two times with ice-
cold PBS pH 7.4, and then further incubated on ice with or without biotinylated 
toxin (at the indicated concentrations) and BSA (3%) in PBS pH 7.4, or mock 
incubated with BSA (3%) in PBS pH 7.4. After 30 min on ice, the cells were 
washed three times with ice-cold PBS pH 7.4, and then fixed by adding ice-cold 
2% formaldehyde and 0.2% glutaraldehyde, and then further incubated at room 
temperature. Preliminary studies indicated that maximal binding occurred 
between 30 and 60 min (not shown). After 15 min, the plate was washed three 
times with PBS pH 7.4 at room temperature, and then incubated at room 
temperature with streptavidin-HRP conjugate (1:15,000, GE Healthcare, Little 
Chalfont, Buckinghamshire, UK) in PBS pH 7.4. After 30 min, the cells were 
washed five times with PBS pH 7.4, and then incubated at room temperature with 
TMB Ultra (100 µl, Thermo Scientific). After 30 min, the supernatant from each 
well was removed and added to an equal volume of sulfuric acid (2 N, 
Mallinckrodt Baker Inc., Paris, KY) at room temperature. The optical density at 
450 nm (O.D.450nm) was measured using a Biotek Synergy 2 plate reader (Biotek 
Instruments Inc., Winooski, VT). The O.D.450nm measured for supernatants 
collected from wells containing cells incubated with PBS pH 7.4 alone 
(background absorbance) was subtracted from the O.D.450nm measured for 
supernatants collected from wells containing cells that had been incubated with 
the toxin. Relative binding was determined by dividing the O.D.450nm minus 
background at each toxin concentration by the O.D.450 nm minus background at 
the highest concentration of toxin used in these studies (200 nM). The 
	  	   168 
dissociation constants (Kd) were calculated by non-linear regression of the curve 
generated from plotting relative binding as a function of toxin concentration, using 
GraphPad Prism (Version 4.03, GraphPad Software, La Jolla, CA). Competitive 
binding assays were conducted as described above, except in the absence or 
presence of 100-fold molar excess of the specified non-biotinylated proteins. 
 
Statistics. Unless otherwise indicated, each experiment was performed at 
least three independent times, each time in triplicate. Statistical analyses were 
performed using Microsoft Excel (Version 11.0, Microsoft, Redmond, WA) or 
GraphPad. The Q-test was performed to eliminate data that were statistical 
outliers (Dixon, 1950). Error bars represent standard deviations. All P values 
were calculated with the Student’s t-test using paired, two-tailed distribution. A P 
value of less than 0.05 indicated that differences in the specified data were 
considered statistically significant. 
 
4.3. Results 
Targeting residues on CdtA. There are only a handful studies that 
explored the topology of CDT to study the contribution of surface-exposed 
residues towards toxin’s binding to the host cell surface, the first step in the 
process of cellular intoxication. To evaluate the role of distinct microdomains on 
the surface of CDT, and their contribution towards cell binding, residues on the 
CdtA were mapped based on their spatial information and chemical nature. 
Either aromatic or basic residues were selected, and based on their vicinity in the 
	  	   169 
folded protein, were grouped into distinct microdomains for further studies 
(modeled in Figure 4.1). Because no difference was observed between the 
binding and activity of holotoxin with or without N-terminus His-tag, studies were 
conducted with recombinant protein with His-tag (data not shown). Site directed 
mutagenesis was carried out for individual regions, testing their impact on the 
toxin binding to the host cell surface. Protein stability of the mutant toxin was 
tested by limited proteolysis, using trypsin digestion assay. All mutants showed 
protein digestion pattern similar to the wild-type control, suggesting the mutants 
made a stable holotoxin (data not shown).  
 
Effect of CdtA mutations on the cytotoxic activity of Hd-CDT. To evaluate 
the importance of specific surface-exposed residues on Hd-CdtA, cell cycle 
analysis was conducted to compare the cytotoxic activity of respective mutants 
against the wild-type control. Mutant holotoxin was prepared using mutated CdtA 
along with wild-type CdtB and CdtC. HeLa cells were exposed to a range of 
indicated concentrations of mutant holotoxin, and compared against the wild-type 
isoform. Cells were harvested 24 h post intoxication, and evaluated for DNA 
content. Our studies revealed that while wild-type Hd-CDT produced cell cycle 
arrest in 50% cell population at around 3 pM, toxin containing mutated forms of 
CdtA demonstrated differing potencies, ranging from 5 pM to 42 pM. Region 1 
mutation (Y119A/Y168A) had CCA50 value of 42 pM (Figure 4.2). Regions 2 
through 6 gave attenuations between 1.5 to 3 fold, and were considered not 
significant biologically. These data indicate that not all residues contribute equally 
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towards the activity of the holotoxin, and some are dispensable. The mechanism 
of activity attenuation in not known, but we propose that owing to its aromatic 
nature, and presence on the surface of holotoxin, Y119 and Y168 might 
contribute towards the binding of holotoxin to the cell surface.  
 
Relative binding of Hd-CDT with the cell surface. Of the surface exposed 
residues on Hd-CdtA, there are two tyrosine residues, Y119 and Y168, flanking 
either side of the tetra-aromatic patch, that were hypothesized to be involved in 
toxin binding to the cell surface (Figure 4.3). To investigate the importance of 
surface exposed Y119 and Y168, alanine was substituted for tyrosine, and the 
effects of alanine substitution were evaluated on the cell binding properties of the 
holotoxin. Wild-type holotoxin was used as the positive control.  
Cell based ELISA (CELISA) was used to investigate cell surface binding of 
the mutant toxin against the wild-type. After binding the toxin for 30 minutes, with 
the cells under conditions non-permissive of cellular uptake, cells were fixed and 
probed for the presence of toxin on the cell surface. Wild-type CDT demonstrated 
saturation binding kinetics with HeLa cells. In contrast, holotoxin with CdtA 
containing Y119A and Y168A substitutions exhibited a statistically significant 
reduction in binding (Figure 4.4). These data suggest Y119 and Y168 residues 
are required for the interactions of CDT with the host cell surface. These results 
indicate that aromatic patch is not restricted to the tetra-aromatic residues W91, 
W98, W100, and Y102, but extends beyond and includes the neighboring 
aromatic residues. These findings will help define the role of CdtA as the B-
	  	   171 
moiety of the holotoxin, while aiding in the characterization of specific residues 
on the toxin surface and their role towards overall intoxication properties of the 
holotoxin.  
 
Targeting residues on CdtC. To evaluate the role of distinct microdomains 
on the surface of CDT, and their contribution towards cell binding, residues on 
the CdtC subunit were mapped based on their spatial information and chemical 
nature. Either aromatic or basic residues were selected, and based on their 
vicinity in the folded protein, were grouped into distinct microdomains for further 
studies (Figure 4.5). Protein stability of the mutant toxin was tested by limited 
proteolysis, using trypsin digestion assay. All mutants showed protein digestion 
pattern similar to the wild-type control, suggesting the mutants made a stable 
holotoxin (data not shown).  
 
Cytotoxic activity of Hd-CDT with mutant CdtC. To evaluate the 
importance of specific surface-exposed residues on Hd-CdtC, cell cycle analysis 
was conducted to compare the cytotoxic activity of respective mutants against 
the wild-type control. Mutant holotoxin was prepared using mutated CdtC along 
with wild-type CdtA and CdtB. HeLa cells were exposed to a range of indicated 
concentrations of mutant holotoxin, and compared against the wild-type isoform. 
Cells were harvested 24 h post intoxication, and evaluated for DNA content. Our 
studies revealed that while wild-type Hd-CDT produced cell cycle arrest in 50% 
cell population at around 3 pM, CdtC-tetramutant demonstrated a CCA50 value of 
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5 pM (Figure 4.6). These data indicate that the tetramutant 
(K82E/F79K/V31K/F121K) might not be critical for toxin activity. Extrapolating it 
back, owing to its failure to attenuate toxin activity, residues in tetramutant might 
not contribute towards holotoxin binding either, as any interference in the binding 
would have reflected in the cytotoxic activity of the holotoxin. Because the CdtC 
mutant did not attenuate the activity of holotoxin, binding studies for the toxin with 
mutant CdtC were not performed.  
 
4.4. Discussion  
Owing to their distinct chemical nature, most aromatic residues are buried 
in the core of a protein or peptide. If surface exposed, it is believed that the 
residues have an important role to play, involving interacting with a specific 
receptor or enzyme. CdtA protein of CDTs also have certain surface exposed 
residues that are distinct for an otherwise exposed residues that come in contact 
with hydrophilic environment. There are at least eight surface-exposed aromatic 
on CdtA, four of which have already been shown important for toxin binding to 
the cell surface. Extending the aromatic patch region, I mutated a tyrosine 
residue on either side of the aromatic patch, to examine the precise contribution 
of these amino acids to the binding of the subunits to the receptor and effect on 
holotoxin’s activity (Figure 4.1). Mutating Y119 and Y168, the activity was 
attenuated by approximately 15-fold, suggesting the residues are important for 
full-activity of the holotoxin. Further, The data obtained extend the initial findings 
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of Nesic et al. implicating primarily residues W91, W98, W100, and Y102 in Hd-
CdtA aid in CDT binding to the receptor. 
While my studies mapped the surface exposed residues on Hd-CDT, 
another study later carried out similar study on Aa-CDT, addressing the aromatic 
residues on CdtA that might be involved in cell binding. In this report, Cao and 
co-workers found that aromatic residues at the periphery of the binding domain 
(Y105 and Y140) of Aa-CdtA were reported to make a weaker contribution to 
binding than those closer to the middle of the domain (Y188 and Y189). Taken 
together, these studies have enhanced the understanding of the residues 
involved on the toxin that are important for engaging with the host cell receptor, 
potentially as the first step towards cellular intoxication.  
Our studies are preliminary as they address only certain residues on CDT 
that might be involved in receptor recognition and cell binding. It doesn't fully 
characterize the binding determinants present on the toxin in its entirety. It also 
doesn't address the molecular details of the receptor that might be involved in 
CDT recognition and binding. Future studies should not only firm up a model for 
toxin binding to the cell, but also investigate the applicability of this model across 
other members of the CDT-family. Though surface-exposed residues are 
conserved through most members of the family, studies reporting differing views 
on cell surface binding properties argue the applicability of a uniform model of 
CDT and host cell binding. We think that a combination of conserved residues, 
along with non-conserved, give CDTs host tissue specificity, setting up the CDT-
family as a non-uniform model for cellular interactions.  
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In summary, analysis of the binding properties of the H. ducreyi CdtA and 
CdtC proteins, having substitutions for surface-exposed molecular determinants, 
improved our understanding of the CDT receptor-binding domain. It also provided 
evidence that the CdtC subunit most likely plays a relatively minor role in cell 
binding. These findings have important implications for studying the specificity of 
the receptor for CDTs in general, and for developing strategies designed to block 
the activity of CDTs, which is part of the arsenal of several Gram-negative 
pathogens.   
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4.5. Figures 
 
 
 
Figure 4.1. Microdomains mutated on Hd-CdtA. Hd-CDT holotoxin protein was 
modeled using UCSF Chimera, and distinct residues were zoned into small 
patches based on their side chain (aromatic or basic). In this model, CdtA is 
colored blue, CdtB is red, and CdtC green, with mutants given distinct colors to 
identify their location on the surface. Total 6 regions on Hd-CdtA were 
investigated, and grouped mutants were created to study their binding and 
intoxication properties. Region 1: Y119A and Y168A, region 2: W76G, W78G, 
andY80A, region 3: F88A, F167A, region 4: E117A, K132A, Q154A, and R156A, 
region5: L71E, K73E, and R74E, and region 6: N121A, T170A, and T172A 
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Figure 4.2. Dose response curve of wildtype and mutant Hd-CDT holotoxin. 
Monolayers of HeLa cells were exposed to indicated concentration of toxin, and 
evaluated for cell cycle phase at 24 h. Data is collected from three independent 
experiments. Error bars denote standard deviation.  
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Figure 4.3. Y119 and Y168 residues on Hd-CdtA. Hd-CDT holotoxin protein 
was modeled using UCSF Chimera, with CdtA colored in blue, CdtB in red, and 
CdtC green. Y119 and Y168 are colored white. The patch between Y119 and 
Y168 is the tetra-amino acid aromatic patch, consisting of  W91, W98, W100, 
and Y102. 
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Figure 4.4. Cell surface binding of Hd-CDT against holotoxin with mutant 
CdtA. (A) Monolayers of HeLa cells were exposed to indicated concentrations of 
holotoxin under conditions non-permissive of cellular uptake, as detailed in 
Material and Methods. The data are rendered as the relative binding after 30 min 
of biotinylated forms of toxin to HeLa cells as a function of toxin concentration (1-
200 nM). Total binding curves were fitted with non-linear regression. Data is 
representative of three independent experiments, each done in triplicate. Error 
bars indicate standard deviation. (B) HeLa cells in suspension were exposed to 
100 nM wildtype or mutated toxin, and bound for 30 minutes before being fixed 
and probed for holotoxin. Cells were analyzed by flow-cytometry with wildtype 
holotoxin labeled in green, mutant in red, and PBS control in gray. Data is 
representative of three independent experiments.  
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Figure 4.5. Microdomains mutated on Hd-CdtC. Hd-CDT holotoxin protein was 
modeled using UCSF Chimera, and distinct residues, either hydrophobic or 
basic, were identified around the putative binding groove. In this model, CdtA is 
colored blue, CdtB is red, and CdtC green, with residues earmarked for mutation 
in pink. Total 5 residues on CdtC were investigated: R23, V31, F79, K82, and 
F121.  
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Figure 4.6. Dose response curve of wildtype and mutant Hd-CDT holotoxin. 
Monolayers of HeLa cells were exposed to indicated concentration of toxin, and 
evaluated for cell cycle phase at 24 h. Data is representative of three 
independent experiments.  
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
 
5.1. Introduction  
 The major objective of this dissertation was to understand the molecular 
mechanisms underlying toxin trafficking inside mammalian cells, which is an 
important requisite for toxins to access its intracellular target and to modulate 
host cell functions (Blanke, 2006). Of various subcellular systems and organelles, 
owing to its control on the genetic information and cell homeostasis, nucleus 
presents itself as an attractive, yet infrequent target for pathogens (Nougayrede, 
Taieb, De Rycke, & Oswald, 2005). In this work, we used CDT as the model to 
study the mechanism how toxins destined to reach nucleus are trafficked through 
specific compartments within the host cell.  
 When considering the CDT family, most of work that has been conducted 
thus far, to identify and characterize the structure-function relationships and 
intoxication properties has appropriately focused on just several CDTs (Aa-CDT, 
Cj-CDT, Ec-CDT, and Hd-CDT) (Eshraghi et al., 2010; Gargi, Reno, & Blanke, 
2012). The conclusions from studying this small subset of the CDT family have 
been extended rather generically across the broader family of CDTs. Yet, neither 
the structure-function relationships nor cellular intoxication mechanisms of the 
vast majority of CDTs have been examined. In fact, the striking diversity in the 
sequences of CDT subunits identified in an increasing number of genomes of 
bacterial species from the γ-Proteobacteria and ε-Proteobacteria suggest that the 
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extent to which individual CDTs function in a similar fashion should be 
reexamined (Gargi et al., 2012). 
 Since its initial discovery in 1988 (Johnson & Lior, 1988a, 1988b), CDT 
has been reported to be produced by over two dozen Gram-negative pathogens, 
contributing towards the virulence properties of the bacteria (Gargi et al., 2012). 
Because of similarities or divergences in primary sequences of the holotoxin, for 
my present study, I investigated CDTs produced by four pathogens: A. 
actinomycetemcomitans, E. coli, C. jejuni, and H. ducreyi. The current state of 
field also aided my selection, in which recent advancements, due to information 
available on the protein crystal structure or structure-activity studies (Nesic, Hsu, 
& Stebbins, 2004; Yamada, Komoto, Saiki, Konishi, & Takusagawa, 2006), or the 
widespread occurrence of infection by certain infecting pathogens (Gargi et al., 
2012; Smith & Bayles, 2006; Young, Davis, & Dirita, 2007), rendered studying 
CDT produced by above mentioned pathogens, critical to understanding the 
molecular pathogenesis model of the CDT-family.  
 
5.2. Major Findings 
 Addressing CDT trafficking and intoxication properties is important not 
only to understand the molecular basis of pathogenesis of CDT-producing 
bacteria, but also to understand the model in which exogenous molecules 
successfully target the host cell nucleus. In my doctoral work, parts in 
collaboration with Ken Bradley’s group, I have addressed the events spanning 
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from cell-surface binding, to the trafficking of CDT through the subcellular 
compartments of the host cell, as a prerequisite for toxin to reach nucleus to 
exert its cytotoxic effects. Multiple cell lines, and CDT produced from divergent 
pathogens were tested, and sometimes directly compared, to validate the 
findings across different species and biological systems. Based on my work, I 
have constructed a model of CDT-trafficking through the eukaryotic cell, which 
reflects our work and current understanding of the field (Figure 5.1). My findings 
enhanced the understanding of CDT intoxication mechanism and its potential 
role in the virulence properties of CDT-producing pathogens. Moreover, my 
studies will also aid in the design of novel tools to target specific subcellular 
compartments and host cell functions. 
 
5.2.1. Cell surface binding 
 Despite several attempts to resolve the identity of host cell surface 
determinants that engage with CDTs, there is only suggestive evidence 
elaborating on the chemical nature of putative CDT-receptor. Moreover, 
information on the domains present on CDT, which are critical for host cell 
surface binding, is limited. While my studies did not make an aggressive attempt 
to identify the nature of CDT-receptor, I explored the general chemical nature 
and the specificity of the toxin receptor. I further investigated subdomains on one 
of the CDT holotoxins (Hd-CDT), mapping residues critical for cell surface 
binding, and intoxication of the mammalian cells.  
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 Recent reports have suggested the biochemical nature of the putative 
CDT receptor, with plasma membrane cholesterol, cell surface glycoproteins, 
and glycosphingolipids playing a major role in aiding cell surface binding of 
different CDTs (Eshraghi et al., 2010; Lin et al., 2011). While testing the ability of 
cholesterol supplementation to increase host cell sensitivity, it was found that 
increasing plasma cholesterol resulted in increased sensitivity to some CDTs, but 
not to Cj-CDT (Eshraghi et al., 2010), which suggested that cholesterol might be 
an important component for binding of most CDTs, but Cj-CDT. Contrarily, 
another group later showed that cholesterol depletion results in resistance to Cj-
CDT (Lin et al., 2011). These results, and further studies that identified a 
cholesterol recognition amino acid consensus (CRAC) sequence in Aa-CdtC and 
a non-traditional CRAC sequence in CdtC from Haemophilus parasuis suggests 
that cholesterol may play a role in the binding of most, if not all, CDTs to the host 
cell surface (Boesze-Battaglia et al., 2009; Zhou, Zhang, Zhao, & Jin, 2012). A 
genetic screen using the KBM7 chronic myeloid leukemia cell line revealed that a 
putative G protein–coupled receptor, TMEM181, contributes to cellular binding 
and sensitivity to Ec-CDT (Carette et al., 2009), thus proposing TMEM181 as the 
potential CDT-receptor. Later studies questioned the presence of TMEM181 on 
the cell surface, refuting its claim as a toxin-receptor. Further studies will be 
required to fully characterize the CDT-receptor, but so far we do know that the 
receptor is rich in cholesterol and might involve the lipid rafts.  
 Receptor recognition and binding is critical for the function of intracellular-
acting toxins because the receptor, in part, functions as a molecular carrier 
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whose normal uptake and trafficking through the cell directly impacts the final 
cellular destination of the toxin. Based on the inability of Ec-CDT or Hd-CDT to 
competitively bind to the surface of cells, we believe that the two toxins might 
utilize distinct cell surface receptors (Gargi et al., 2013). This idea was further 
supported by studies in which I observed lectin EEA inhibited the cell surface 
binding of Ec-CDT, but not Hd-CDT (Gargi et al., 2013). The highly dissimilar 
protein sequences of the CdtA and CdtC subunits of Ec-CDT and Hd-CDT are 
consistent with the idea that these two toxins may interact with and intoxicate 
cells by disparate mechanisms. Consistent with the idea that Ec-CDT and Hd-
CDT may bind to different receptors on the surface of sensitive cells, in 
collaboration with Bradley group, we reported that a mutant CHO cell line, 
characterized by abbreviated glycan sequences on membrane glycoproteins and 
glycolipids, was hypersensitive to Hd-CDT, but demonstrated the same 
sensitivity as the parental CHO cells to Ec-CDT (Eshraghi et al., 2010), which 
further supports the idea that the receptor for different CDTs might not be the 
same. Additional studies will be required to determine whether or not differences 
in intracellular trafficking pathways between Ec-CDT and Hd-CDT directly 
contribute to the disparity in the potencies exhibited by the two toxins towards 
sensitive cells. Nonetheless, we speculate that differential cell surface 
requirements for toxin association is critical for targeting Ec-CDT and Hd-CDT to 
their respective uptake and intracellular trafficking pathways. 
 Another important feature of toxin-receptor interaction is to understand the 
determinants on the toxin important for receptor engagement. Of three CDT 
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proteins that are required to make holotoxin, CdtA and CdtC are believed to be 
responsible to engage with the cell surface as the initial point of contact with the 
host cell, which is then followed by toxin uptake and cellular intoxication, 
delivering the active moiety, CdtB, inside the cell (Nesic et al., 2004). One of the 
unusual features highlighted by the crystal structure of Hd-CDT is a region of 
aromatic and heterocyclic amino acids exposed on the surface of CdtA (Nesic et 
al., 2004). Studying the topological information of Hd-CdtA, I mapped the surface 
exposed residues to investigate additional domains not covered by Nesic and co-
workers (Nesic et al., 2004), which might be important for cell-surface binding. In 
fact, I found at least two additional tyrosines on the surface of Hd-CdtA, Y119 
and Y168, mutating which produced almost complete loss of cell surface binding, 
and a significant attenuation in the cytotoxic properties of the Hd-CDT holotoxin. 
My results reflect on the importance of CdtA aromatic residues in host-pathogen 
interactions, and that the receptor binding regions are not limited to just four 
aromatic residues first described by Stebbins groups. Studying Aa-CDT, another 
group later reported similar results in which two-tyrosine residues, both 
homologous to my study of Hd-CdtA, lead to the loss in the binding properties of 
the holotoxin (Cao, Bandelac, Volgina, Korostoff, & DiRienzo, 2008).  
 I extended the studies on understanding the topological domains of CDT 
in cell binding, by characterizing residues on Hd-CdtC, which might play a role in 
toxin binding to the cell surface. I selected the aromatic and basic residues that 
were around the putative cell-binding groove on CdtC, hypothesizing that their 
mutation will result in a phenotype different from wild-type toxin. Mutating two 
  
189 
aromatic residues, F79 and F121, and two basic residues, R23 and K82, I 
investigated the effect on cell binding and cytotoxic properties of the holotoxin. 
Contrary to our expectations, single mutants, or all mutants put together as a 
tetramutant, did not demonstrate results different from the wild-type, suggesting 
the aromatic or basic residues around Hd-CdtC groove may not play a role in 
toxin binding. Further studies will be required to map domains present on CdtC 
and characterize their role in the cytotoxic properties of CDT.  
 Taken together, my findings suggest that CdtA predominantly mediates 
cell surface receptor binding. Further studies will be required to fully characterize 
all subdomains on the surface of CdtA and CdtC, and their role in cell surface 
binding, which will be important for developing strategies to block the activity of 
CDTs. 
 
5.2.2. Trafficking through the endolysosomal system 
 Following docking and binding to the mammalian cell membrane, toxins 
are endocytosed inside the cell using one of several differentially regulated 
endocytic mechanisms, which sometimes may operate in parallel (Lamaze et al., 
2001; Nichols & Lippincott-Schwartz, 2001; Sandvig & van Deurs, 2000, 2002). 
Limited studies done on CDT-endocytosis suggest that the toxin internalization is 
dynamin-dependent, which may or may not follow the clathrin-dependent 
pathway (Cortes-Bratti, Chaves-Olarte, Lagergard, & Thelestam, 2000). Induction 
of CDT’s cytotoxic activity is completely inhibited under conditions that block the 
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fusion of the endosomal vesicles with downstream compartments, indicating that 
the toxin is further trafficked through the endosomal compartment (Cortes Bratti 
2000). Depending on the toxin and host cell type, researchers have reported 
differing findings on the mechanism of toxin transition through the endolysosomal 
system. Several earlier models of CDT intoxication predicted that the CDT 
holotoxin, rather than a CdtA-CdtB or CdtB-CdtC dimer, or CdtB alone, is taken 
up by early endosomes (Boesze-Battaglia et al., 2009; Cortes-Bratti et al., 2000; 
Guerra et al., 2009), but a conclusive evidence on the fate of CDT subunits post-
internalization is lacking.  
 Because of the changing conditions within endosomal lumen with the 
vesicle maturation, which includes drop in luminal pH and a shift in molecular 
components associated with endosomal vesicle, cargo might respond to the pH 
trigger and undergo conformational change that may allow it to escape to the 
cytosol, or may engage with specific components of the vesicle thus allowing 
itself to be transported to its subsequent target (Huotari & Helenius, 2011). If 
toxins cannot escape the endosomal compartments, most likely they are 
degraded in the lysosomes (Huotari & Helenius, 2011). In my studies, I 
addressed the differential fate of CDTs while being transported through 
endosomal compartments. 
 For the toxins following retrograde pathway, most cargoes exit the 
endolysosomal system out of the early endosomes. Our initial hypothesis was 
that, just like cholera toxin and shiga toxin, CDTs might the directed to the Golgi 
apparatus from the early endosomes, thus escaping the degradation fate in the 
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lysosomes (Lauvrak, Torgersen, & Sandvig, 2004; Lencer, Hirst, & Holmes, 
1999). In fact my studies demonstrate that Ec-CDT does not transition through 
the late endosomes, as it was insensitive to the perturbations in the endosomal 
pH, or the molecular components involved in late endosome to Golgi trafficking 
(Gargi et al., 2013), suggesting that CDTs might not traffic through late 
endosomes at all. But the unexpected results were obtained when I evaluated 
the trafficking of Hd-CDT (Gargi et al., 2013), and later of Cj-CDT (unpublished 
data) through the endolysosomal system. I demonstrated that blocking 
endosomal maturation, or perturbing the molecular machinery that directs cargo 
from late-endosomes to the Golgi apparatus, alters the trafficking and activity of 
Hd-CDT and Cj-CDT, but not of Ec-CDT (Gargi et al., 2013). I did not study 
endosomal trafficking model for Aa-CDT, but given its structural and functional 
similarities with Hd-CDT, we predict that Aa-CDT might transition through the late 
endosomes before being trafficked to the Golgi apparatus.     
 
5.2.3. Trafficking through the Golgi apparatus 
 Being the central cargo-sorting platform of eukaryotic cells, Golgi 
apparatus not only can modify transitioning biomolecules, but it plays a critical 
role both in anterograde, and retrograde trafficking of the cargo. Current model of 
CDT trafficking suggests that the toxin transitions through the Golgi apparatus 
after exiting endolysosomal system. But the understanding is speculative, and 
the model is based merely on the effect of small molecule inhibitors that 
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disintegrate the Golgi apparatus. As it is well know that small molecule inhibitors 
like brefeldin A have strong pleiotropic effects (Klausner, Donaldson, & 
Lippincott-Schwartz, 1992), it is hard to characterize precise involvement of the 
Golgi apparatus in toxic trafficking and activity.  One report comes close to 
confirming that CDT is trafficked through the Golgi apparatus. By observing 
sulfation of CdtB, containing an engineered tag that could be sulfated, one group 
demonstrated the toxin transitions through the Golgi when holotoxin is applied on 
the cells (Guerra et al., 2005). But this study still doesn’t address the absolute 
requirement of CDT transition through the Golgi apparatus, or identify the 
molecular mechanism of trafficking through the central sorting portal of the cell.   
 My studies address several of these questions: is trafficking through the 
Golgi apparatus absolutely essential for the toxin activity? What are the kinetics 
of toxin trafficking through the Golgi apparatus? What compartments within the 
Golgi apparatus play a role in toxin trafficking? What are the molecular 
components on the Golgi apparatus, that interact with CDT-containing cargo 
vesicles.  
 Using localization studies and specific inhibitors for Golgi sub-
compartments, I demonstrated that CdtB traverse through all stacks of the Golgi 
apparatus, from trans- to cis-Golgi. First instance when CdtB is detected in the 
Golgi apparatus is at 20 minutes, positioning CDT’s retrograde trafficking through 
the Golgi apparatus between endolysosomal system, where it is detected 
between 5 to 15 minutes of intoxication, and the ER, where it is observed at one 
hour post-intoxication. This is first such evidence, supported by toxin kinetics and 
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controlled disruption of cellular functions, in which the itinerary of CDT’s 
retrograde trafficking is mapped inside a eukaryotic cell. I also identified the 
absolute importance of the Golgi apparatus on the activity and trafficking of the 
members of CDT-family. All CDT holotoxins, which were tested for their reliance 
on a functional Golgi apparatus, showed that disruption in the Golgi apparatus 
confers resistance to the intoxicated cells. This is one instance where all CDTs 
agree on the commonality of a single subcellular compartment involved in the 
toxin trafficking and activity. I further characterized the molecular components 
that play a role in CdtB transition through the Golgi apparatus.  Evaluating the 
components involved in CdtB trafficking from the endolysosomes to the Golgi 
apparatus, I discovered that the conserved oligomeric Golgi (COG) complex 
plays a critical role in receiving CdtB containing cargo at the Golgi apparatus. 
COG complex is a resident member of the Golgi apparatus membrane. 
Perturbations in the trafficking factors that associate with COG complex, i.e. 
STX10, or altering the presence of the complex on the Golgi apparatus, led to 
loss in the activity of CDT, which was detected to be because of disruption in the 
retrograde trafficking of the toxin. Taken together, my studies not only 
underscore the importance of the Golgi apparatus in the transport and activity of 
CDT, but it also identifies the molecular machinery that plays a role in toxin 
trafficking through the central sorting machinery of the cell. This is first such 
volume of work that dissected the molecular mechanism of CDT pathogenesis at 
the organelle that is used by all members of CDT-family for their transport to the 
nucleus.  
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5.2.4. Trafficking through the Endoplasmic Reticulum 
 Endoplasmic Reticulum (ER) is the site used by several AB toxins to exit 
to the cytosol, making it an important portal for toxins to be able to access their 
intracellular target. Using fluorescence microscopy, and also by studying the 
glycosylation of engineered CdtB, CDT also has been shown to transition 
through the ER before it can reach nucleus (Eshraghi et al., 2014; Gargi et al., 
2013; Guerra et al., 2005).  
 There are two main pathways that the toxin might take to reach the 
nucleus from ER: directly from ER lumen to the nucleus, or by exiting ER lumen 
and reaching cytosol, and then targeting the nucleus. In CDT field there are 
conflicting opinions on how CdtB is trafficked from ER to the nucleus. While 
failing to detect CdtB in the cytosol of the nucleus, one group inferred that CdtB 
is trafficked directly from ER to the nucleus (Guerra et al., 2009). In contrast, our 
research, in collaboration with Ken Bradley’s, believes that CdtB must first 
escape to the cytosol before it can reach the nucleus (Eshraghi et al., 2014). We 
identified the importance of ERAD-pathway, a system that transports cargo 
across the ER membrane, on the trafficking and intoxication properties of Ec-
CDT and Hd-CDT, which clearly supports the model that CDT must traffic from 
ER lumen to the cytosol before it can exert its cytotoxic effect inside the nucleus 
(Eshraghi et al., 2014). One exception to this model is when we tested the effect 
of Derlin 2 or Hrd1 mutants, both important factors in ERAD-pathway, on the 
activity of Cj-CDT. Contrary to the inhibition of intoxication properties of Ec-CDT 
and Hd-CDT, Cj-CDT was resistant to any perturbations in the ERAD-pathway, 
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suggesting that it might take an alternate route to reach the nucleus (data not 
published). Further studies will be required to evaluate the transportation 
mechanism of Cj-CDT from ER to the nucleus, and underlying physiological 
importance of this divergence in retrograde trafficking.  
 
5.2.5. Trafficking to the nucleus 
 Several reports have expounded on the requirement of CdtB reaching the 
host cell nucleus to cause DNA-damage, and trigger a series of signaling events 
leading to cell cycle arrest. Studies involving transient transfection, direct 
microinjection of CdtB, or mutation of toxin’s nuclear localization signal (NLS) 
underscored the importance of accessing host cell nucleus as a requisite for CDT 
to elaborate its cytotoxic effects (McSweeney & Dreyfus, 2004; Nishikubo et al., 
2003). But none of previous studies conclusively established the presence of 
CdtB inside the host cell nucleus. I presented first physical evidence that the 
catalytically active subunit of the holotoxin could be detected in the nucleus of 
intoxicated mammalian cells (Gargi et al., 2013).  
 By testing the ability of CdtB to reach nucleus, I demonstrated that when 
applied externally, the catalytically active subunit of holotoxin CDT has the 
capability to reach nucleus within 60 minutes for Ec-CDT and Hd-CDT (Gargi et 
al., 2013), and by 90 minutes for Cj-CDT (unpublished data). Most cytotoxic 
effects of CDT, like H2AX phosphorylation and cell cycle arrest, were observed 
at time points much later than CdtB arrival at the nucleus. These findings support 
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the model that the cytotoxic effects of CDT are downstream of CdtB reaching the 
nucleus, and that trafficking to the nucleus might be necessary for the toxin 
activity. This implies that perturbations in the trafficking of CdtB to the nucleus 
must block the cytotoxic effect of the holotoxin. In fact, I tested and demonstrated 
that under conditions non-permissive for CdtB trafficking leading to the nucleus, 
i.e. endosomal acidification, Golgi disruption, or disruption of ERAD-pathway, 
depending on the path taken by different CdtBs, the transport of toxin to the 
nucleus was blocked, which was followed by failure of CDT to produce DNA-
damage or trigger events downstream of dsDNA-break.  
 Of the toxins evaluated, comparing the trafficking properties of three 
different CDTs, Cj-CDT, Ec-CDT, and Hd-CDT, I discovered that the toxin-
trafficking pathway converge and diverge at certain organelles, giving each CDT 
a unique transport map, which might be dependent on the site of pathogen-
colonization and intoxication of the mammalian tissue. While blocking endosomal 
maturation affected transport of Cj-CdtB and Hd-CdtB, it had no effect on Ec-
CdtB trafficking to the nucleus, suggesting that Ec-CDT might bypass the 
trafficking through the late endosomes. Further, transport and activity of all CDTs 
investigated in this study were affected by Golgi apparatus disruption, clearly 
suggesting that Golgi apparatus might be the bottleneck for the trafficking and 
activity of all CDTs. Interesting, just like trafficking through the endolysosomal 
system, mechanism of exiting the ER might not be similar for all CDTs. While Ec-
CDT and Hd-CDT were clearly affected by the perturbations in ERAD-pathway, a 
major protein translocation system required for cargo transport across ER lumen 
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and the cytosol, biological activity of Cj-CDT was unaffected by disruptions in the 
ERAD-pathway. In summary, Hd-CDT trafficking and activity is affected by 
endosomal, Golgi, and ERAD-pathway perturbations. Cj-CDT is also affected by 
endosomal and Golgi apparatus perturbations, but not by ERAD-pathway 
disruption. While Ec-CDT is unaffected by endosomal pH perturbations, its 
trafficking and cytotoxic activity is sensitive to the Golgi apparatus and ERAD-
pathway disruptions. One question that remains unanswered, is how does the 
CdtB from C. jejuni escape the ER, and is targeted to the nucleus. There is a 
possibility that Cj-CdtB utilize an alternate route to the nucleus that does not 
involve the ERAD-pathway. Another exciting area to explore is to find the precise 
role of the Golgi apparatus and ER in toxin trafficking and activity. My studies 
show that if CdtB is allowed to escape to the cytosol directly from endosomes, 
effectively bypassing transition through the Golgi apparatus and the ER, toxin is 
still capable of exerting DNA-damage in the intoxicated cells. But the toxin 
concentrations used in the studies, for detection purpose, were several-fold 
higher than the cytotoxic dose, which might question the overall potency and 
physiological relevance of method in our study. Overall, my studies not only 
characterize the transport path taken by CdtBs to reach nucleus, but also 
supports the idea that trafficking to the nucleus is indispensible for the toxin to 
exert its cellular activity.  
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5.3. Conclusion 
 The fact that CDT is one of few, or in some instances, only exotoxin in the 
arsenal of CDT-producing Gram-negative pathogens, makes it an intriguing 
model to understand its role in microbial pathogenesis (Gargi et al., 2012). 
Another outstanding feature that warrants investigating the intoxication model of 
CDT-family is the fact that CDTs are one of only few bacterial toxins known to 
produce cytotoxic effects within the nucleus of the host cell, making them an 
important model to study the nuclear microbiology (Nougayrede et al., 2005). 
One of the interesting pieces of CDT complexity is the significant structural and 
functional difference within the members of the family (Gargi et al., 2012; Hu, 
Nesic, & Stebbins, 2006). Members of CDT-family exhibit significant differences 
and similarities, ranging from primary sequence diversity, heterogeneity in cell 
attachment mechanisms, toxin-potency and sensitivities to different mammalian 
tissues, to variability in the way it carries out mammalian cell intoxication. Some 
CDTs appear to bind specifically structured glycan residues on glycoproteins or 
glycolipids, others were shown to engage with cholesterol rich microdomains, 
bind certain gangliosides, or transmembrane G-protein-coupled receptor proteins. 
Also, intoxication by some CDTs leads to cell cycle arrest at either the G1 or 
G2/M checkpoint or cell death via an apoptotic pathway. Exhaustive phylogenetic 
analyses and comparisons within each of the three subunits across the species-
specific CDTs have been performed to attempt to understand this heterogeneity 
(Gargi et al., 2012). This approach has been yielded mixed results, which 
unfortunately, doesn't always translate to functional relationships. Arguably, 
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underlying difference in functional outcomes of CDT activity might be due to 
tissue tropism, or the influence of CDT-subunits of the cognate holotoxin. Further 
studies will be required to dissect the phenotypical differences among members 
of CDT family, despite carrying significant primary sequence, and structural 
similarities. 
 Current challenges are to uncover the details of the CDT intoxication 
process, determine whether there are truly multiple distinct receptors for each 
CDT, or interplay between components in highly specialized regions of the cell 
membrane, and identify if this specificity relates back to the tissue tropism. 
Moreover, the precise role of cellular compartments in the intoxication properties 
of specific CDTs is still unclear, and would it would be exciting to study how CDT 
trafficking may dictate different outcomes for CDT behavior, which may further 
explain the commonality and evolutionary relationship among the species-
specific CDTs. 
 
5.4. Future Work 
 The degree to which the large sequence diversity among CDTs reflects 
functional differences between individual members of the CDT family is largely 
unexplored. Nonetheless, as discussed in this study, there are some hints from 
several recent studies that CDTs may in fact be highly divergent in their 
potencies and host requirements for intoxication. It will be interesting to test the 
premise that the functional differences between CDTs may reflect the diversity of 
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host cells and tissues that comprise the infection microenvironments targeted by 
CDT-producing pathogenic bacteria. 
 One of the true challenges in the CDT field is to understand the in vivo 
consequences of CDT action during infection. Studies to understand, from an 
evolutionary perspective, the benefit of CDT-mediated genotoxicity for promoting 
host-pathogen interactions, remain a particular challenge, because any benefits 
may in fact be highly idiosyncratic to the specific pathogen and the host niche 
occupied by that pathogen.  
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5.5. Figures 
 
 
 
 
Figure 5.1. CDT is trafficked retrogradely to the host cell nucleus. CDT is an 
AB toxin that has a two component architecture, with A moiety, composed of 
CdtB, carrying the toxic activity, and B moiety, composed of CdtA and CdtC, 
responsible for cell binding and facilitating CdtB delivery to its target. Following 
cellular uptake, CDT is trafficked through the endolysosomal system to the Golgi 
apparatus, from where it is further targeted to the endoplasmic reticulum. Using 
the ERAD-pathway, CdtB escapes to the cytosol, from where it is subsequently 
transported to the nucleus to exert genotoxic activity.  
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